Pharmaceutical powder compressibility - a science-based approach by Gentis, Nicolaos D.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  

  
 
 
Pharmaceutical powder compressibility  
– a science-based approach 
 
 
 
 
Inauguraldissertation 
zur 
Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der 
Philosophisch-Naturwissenschaftlichen Fakultät 
der Universität Basel 
 
 
von 
 
Nicolaos D.Gentis 
 
aus  
      
               Egrigoros (Chios)     Griechenland  
               Oberkulm (AG)         Schweiz 
 
 
 
 
 
 
 
 
 
Basel, 2012 
 2 
 
 
Approval 
 
 
Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät 
auf Antrag von 
Prof. Dr. Matthias Hamburger 
und 
PD Dr. Gabriele Betz 
und 
Prof. Dr. Thierry F. Vandamme 
 
 
Basel, den 21. Februar 2012 
 
 
 
 
        Prof. Dr. Martin Spiess 
        Dekan 
  
 
 
 
 
 
 3 
 
  
 
 
 
 
 
 
 
 
 
 
 
 





Dedicated to my parents 
with love, appreciation and respect
 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Σωκράτης  

 
 
 
 
 
―I know one thing, that I know nothing‖ 
 
Socrates 
c. 469 BC – 399 BC 
 
 
 
 
 
 5 
 
Acknowledgements 
The work for this PhD thesis was carried out in the Industrial Pharmacy Lab, Department of 
Pharmaceutical Sciences, University of Basel and at the facility of Natoli Engineering Inc. in 
Saint Louis, Missouri (USA).  
I would like to express my appreciation and sincere gratefulness to PD Dr. Gabriele Betz for 
giving me the opportunity to do a PhD under her excellent supervision with essential, 
continuous support, guidance and brilliant, positive motivation. 
I would like to thank Prof. Dr. Matthias Hamburger for accepting to be my Faculty 
Responsible and for the support. 
My appreciation goes also to Prof. Dr. Thierry F. Vandamme for accepting to assume the 
co-referencing of this PhD thesis.  
At this point I would like to thank all former Industrial Pharmacy Research Group members 
for the unique support and for the great, crazy working atmosphere in the laboratory.  
Especially I would like to thank Mr. Branko Z. Vranic for his great collaboration and support 
in the research work of project 2 in this thesis. Additionally, I thank Branko for a great support 
in the teaching obligations (Physical Chemistry classes) and for the great friendship.  
A special appreciation goes also to Dr. Felicia Flicker, Dr. Muhanned Saeed  
and Dr. Sameh Abdel-Hamid for their great collaboration and support during the last three 
years. 
During my PhD - internship stay at Natoli Engineering I had the chance meet and to work 
together with numerous great people. Namely, I would like to thank Dale Natoli, Dr. Chuck 
Kettler and his dear wife Julie, Vince and Tammy Natoli, Cammi Grittini, Kim Williams, Dave 
Holleran and my dear friend Stephen Natoli for their big support and for making my time in 
the States to be unforgettable. Also the people outside the company, who supported me a lot 
deserve a big ―Thank you!‖. Namely, Pater Joseph and his son John Strzelecki, John 
Gialouris and Mr. Isidoros Spanos with family for their hospitality. 
 
 6 
 
For me, this chapter of the thesis is really essential, since it gives me the opportunity to thank 
my close family and friends for all their support during the last years and for their company in 
really happy but also in difficult moments of life: 
Mrs. Anna-Ruth Schlapbach for her help and guidance in every up and down of my life,  
my dear ―koumpari‖ Mrs. Iliàs Charlafti, Mr. Polychronis Dimitrakis and of course Mrs. Stella 
Christou, my dear godchildren Andromeda and Eleni Irini for enriching my life, my loved 
godparents Notis and Sevasti Michelis, my cousins Sotiria Tsangeou-Tsichla and Giannis 
Datseris with their families, my dear friend Georgios Nikolaids with family and also family 
Kasapidis for all their support.  
A special word of appreciation goes to my dearest brother Georgios for his company and big 
support through my life and to his family.  
 
The biggest gratitude I have to express to my parents: Thank you for being the most 
wonderful parents one can have and for your support and love throughout my whole life! 
 
          
   
 
 
 
 
 
 
 
 7 
 
 
 
 
Table of Contents 
 
Approval .................................................................................................................................2 
Acknowledgements ................................................................................................................5 
Table of Contents ...................................................................................................................7 
List of Figures ....................................................................................................................... 11 
List of Tables ........................................................................................................................ 13 
List of Original Publications .................................................................................................. 14 
List of Abbreviations ............................................................................................................. 15 
Thesis Abstract .................................................................................................................... 17 
Background ...................................................................................................................... 17 
Objective ........................................................................................................................... 17 
Materials and Methods ...................................................................................................... 17 
Results and Discussion ..................................................................................................... 18 
Conclusion ........................................................................................................................ 18 
Theoretical background ........................................................................................................ 19 
Material ............................................................................................................................. 19 
Cellulose ....................................................................................................................... 19 
Microcrystalline Cellulose: Polymorphism and its influence on the compaction ............. 22 
Paracetamol .................................................................................................................. 23 
Mefenamic acid ............................................................................................................. 25 
Starch ............................................................................................................................ 27 
Calciumhydrogenphosphate .......................................................................................... 30 
Pharmaceutical powder: Analytical investigation ............................................................... 32 
Powder sampling ........................................................................................................... 33 
Pycnometry ................................................................................................................... 34 
Particle size measurement ............................................................................................ 39 
 8 
 
Scientific term ―density‖ ................................................................................................. 41 
Powder compaction ....................................................................................................... 42 
Powder behaviour under pressure and its predictabiliy .................................................. 47 
Instrumented tablet presses .......................................................................................... 57 
Compaction simulators .................................................................................................. 62 
Near-Infrared Spectroscopy .......................................................................................... 68 
Research Project 1: Compressibility of binary powder formulations:                      
Investigation and evaluation with compaction equations....................................................... 75 
Abstract ............................................................................................................................ 75 
Introduction ....................................................................................................................... 76 
Research aim ................................................................................................................... 81 
Theoretical section ............................................................................................................ 82 
Heckel- Plot ................................................................................................................... 82 
Modified Heckel- Plot .................................................................................................... 83 
Leuenberger equation ................................................................................................... 84 
Binary mixtures: compaction properties and percolation theory ..................................... 85 
Materials and Methods ...................................................................................................... 87 
Materials ....................................................................................................................... 87 
True density measurement of pure materials ................................................................. 87 
Density calculation of powder mixtures .......................................................................... 87 
Particle size measurement ............................................................................................ 87 
Design of powder formulations ...................................................................................... 88 
Compaction ................................................................................................................... 88 
Measurement of tablet tensile strength .......................................................................... 89 
Equations and concepts of Physics for the calculation of the outcomes ........................ 89 
Results and discussion ..................................................................................................... 90 
True density and particle size measurement ................................................................. 90 
Compaction force behaviour with increasing drug load .................................................. 90 
Outcomes of Tensile strength measurement ................................................................. 91 
 9 
 
Ejection force measurement .......................................................................................... 92 
Calculation and Evaluation of the technical factors ........................................................ 92 
Compressibility parameters: factor K (Heckel-Plot), factor C (modified Heckel-Plot)     
and factor (Leuenberger equation) .............................................................................. 93 
Factors K and C ............................................................................................................ 95 
Factor  ......................................................................................................................... 96 
Effect of drug load on equation parameters ................................................................... 98 
Critical relative density c ............................................................................................ 100 
Leuenberger equation: tmax  (maximum tensile strength)............................................. 101 
Evaluation of the mathematical equation factors ......................................................... 104 
Conclusion ...................................................................................................................... 106 
Research Project 2: Assessing compressibility and compactibility                                           
of powder formulations  with Near-Infrared Spectroscopy  .................................................. 108 
Abstract .......................................................................................................................... 108 
Context ........................................................................................................................ 108 
Objective ..................................................................................................................... 108 
Materials and Methods ................................................................................................ 108 
Results & Discussion ................................................................................................... 108 
Conclusion .................................................................................................................. 109 
Introduction ..................................................................................................................... 110 
Theoretical section ...................................................................................................... 113 
Aim of the Study .......................................................................................................... 115 
Materials and Methods .................................................................................................... 116 
Materials ..................................................................................................................... 116 
True density measurement .......................................................................................... 118 
Design of binary powder mixtures ............................................................................... 118 
Methods: Calculation of the true density for binary mixtures ........................................ 118 
Partical size distribution ............................................................................................... 119 
Powder compaction ..................................................................................................... 119 
 10 
 
Measurement of tablet tensile strength ........................................................................ 119 
NIR measurements ..................................................................................................... 120 
Model development ..................................................................................................... 121 
Equations and concepts of Physics for the calculation of the outcomes ...................... 122 
Mathematical comparison of the technical factors ....................................................... 122 
Results ........................................................................................................................... 123 
True density of components ........................................................................................ 123 
Particle size measurement .......................................................................................... 123 
Powder compaction: Technical factor outcomes .......................................................... 124 
Powder susceptibility  ................................................................................................ 127 
Near – Infrared Spectroscopy measurement and model development ......................... 129 
Comparison of numerical factors values, measured with traditional                              
and predicted approach ............................................................................................... 134 
Conclusion ...................................................................................................................... 142 
Declaration of interest ................................................................................................. 142 
Overall discussion .............................................................................................................. 143 
Final conclusion and outlook .............................................................................................. 147 
References ......................................................................................................................... 149 
Curriculum vitae ................................................................................................................. 166 
 
 
 
 
 11 
 
List of Figures 
 
Fig. 1: The different types of solid forms (taken from: Hilfiker, et al., 2006) (Sehic, 2008) ..... 21 
Fig. 2: Chemical structure of Mefenamic acid ....................................................................... 27 
Fig. 3: Wadson-type Pycnometer ......................................................................................... 36 
Fig. 4: Pycnometer for constant gas volume methode .......................................................... 36 
Fig. 5:  AccuPyc 1330 (Micromeritics, USA) ......................................................................... 38 
Fig. 6: Schematic view of the AccuPyc 1330 working device ................................................ 38 
Fig. 7: Schematic laser diffraction system  (Malvern) ............................................................ 40 
Fig. 8: Mastersizer X ............................................................................................................ 41 
Fig. 9: Schematic illustration of the different powder densities .............................................. 42 
Fig. 10: Schematic illustration of the compaction process ..................................................... 44 
Fig. 11: Particle association below and above the percolation threshold (TDA) .................... 52 
Fig. 12: Sensor signal conversions in tablet press ................................................................ 58 
Fig. 13: Definiton of Strain (taken from: National Instruments) .............................................. 60 
Fig. 14: Bonded metallic strain gauge (taken from: National Instruments) ............................ 61 
Fig. 15: Linear variable differential transformer for measuring punch displacement .............. 63 
Fig. 16: Schematic view of the Presster instrument .............................................................. 64 
Fig. 17: Presster software: main screen, motor speed adjustment with calculation         
of dwell time and tooling selection ........................................................................................ 65 
Fig. 18: Excel  - sheet of Presster measurement data .......................................................... 66 
Fig. 19: Ejection force and take off force diagram: (1) Ejection force; (2) Take off force; 
(3) Lower punch displacement .............................................................................................. 66 
Fig. 20: Compression data diagram for pressures and displacements:                               
(1) Compression force of upper punch; (2) Compression force of lower punch;             
(3) Upper punch displacement; (4) Lower punch displacement;                                    
(5) Radial die-wall pressure (not monitored in the research projects of this PhD thesis) ....... 67 
Fig. 21: Types of NIR radiation with solid powder systems, in practice,                      
only diffuse transmission and reflection are seen (Saeed, 2011). ......................................... 72 
Fig. 22: Mefenamic acid drug load [%] vs. RCF [N] .............................................................. 91 
Fig. 23: Mefenamic acid / MCC 101: Tensile strength [MPa] vs. drug load [%] ..................... 92 
 12 
 
Fig. 24: Heckel-Plot for the determination of its linear part .................................................... 94 
Fig. 25: parameter values (k, C, ) vs. drug load [%] ............................................................. 95 
Fig. 26: Value differences between drug loads:  factor K, C [MPa -1]                           
and factor  [10-3  MPa -1] vs. drug load [%].......................................................................... 98 
Fig. 27: Critical density critical  vs. drug load [%]: ................................................................. 100 
Fig. 28: maximum tensile strength tmax  [MPa] vs. drug load [%]: ....................................... 102 
Fig. 29: values k and C of investigated formulations: (a) low speed; (b) high speed ........... 127 
Fig. 30: powder susceptibility  : (a) low speed; (b) high speed .......................................... 127 
Fig. 31: Transmittance spectra of MCC 102G tablets with increasing tensile strength 
and relative density ............................................................................................................ 129 
Fig. 32: Calibration and internal validation reference vs. predicted property ....................... 130 
Fig. 33: Spectra of MCC 102G tablets pretreated with normalization by closure; ................ 130 
Fig. 34: The first loading vector of MCC 102G tablet RD prediction model; ........................ 131 
Fig. 35: Spectra of MCC 102G tablets pretreated with Standard Normal Variate         
and Savitsky-Golay first derivative; ..................................................................................... 131 
Fig. 36: The first loading vector of MCC 102G tablet TS prediction model; ......................... 132 
Fig. 37: Comparison of the RMSEP values of the external validation set relative density 
(a) and tensile strength (b) predictions for all the studied formulations;                          
L: low tableting speed, H: high tableting speed. .................................................................. 134 
Fig. 38: low speed batches: values k (a) and C (b) of investigated formulations ................. 136 
Fig. 39: high speed batches: values k (a) and C (b) of investigated formulations ................ 136 
Fig. 40: critical data comparison: (a) low speed batches; (b) high speed batches ................ 136 
Fig. 41: gamma data comparison: (a) low speed batches; (b) high speed batches ............. 137 
Fig. 42: tmax  data comparison: (a) low speed batches; (b) high speed batches ................. 137 
Fig. 43: similarity evaluation of factor k for the investigated formulations ............................ 140 
 
 
 13 
 
List of Tables 
 
Table 1: Bonding mechanism specifications for compacted dry powders (Mueller, 2008) ..... 45 
Table 2: Investigated powder formulations ........................................................................... 88 
Table 3: True density and particle size distribution of components ....................................... 90 
Table 4: drug load regions [%] with higher factor value decrease, ........................................ 99 
Table 5: values of k [MPa-1], C [MPa-1], [10-3 MPa-1] ......................................................... 103 
Table 6: List of investigated powder formulations ............................................................... 116 
Table 7: Deformation mechanisms of investigated powders ............................................... 118 
Table 8: True density of components .................................................................................. 123 
Table 9: Particle size distribution of investigated compounds ............................................. 124 
Table 10: technical factors of the investigated formulations: (a) low speed;                  
(b) high speed .................................................................................................................... 125 
Table 11: Summary of the figures of merit obtained for the relative density                
and tensile strength calibration models ............................................................................... 133 
Table 12: outcomes of factor values by using the traditional (tra) approach                   
or the developed method (pre) for low speed batches ........................................................ 138 
Table 13: outcomes of factor values by using the traditional (tra) approach                   
or the developed method (pre) for high speed batches ....................................................... 139 
Table 14: values of  and for the technical factors ........................................................... 141 
 
 
 
 
 
 14 
 
List of Original Publications 
 
 
This PhD thesis is based on the following publications: 
 
1. Nicolaos D. Gentis, Gabriele Betz. Compressibility of binary powder 
formulations: Investigation and evaluation with compaction equations.  
J Pharm Sci. 2012, 101 (2), S. 777-793  
 
 
2. Nicolaos D. Gentis, Branko Z. Vranic, Gabriele Betz.  
Assessing compressibility and compactibility of powder formulations  
with Near-Infrared Spectroscopy.  
Pharm Dev Technol. under review 
 
 
 
 
 15 
 
List of Abbreviations 
API  Active pharmaceutical ingredient 
BET  surface area measurement method  
(abbr. of the scientists initials Brunauer, Emmett, and Teller) 
CaHPO4 Calcium hydrogen phosphate 
FT  Fourier transformation 
GIT   gastrointestinal tract 
HCl  Hydrogen chloride 
InGaAs Indium-Galium-Arsenide 
IR  Infrared 
JRS  Pharmaceutical company name (JRS Pharma) 
LVDT  Linear variable differential transformer 
MCC   Microcrystalline Cellulose 
NaOH  Sodium hydroxide  
ncl  Normalization by closure 
NIR  Near-Infrared Spectroscopy 
NIRCal Near-Infrared  Spectroscopy software  
NIRWare Near-Infrared  Spectroscopy software 
NSAID  Non-steroidal anti-inflammatory drug 
PC  Personal Computer 
PLS  Partial least square 
PVC  Polyvinyl chloride 
R&D  Research & Development 
SMCC  Silicified microcrystalline cellulose 
 16 
 
SMCC-HD Silicified microcrystalline cellulose with high density 
SNV  Standard normal variate 
UICEL  University of Iowa Cellulose 
UV-VIS Ultraviolet-visible 
 
 
 
 
 
 17 
 
Thesis Abstract 
Background 
The compressibility is a crucial property of powder formulations. For being able to compress 
a powder mixture to tablets with satisfactory pharmacocinetical behaviour, its compressibility 
has to be within a certain range.  
Especially nowadays, where powder formulations for tablets can contain a big number of 
different compounds, a reliable determination and monitoring of the compressibility is very 
important.  
Objective 
Investigation of three methods to determine powder compressibility (Heckel-Plot, modified 
Heckel-Plot, Leuenberger equation) with focus on their scientific reliability and their ability to 
show the influence of small composition adjustments to the compressibility of the formulation.  
Development of a method to determine and monitor powder compressibility and additional 
quality aspects by scanning the final tablet with Near-Infrared Spectroscopy.   
Materials and Methods 
Binary mixtures of poorly compressible API and well-compressible excipient were 
compressed to tablets within a range of relative densities. The compaction pressure, the 
relative density of the tablet and its tensile strength were used to calculate the compressibility 
value of the formulation. In a second step, the API of the formulation was increased to detect 
and investigate the change of the compressibility values.  
An investigation with compaction and analysis of the final compacts was performed with 12 
different powder formulations. Relative density and tensile strength were the main 
investigation targets since these elements are used to establish the powder compressibility 
with the chosen approaches.  
One part of the final compacts was tested for relative density and tensile strength with the 
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traditional method, while another part of the tablet collection was investigated with Near-
Infrared Spectroscopy. These research steps led to a development of a method for 
compressibility determination with Near-Infrared Spectroscopy. 
Results and Discussion 
The results of the investigated binary mixtures showed the values for compressibility to be 
really individual for the three different approaches. Additionally, it could be shown that the 
change of the compressibility value with increase of the poorly-compressible API led to 
individually different changes in compressibility values for the three different plots.  
The developed NIR-method showed really similar results in comparison to the traditional 
method for the compressibility values, calculated with the Heckel-Plot and the modified 
Heckel-Plot. Additionally the values of relative density and tensile strength could be detected 
in a reliable way with the established method.  
Conclusion 
The importance of a reliable compressibility determination and all the challenges associated 
with it could be shown clearly with the research work of this thesis. Especially the sensitivity 
of the chosen method to small variations within the formulation could be identified and 
shown.  
The developed NIR-method showed promising results and underlined its usability for online 
monitoring of the tablet production and of the final compact quality.  
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Theoretical background 
 
Material 
 
Cellulose 
Cellulose (C6H10O5) is a chemical compound consisting of a long-chain polymeric 
polysaccharide of beta-1,4-linked polyanhydroglucopyranose (Sonnenberg, 2008). 
Cellulose is mainly found in the primary cell walls of green plants and some forms of algae. It 
is actually the most common organic compound on Earth. 
A high percentage of the industrially manufactured cellulose originates from cotton and 
several types of wood. Raw cotton contains 85 – 90 % of cellulose while 40-60 % of cellulose 
can be found in wood (Malcolm Brown, et al., 2007).  
For potential use in the pharmaceutical field, Cellulose is usually dispersed in a 17.5 % 
sodium hydroxide solution. While the non-dissolved -cellulose is removed, the white residue 
is washed and mechanically pulverized. The resulting compound of this treatment chain is 
Cellulose powder with low crystallinity and a wide range of polymerization degree (between 
100 and 1300) (Blaschek, 1990; Sullivan, 1997; Mueller, 2008). 
In a further step, a treatment of this Cellulose powder with an HCl-solution (aq) is needed for 
the production of Microcrystalline Cellulose (MCC). This additional treatment leads to a 
partial chemical hydrolysis of the cellulose, which increases its crystallinity and mainly lowers 
the degree of polymerization to around 200-300.   
A lot of different adjustments of this method for the production of Cellulose derivates have 
been developed in the last decades. The result is a big variety of Cellulose and 
Microcrystalline cellulose subtypes (S.Wei et al., 1996). 
Depending on the starting cellulose source and processing variables used during their 
manufacture, the cellulose products vary in physicochemical properties and consequently in 
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their usability as direct compression excipients  (E. Doelker et al., 1987; R.C. Roberts et al., 
1987). 
The country of origin (Landin, et al., 1993), the biological source of the starting material  
(Landin, et al., 1993) and the production method (Parker, et al., 1988) influence crucially the 
quality and properties of the final product. 
A nice example of an innovative production method for cellulose is the choice of a 
mercerization step for the production of so called UICEL (University of Iowa Cellulose). 
Different raw material, like e.g. -cellulose, cotton linter and pulp are treated with a NaOH 
(aq) –solution to produce a gel, which is purified with water and dried. The final compound 
shows lower crystallinity and polymerization degree in comparison to MCC (Kumar, et al., 
2002; Reus-Medina, et al., 2004; Kumar, 2002; Lanz, 2006; Mueller, 2008). The production 
and application of further Cellulose modifications are described in the works of Reus Medina 
and Kumar  (Reus Medina, et al., 2007; Kumar, et al., 2002) and Kumar et al.  (Kumar, et al., 
2002). A basic research focus was set here to the improvement of the binder characteristics 
with keeping the fast disintegration nature of produced tablets. The main approach was the 
cross-link step of Cellulose with glutaraldehyde.  
The described different ways and options for the production of cellulose-based excipients 
show clearly the polymorphic nature of this compound.  
In general, polymorphism is found in excipients and also active pharmaceutical ingredients.  
Polymorphic compounds have the ability to crystallize in different crystalline phases with 
specific molecular arrangements and conformations within the crystal lattice. 
Polymorphs can build different crystalline forms of the same pure chemical compound  
(Sehic, 2008; Grant, 1989). 
Solvates represent a crucial subcategory of polymorphic compounds. They contain an 
amount of a solvent incorporated within the crystal structure. In many cases, the incorporated 
solvent is water. These very important solvates are commonly known as hydrates         
(Grant, 1989).  
Also a non-crystalline – amorphous – form can exist for numerous pharmaceutical solids. 
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Such solids show disordered arrangements of molecules and do not exhibit a crystal lattice. 
Consequently, they have zero crystallinity.  
Since the stabilizing lattice energy is absent for amorphous compounds, the molar enthalpy 
is higher than for the stable crystalline state (Grant, 1989; Sehic, 2008).   
 
Fig. 1: The different types of solid forms (taken from:  (Hilfiker, et al., 2006; Sehic, 2008) 
By taken into consideration the different arrangements of the molecules in the several 
polymorphic forms of a compound, an essential difference in the exhibition of the chemical 
and physical properties can be expected. Actually, such differences are shown on the 
melting point, the chemical reactivity, the dissolution rate, the mechanical properties and 
many other properties.  
For a successful application of a polymorphic powder compound in tablet production, the 
potential differences between the polymorphic forms in the mechanical properties like e.g. 
hardness, tensile strength, compressibility, flowability and blending should be considered.  
For example, the difference in particle size can influence the powder flowability and 
compressibility, whereas the melting point plays an important role in the occurrence of 
sticking and picking during powder compression. 
Mc Crone (McCrone, 1965; Sehic, 2008) stated that every compound has different 
polymorphic forms with the number of known forms for a compound being proportional to the 
money and time spent for research in the field of that compound.  
Since about one third of the organic compounds and approximately 80% of all marketed 
pharmaceutical drugs show polymorphism under experimentally accessible conditions  
(Hilfiker, 2006) and these polymorphic forms can vary a lot on terms of mechanical 
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properties, the choice of the most ideal polymorphic form is crucial for a successful tablet 
production.  
Microcrystalline Cellulose: Polymorphism and its influence 
on the compaction 
In industrial production, Microcrystalline Cellulose is manufactured by acid hydrolysis. An 
essential influence of the conditions during hydrolysis for the particle morphology, the 
molecular weight and the crystallinity of the resulting Microcrystalline Cellulose has been 
reported some researchers in this field (Iida, et al., 1997; Wu, et al., 2001). 
Pesonen and Paronen  (Pesonen, et al., 1990) claimed that the remaining amorphous phase 
of MCC molecules after hydrolysis could have a positive influence on the compressibility of a 
powder, since in their research project the most amorphous cellulose batches showed the 
greatest tendency to both total and plastic deformation. Nevertheless, also the ability of 
agglomerated cellulose powder to fragmentate at small compressional pressure into smaller 
plastically deforming particles was shown to be an additional advance for the tablet 
formation.  
Moisture content and particle size showed to be crucial parameters for the compaction 
nature of MCC (Wu, et al., 2001).  Additionally, the mechanical interlocking between 
irregularly shaped MCC - particles shows to influence in a positive way the compaction step  
(Nyström, et al., 1993). An irregular shape of a particle indicates a bigger surface area, which 
on its part can be seen as bigger area of contact for interfering with other particles during the 
compaction process.  
The ability of microcrystalline cellulose to deform in a plastic way is well reported  (Roberts, 
et al., 1987; Roberts, et al., 1987). 
The presence of slip planes and dislocations on microscale and the ability of the cellulose 
aggregate to deform on macroscale, make microcrystalline cellulose powder extremely 
compressible (Pesonen, et al., 1990).  
The high compressibility of microcrystalline cellulose is a main reason why this material is 
seen as attractive choice for a good powder compact excipient. Nevertheless, 
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microcrystalline cellulose is a main subcategory of cellulose products, containing of a big 
number of different kinds of microcrystalline cellulose (MCC 101L, MCC 102G, UICEL, etc.) 
with varying physical and pharmaceutical properties.  
Therefore, the choice of the most suitable microcrystalline cellulose product should be made 
carefully to prevent undesirable troubles during compaction, disintegration, dissolution or 
final drug effect. 
Paracetamol 
Paracetamol is an analgesic and antipyretic compound, which is used widely for the relief of 
minor pains, headaches and side-symptoms of cold and flu. It is sold over the counter in the 
most countries worldwide.  
Its major advantages over non-steroidal anti-inflammatory drugs (NSAIDs) are the safe 
administration to patients with a history of peptic ulcers or asthma and its crucial lack of 
interference with the function of the platelets  (Hyllested, et al., 2002). The efficacy of oral 
paracetamol for the treatment of acute pain could be confirmed by reviewing systematically 
randomized controlled trials (Perrot, et al., 2004; Toms, et al., 2008).  
1g of Paracetamol achieved a pain release of 50% in one of four patients (Hyllested, et al., 
2002; McNicol, et al., 2011). 
Three polymorphic forms of Paracetamol can be found in the literature (Di Martino, et al., 
1997). In addition to this, several molecular solvates and hydrates have been identified 
(Oswald, et al., 2002; McGregor, et al., 2002). 
The monoclinic form I is the most used and marketed polymorphic form of Paracetamol. 
Back in 1974, Haisa et al.  (Haisa, et al., 1974) could obtain a new crystalline form by 
ethanolic solution. This new form was identified as orthorhombic form (Di Martino, et al., 
1997) and is validated by research works of further scientists  (Al Zoubi, et al., 2002).   
A third polymorphic form (Form III) was recrystallized but was too unstable for further 
investigation of its crystalline structure (Peterson, et al., 2002). 
There is a wide industrial interest to further investigate metastable forms of Paracetamol 
 24 
 
since the commercial form I shows a poor compressibility and needs additional binders to be 
compacted in a commercial tablet.  
Fachaux et al. (Fachaux, et al., 1995) could reach an improvement in compressibility of 
Paracetamol by varying the crystallite habits of the compound. The orthorhombic form II of 
Paracetamol shows slip planes, which allow plastic deformation (Nichols, et al., 1998). 
Nevertheless, this process step has a main challenge: The elimination of solvent residues 
(Beyer, et al., 2001). 
In the current available literature, there are several methods reported for the crystallization of 
orthorhombic paracetamol from solution (Kachrimanis, et al., 2008). Some of them can even 
be implemented for industrial use. Seeding of ethanol solutions with melt-grown form II 
crystals (Nichols, et al., 1998) and high-pressure crystallization (Fabbiani, et al., 2004) are 
just two of the numerous recommended ways. 
Up to date, the only reproducible method is the seeding technique (Kachrimanis, et al., 2008; 
Nichols, et al., 1998). The extensive study (Al Zoubi, et al., 2002; Al Zoubi, et al., 2002; Al 
Zoubi, et al., 2003) of this method showed the harvesting and drying process steps to be 
very critical for affecting polymorphic purity. The main reason is the induction of 
transformation to form I after prolonged contact with the solvent. 
A basic issue and challenge for the use of orthorhombic paracetamol is the long-term 
polymorphic stability of the crystals. Concerning this, conflicting data can be found in the 
literature (Kachrimanis, et al., 2008). In dependence of the used method, the produced 
orthorhombic crystals show different stability. Crystals obtained from ethanol solutions show 
to be stable at dry atmosphere, when their moisture content is properly low, while crystals 
from water solutions have been reported to transform easy to form I in all the range of 
investigated storage conditions (Kachrimanis, et al., 2008; Nichols, et al., 1998). Quiet stable 
orthorhombic paracetamol crystals were obtained by melt crystallization (Di Martino, et al., 
1996). Without special storage conditions they showed a satisfying stability over 11 months.  
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Even though, the industrial importance of the orthorhombic form of Paracetamol is very 
essential, there are crucial scaling up problems in combination with the controversial data 
outcomes concerning the transformation to form I during storage or compaction which make 
this form not to be ready yet for industrial production. 
Paracetamol is often used in scientific research projects as model drug with a main property 
being its low compressibility and brittle deformation mechanism. A main challenge is the 
combination of Paracetamol with excipients, to design a well-compressible formulation with 
satisfying pharmacocinetical and pharmacodynamical properties. 
Mefenamic acid 
N-(2,3-xylyl)anthranilic acid, also known as mefenamic acid, is a non-steroidal anti-
inflammatory drug (NSAID) which is used often for treating pain of dysmenorrhoea as well as 
mild up to moderate pain (including toothache, headache and postoperative pain) (Moll, et 
al., 2011). Similar to other NSAIDS, mefenamic acid shows analgesic, anti-inflammatory and 
antipyretic activities. It inhibits the prostaglandin synthetase, which is responsible for the 
synthesis of prostaglandins and leads that way to its pharmacological effect. 
Prostaglandins show numerous physiological functions in the human body such as the 
regulation of the renal blood flow and the maintenance of gastricomucosal barrier (Hawkey, 
et al., 1998). Since prostaglandins have an important role in nociceptive and inflammatory 
processes, the inhibition of their production can lead to the pharmacological effect of the 
NSAIDs. It has to be underlined, that the amount of knowledge concerning additional 
mechanisms of action of NSAIDs beside the described one is very little.  
The pharmacokinetic behaviour of mefenamic acid shows a rapid absorption after oral 
administration and its half-life is of about two hours (Moll, et al., 2011).  
From a pharmacokinetic perspective it shows a poor solubility in water and aqueous media 
(Romero, et al., 1999). On the basis of the biopharmaceutical classification system (Amidon, 
et al., 1995) it is classified as class II  (Kimura, et al., 2007).  
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Mefenamic acid powder is not easy to be handled for compaction since it has a high 
tendency to stick to any kind of surface  (Adam, et al., 2000). The powder formulation for 
mefenamic acid tablets is usually developed as a high-dose immediate release formulation 
with active drug content of 500 mg and higher (Adam, et al., 2000). Having such a starting 
position in powder formulation development the choice of a granulation step before final 
compaction can be seen as warmly recommended.  
Also mefenamic acid, like many other pharmaceutical compounds, show some polymorphism 
and can have an essential batch – to – batch deviation in basic properties (Romero, et al., 
1999). Therefore, if numerous different batches are used for commercial tablet production or 
research studies, the similarity of the powder properties between the batches should be 
verified.   
The different polymorphic forms and the variation in crystallinity of mefenamic acid can also 
influence the dissolution behaviour of the compound. Aguiar and Zelmer  (Aguiar, et al., 
1969) evaluated the dissolution behaviour of different polymorphic forms. A variation in 
solubility and even a convertion between the polymorphic forms during dissolution could be 
shown.  
The crystal habit of mefenamic acid can also affect its compressibility. Halelian (Halelian, 
1975) underlined in his research work, that the compressibility and the problematic nature of 
mefenamic acid powders with different crystal habit can vary significantly, even when the 
melting point and the X-ray pattern between the formulations is similar. 
For the research work of this PhD – thesis, a mefenamic acid powder with really poor 
compressibility and a really high tendency for sticking was chosen. In the designed powder 
formulations the mefenamic acid was mainly playing the role of a brittle, poorly compressible 
compound, being mixed with a well-compressible, plastic excipient (microcrystalline 
cellulose). 
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Fig. 2: Chemical structure of Mefenamic acid 
Starch  
Starch is a carbohydrate, belonging to the group of the so-called polysaccharides. The term 
polysaccharide has a greek origin and is an assembled word of the expressions poly (greek: 
many) and saccharide (derived from the greek word sugar) referring to the 
structure of polysaccharides, being a chain of carbohydrate or sugar groups. 
Starch consists of two principal components, which are both polymers of glucose: 
Amylopectin, a highly branched molecule and amylose, which has an essentially linear 
molecular structure (Ellis, et al., 1998). Starch usually occurs as granules in the chloroplasts 
of green leaves and in the amyloplasts of storage organs, like for example seeds or tubers  
(Preiss, J, 2004).  
Much has been written during the last decades concerning the structure of starch, its 
properties and its biosynthesis (Tester, et al., 2004).  The level of analytical understanding of 
the starch structure development and how functional properties are connected with it is quiet 
evident from the developing literature base. With the available molecular biology tools the 
process of starch biosynthesis with all its subcategories, numerous cascades and processes 
involved could be explored in depth (Tester, et al., 2004). 
The amyloplasts in starch is deposited over a period of days or weeks and stored till the 
germination of the seeds and the sprouting of tubers arrives, where this amyloplast is re-
mobilised. On the other hand, a rapid turnover of starch can be found in chloroplasts       
(Ellis, et al., 1998). 
Being an ingredient of many natural and processed food products, starch is the most 
important carbohydrate source in human nutrition (Belitz, et al., 2009). Starch and its 
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derivatives are also products of choice for a lot of different industries, e.g. the textile and 
paper industry.  
Starches play an important role as excipients in tablet manufacturing. They are used as filler, 
disintegrating agent and as a binder in form of starch paste during moist granulation 
(Muzikova, et al., 2011). Even though natural starches show good compacting properties, the 
bad powder flowability in combination with a high lubricant sensitivity leads to a low choice 
attractivity of natural starches for powder formulation design, since they are not suitable to 
serve as dry binders for direct compression. The compressibility of starches depends 
strongly on the air humidity of the storage environment (Muzikova, et al., 2011). Absorbed 
water inside starch particles can influence significantly properties of a compact by changing 
its viscoelasticity  (Malamataris, et al., 1993; Muzikova, et al., 2011). This can have also an 
impact on the sensitivity of starch powder to lubricants, which should in general never be 
neglected.  
An increased attention has been given by pharmaceutical researches to the extraction, 
development and potential use of different starch in powder dosage forms  (Alebiowu, et al., 
2002). For improving the usability of starches in powder formulations for tablet production a 
wide range of modified starches have been developed by chemical treatment. These steps 
have lead to starch being the most commonly employed adjuvant in tablet formulations in the 
beginning of the 1990s (Garr, et al., 1991). 
Pregelatinization and granulation are two of two most prominent methods for receiving starch 
products with satisfying compaction properties.  
Granulation of rice starch could show improved flowing properties but this improvement could 
not be reached with other starches (Muzikova, et al., 2011). On the other hand, 
pregelatinization is applied to increase the densification tendency of starch particles during 
matrix filing and at low compression forces. Additionally, the tendency to deform plastically 
after application of a compression force is increased (Alebiowu, et al., 2002). 
During the gelatinization process, the intermolecular bonds of starch molecules are broken 
down. By using heat and water, the chemical active side-groups of the starch start to interact 
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with the water-molecules, which leads to a final dissolvation of the starch granule  (Donald, 
2004). The crystallinity of the particle changes essentially. More and more amorphous forms 
are build up and a swelling effect can be noticed. The viscosity of the liquid mixture increases 
and the rheology is changed essentially. This effect is also used in cooking and pastry 
science, e.g. for preparation of thick liquids and sweet desserts. 
After drying, a huge variety of powder products can be reached out of this gelatinization 
products. Some of them show good flow and compaction properties.  
Starch 1500 is one of those attractive pregelatinized starch products. Is is widely regarded as 
next choice excipient after lactose and microcrystalline cellulose (Jivraj, et al., 2000). Starch 
1500 was designed with aim to have higher compressibility and flowability. It appears as 
odourless, white to off-white powder of moderately coarse-to-fine nature. A distinctive taste 
of the powder has been reported  (Wade, et al., 1994).   
For receiving a Starch 1500 with good compaction quality, some of the hydrogen bondings 
between amylose and amlopection have to be ruptured partially so that the final product will 
contain about 80% of unmodified starch, 5% of free amylose and 15% of amylopectin  (Jivraj, 
et al., 2000). The free amylopectin is mainly responsible for the cold water solubility and the 
desired binding properties of the excipient, while the free amylose is mainly responsible for 
the positive disintegration properties  (Bolhuis, et al., 2006). 
A main property of Starch 1500 is its extreme sensitivity to alkaline stearate lubricants, 
mainly because of a tablet softening effect by this interaction (Shangraw, et al., 1981). A 
reliable way to prevent this interaction is to avoid the use of magnesium stearate for powder 
formulations with Starch 1500 or to keep the concentration level below 0.5% (m/m). Higher 
concentrations may influence the tablet strength and dissolution in a negative way  (Bolhuis, 
et al., 1973; Jivraj, et al., 2000). Therefore, stearic acid is usually the chosen lubricant with 
pregelatinized starch.  
Even though, starch showed very attractive properties to be used as disintegrant, friablity 
problems could occur in a long-term. Additionally, at higher compression forces, the 
mechanism of deformation takes place in an elastic way, which lead to a high elastic 
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recovery during ejection. With high percentages of elastic recovery, tablet capping can be 
induced  (Rees, et al., 1978; Jivraj, et al., 2000). 
Nevertheless, the attractivity of Starch 1500 as filler and tablet excipient is indisputable, since 
a high percentage of marketed tablet products contain Starch 1500 as part of the total 
formulation mixture. 
Calciumhydrogenphosphate  
Calcium phosphates, like e.g. dibasic calcium phosphate or calcium hydrogen phosphate 
have gained importance in pharmaceutical and nutritional formulations (Carstensen, et al., 
1990). The reason for this gain in importance can be found in their high calcium content, 
which makes these compound really attractive for dietary supplements and in their low 
manufacturing cost. By using skillful manufacture techniques, also satisfying flow and 
compressibility characteristics can be reached.  
The chemical nomenclature of Calciumhydrogenphosphate is CaHPO4. There are numerous 
synonymes for this chemical compound like Calciumhydrogenphosphate, Anhydrous dibasic 
calcium phosphate, Calcium monohydrogen phosphate and Dicalcium orthophosphate (JRS 
Pharma, 1995). Commercial brands of this compound are A-Tab (Sanofi-Aventis,France), 
Dicaphos (Budenheim, Germany) and Emcompress anhydrous (JRS Pharma,Germany).  
In our research project, Emcompress anhydrous was used for compaction experiments with 
the Presster-simulator. 
JRS Pharma markets basically two compounds for their Emcompress branch:  
Emcompress (Calciumhydrogenphosphate dihydrate) and Emcompress anhydrous  
(Calciumhydrogenphosphate) (Joshi, et al., 2003). Both compounds are used in solid dosage 
forms as tablet binder, for enhancing formulation flow or as a capsule diluent  (JRS Pharma, 
1995). The excellent flow properties and deformation characteristics make the Emcompress 
products to be an excellent choice for solid powder formulations.  
The deformation mechanism of Emcompress and Emcompress anhydrous is a brittle particle 
fraction, where the compound particles fragment into smaller particles  (JRS Pharma, 1995). 
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This way, less lubricant surface is exposed to the particles what improves the tablet binding. 
It was shown  (JRS Pharma, 1995) that Magnesium Stearate has almost no influence on the 
hardness and dissolution times of powder formulations with Emcompress and Emcompress 
anhydrous.   
The compaction behaviour of Calciumhydrogenphosphate showed also that its low capping 
tendency and also a reduced sensitivity to compaction speed. In some ways a similar 
compaction behaviour to lactose was observed, which makes it an attractive solution for 
powder formulations being applied to patients with  lactose intolerance  (JRS Pharma, 1995). 
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Pharmaceutical powder: Analytical investigation  
Powder is a bulky material consisting of a larger number of fine particles. This type of 
material shows a unique and very interesting behaviour. The question raises, in what state of 
matter a powder can be categorized. On a first sight, powder is assumed to be a solid 
material. Even though, the powder particles themselves are small units of solid material, a 
pile of these particles together show some behaviour elements, which are non-typical for a 
solid body.  
In the PhD – Thesis of Michael Lanz  (Lanz, 2006), powder was described as 4th state of 
matter, since it shows some behaviour as solid (reversibel and irreversibel deformation), 
some as liquid (flowing abilities) and some gaseous behaviour (extend compressibility). 
In a further step, the attempt was made to compare the nature of a single particle with the 
natural behaviour of a molecule in a liquid or gaseous environment. This attempt failed due 
to two reasons: i.) No random Brownian movements are shown by powder particles ii.) the 
thermal energy can be neglected, since powder particles show a significant potential energy, 
due to their much higher mass in comparison to single chemical molecules.  
The biggest part of the pharmaceutical raw materials are available in form of powders. This 
fact underlines the importance of this material form for the pharmaceutical industry. 
Even though, a lot of scientific research work has been performed in the field of 
pharmaceutical powder technology in the last decades, the daily implementation and 
handling of powders in industry and academia is still executed in a way, which can be 
considered more as an art than a science  (Leuenberger, et al., 2002). 
Bringing the powder technology from a level of handling and operating experience to Science 
still remains a big challenge, basically due to two reasons: 1. A powder formulation is a really 
complex system, which is influenced by a big number of parameters, 2. The large amount of 
poorly understood processes in tablet manufacturing. Still today, the development of a 
powder formulation is based on traditional ―trial and error‖ experiments, which then results 
often in a non-robust final tablet product (Lanz, 2006). Developing a robust powder 
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formulation by application of a wide range of scientific knowledge is able to reduce the R&D 
costs in a crucial way.   
Even though, many concepts, like e.g. percolation theory, force-distance compaction curves 
and dissolution formulas are already at our disposal, there is still a long road for us to walk to 
reach the stage of a completely science based pharmaceutical powder technology. 
Powder sampling (Allen, 2003; Lohr, 2010) 
If a powder batch consist of a big amount of powder, just a small part of it can be 
characterized in a physical and chemical way, basically because of logistic reasons. A 
complete characterization of a big powder quantity can not be performed in its entirety. 
Therefore, a collection of smaller powder amounts is performed for receiving a representative 
sample assortment of the total powder bulk.  
This can be seen as the big challenge of the whole powder analysis concept: When a 
powder is analyzed with focus on chemical or physical aspects, the quality of the final results 
depend crucially on the representativeness of the chosen bulk samples. When a sample of a 
few miligrams is taken from a bulk of several tonnes, the chances of having chosen a non-
representative sample is really considerable.  
The total error of a result in sample analysis can be seen as a combination of the primar 
sample choice and the analysis itself. Usually a non-ideal sampling shows analysis results 
which differ significantly between the single samples taken, expressed by a high standard 
deviation of the final analysis results.  
Segregation is a common problem in powder technology because it can generate a high 
quality deviation between powder fractions within the same bulk batch. This phenomenon 
can be minimized by a suitable mixing of the powder and by taking a representative number 
of increments for analysis from the bulk material. 
Statistical errors are the second main factor for analysis deviations in sampling. This factor is 
difficult to be prevented since even in an ideal mixture the quantitative distribution of the 
particles within the samples is seen as subject to random fluctuations. 
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Pycnometry 
An important factor in the field of solid dosage forms for the scientific investigation of powder 
formulations is a correct qualitative determination of the involved powder particles and their 
dimensions. The dimension measurement of a material with simple geometry can be 
performed really easy (Myers, 2006). However, the measurement of a particle volume with 
an irregular shape is challenging.  
Powder usually consists of a high number of small solid particles with an irregular shape and 
in many cases the presence of open and closed pores further complicates the scientific 
measurement of its dimensions values (specific surface, true density, etc.).  
Archimedes of Syracuse (greek: 287 B.C. – 212 B.C.) faced such a problem with 
the crown of King Hiero II (Boudon, 2002). The king of Syracusa requested the help of 
Archimedes in resolving a problem: According to Marcus Vitruvius Pollio, an arbitrarily 
shaped crown was made by a goldsmith from pure gold. The raw gold was supplied for this 
reason by King Hiero himself. However, the suspicion was in the air that the goldsmith 
worked in a dishonest way, substituting an amount of gold with cheaper silver.  
Archimedes from his side had to determine if the crown consisted of pure gold or not. An 
easy solution for this problem would have been the melting of the crown into a regularly 
shaped form with following classical density measurement over the dimensions of the form  
(Angelo, et al., 2008). But Archmiedes had to act scientifically without causing any damage 
to the artfully made crown. While at the local baths, upon immersing himself into the bathtub, 
Archimedes could see how the tub water overflowed. This phenomenon led to the solution of 
the big problem. Archimedes could put a mass of gold equal to the mass off the crown into a 
container filled to the top with water. The amount of overflow from this teld could then be 
compared to the amount of water being overflown by placing the crown in the container. An 
equal amount of overflowing water with the two methods would allow Archimedes to 
conclude that the crown was made with pure gold. A smaller water amount overflowing with 
the placing of the crown in the container in comparison to the calibrated gold mass would 
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proof the unpure nature of the crown metal (Myers, 2006). With this applied method, the 
density of the crown was determined in an indirect way, by dividing the mass of the crown by 
the volume of the displaced water. In a following step the density of the crown could be 
compared with the density of pure gold.  
Archimedes was so happy and excited about his genious idea, that forgotten to get dressed, 
he started running through the streets naked and shouting Eureka! (greek: ‖I have 
found it!‖). At the end, the test was performed in a successful way, proving the existence of 
silver in the metal alloy of the crown (Hidetaka, 2010).  
The principle applied by Archimedes is still today known as Law of Buoyancy and is a basic 
element in pycnometry. The technique of pycnometry is very appropriate for nonporous and 
porous objects. The displaced medium may be a gas, a liquid or even a fine powder for 
bigger macroscopic objects.  
The pycnometry method with a liquid displaced medium can be applied with a Wadon-type 
pycnometer, as seen in Fig. 3 (Kousaka, et al., 2006). This vessel has a constant volume. As 
first step, the different numbers of involved masses and factors have to be calculated and 
defined, namely the mass of the empty pycnometer m0, the mass of the pycnometer 
containing liquid ml, the mass of the pycnometer including sample particles msl and the 
density of the applied liquid l. With these factors, the density of the particles can be 
calculated with the following equation 1: 
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Equation 1  
  
The right choice of liquid is very important since the particles should be wetted and 
completely unsoluted.  
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Fig. 3: Wadson-type Pycnometer 
Another really usual measurement method for the true density of a powder is the constant 
gas voulme method. The basic principle of this method is shown in Fig 4. 
 
Fig. 4: Pycnometer for constant gas volume methode 
 In a first step, the volume and pressure values of the empty vessel are calbirated by moving 
the piston from position A to B and the changes in pressure and volume are measured as 
follows:  
laa PPP
VvV

 0
 
Equation 2   
 
Where V is the volume of the vessel between position B and the bottom, and v0 is the vessel 
volume between the positions A and B.  
The Boyle-Marriotte law states that for a fixed amount of ideal gas at constant temperature 
the pressure and the volume show an inverse proportionality to each other  (Windisch, 2008). 
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For the described pycnometry instrument, this law can be expressed mathematically as 
follows: 
VPPvVP laa  )()( 0  
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Equation 3   
 
When a known weight of powder sample is added into the vessel, the above described 
procedure is repeated. This way, the change in volume and pressure can be expressed as 
ss VVVvV  0    2PPP aa    
Equation 4   
 
The following equation can be formed by using this approach 
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For calculating the desired final particle volume Vs of the added powder sample, the 
following equation can be used, which was formed by using the already mentioned 
equations: 
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In the research projects of this PhD – thesis, the gas displacement method was used to 
measure the volume in an accurately way. The investigation was performed with a AccuPyc 
1330 apparatus, as seen is the following Fig. 5. 
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Fig. 5:  AccuPyc 1330 (Micromeritics, USA) 
The gas displacement method is a real advancement of the described constant gas volume 
method. Helium, as inert gas is used as the displacement medium. A powder sample is 
added in an instrument vessel of known volume. The vessel is sealed and helium is admitted 
before expanding into another precise internal volume.  The vessel pressure before and after 
expansion is measured and the sample volume determined. By simply dividing the known 
sample mass by the measured sample volume, the gas displacement density (seen as true 
density) of the powder sample can be calculated (Micromeritics, 2011). 
A schematic view of the working principles for the AccuPyc 1330 can be seen on the 
following figure.  
Fig. 6: Schematic view of the AccuPyc 1330 working device 
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The scheme shows the different parts of the pycnometer, where 1 is the helium gas tank, 2 is 
the fill valve, 3 is the sample chamber cap, 4 is the sample chamber, 5 is the sample 
chamber pressure transducer, 6 is the equilibration valve, 7 is the reference chamber 
pressure transducer, 8 and 9 are the internal reference chamber and 10 is the vent valve  
(Hintz, et al., 2009). 
Particle size measurement 
The size and shape of the investigated particles play an important in compaction studies 
since they affect directly the quality of the compaction process and the final tablet.  
Therefore, an appropriate analysis of the particle size distribution of the powder compounds 
is crucial for the understanding of the powder behaviour under punch pressure  (Thomas, et 
al., 1993).  
There are numerous techniques available for the particle size measurement of a powder 
batch. Sieving, BET surface area measurement, electrozone sensing, sedimentation, 
aerodynamic techniques, image analysis are an assortment of the available methods for the 
particle size investigation. 
Since the beginning of the 21st century, optical instruments based on the measurement of 
laser light scattered by particles in forward direction have become a standard and very 
popular technique for laboratory applications in powder characterization and analysis.  
The use of the diffraction theory to accurately approximate the scattered light made this class 
of analysis devices to be named as ―laser diffraction instruments‖. 
By comparison to other techniques for the determination of powder particle size, laser -
diffraction shows advantages in term of good reliability, a high reproducibility and very high 
measurement speed with included detailed analysis (Ma, et al., 2000).  
The scientist Mie investigated back in 1908 the behaviour of light waves on spherical 
particles. Mie formulated a theory which describes the scattering of a plane wave of light on 
spheres  (van de Hulst, 1969). This theory is used to predict the electromagnetic field in 
space.  
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Lets take a light source which strikes a particle which is much larger than the wavelength of 
the incident light. By assuming the refractive index of the particle being much different from 
the surrounding medium, the biggest part of the light can be expected to scatter in the 
forward direction at small angles relative to the direction of the incident beam.  
By taking into consideration the Fraunhofer diffraction theory, the scattering phenomena can 
be described for most applications  (Ma, et al., 2000; Hecht, 1987). In a further step, this 
forward scattering pattern which is produced by any particle can be numerically calculated 
with Fourier transformation algorithms on a PC.  
This subject contains a lot of detailed mathematical approaches and calculations. For not 
going into further details, we simply can keep in mind that the observed scattering angle of 
the light increases logarithmically with linear decrease of the investigated particle size. Also 
the observed scattering intensity depends on the particle size. The intensity value diminishes 
in relation to the particle cross-sectional area.  
The measurement system usually consists of  
(I) A laser source, which provides a coherent, intense light (fixed wavelength) 
(II) A handling system, which is responsible for providing the laser beam with the powder 
under investigation as a homogenous particle stream 
(III) Detectos for the reliable light pattern measurement 
The following Fig. 7 shows the schematic organization of the laser diffraction system.  
 
Fig. 7: Schematic laser diffraction system  (Malvern) 
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The Mastersizer X was used for the particle size distribution investigation of this thesis. An 
example of this instrument can be seen on the following Fig. 8. 
 
Fig. 8: Mastersizer X 
Scientific term “density” (Litster, et al., 2004; Mueller, 2008) 
The density of a powder formulation or a compressed tablet is a very important parameter for 
the understanding of the compound’s behaviour during flowing, mixing, granulation, 
compaction, etc.  
For solid bodies, the classic term ―density‖ is known as mass divided by its volume, giving us 
a precise number for every object. Also in liquids and gases, the density can be measured 
and calculated. Since the behaviour of a powder shows similarities to a solid body (force 
resistance, elasticity, plastic deformation, etc.), to a liquid (e.g. flowing nature) and also 
shows similarities to a gas (certain compressibility), the term density needs some further 
developed and explained here.  
i. Bulk density (bulk) : This term is related to the volume which is occupied by the total 
bulk, including the void space. 
ii. Apparent particle density (ap): This term is related to a single particle and precisely to 
the volume it occupies, including the internal porosity 
iii. True density (true): this terms refers to the true solid density of the investigated 
material. 
The following Figure 9 illustrates the terms in a schematic way. 
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Fig. 9: Schematic illustration of the different powder densities 
For compacts, we know mainly the apparent density app and the relative density r.  
The apparent density app is defined as the density of the tablet including all pores and is 
calculated from the mass, the height and the radius of the compact. With the true density true 
(see paragraph above) we can calculate the relative density r. 
 
 
 
Equation  7 
where m is the compact mass and r is the compact radius. 
The factor relative density is also used for determining the porosity of a compact, since the 
porosity  is calculated with the following equation, having as main calculation factor the 
relative density r: 
 
Equation  8
Powder compaction 
Powder compaction is the conversion of a loose powder bed into a solid, compact body with 
usually a defined strength and shape. The success of a compaction is mainly dependent on 
four factors: The formulation, the tablet design, the compaction tooling and the chosen 
tableting process parameters.  
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The secret of successful industrial tablet manufacturing is mainly based on a wide scientific 
background knowledge and manufacturing experience of the staff involved in the set up of 
the process.  
Since there is a big range of possible set up for every single of the above mentioned factors, 
the challenge is usually to choose correctly the levels of the numerous involved parameters. 
The powder formulation itself should show a satisfactory compaction behavior, usually 
expressed as the powder compressibility and compactibility.  
Compressibility is defined as the ability of a powder to decrease in volume under pressure, 
while compactibility is seen as the ability of a powder to be compressed into a tablet of 
specific strength (Leuenberger, 1982). 
The raw formulation for tablet compaction is usually a granulation or a directly compressible 
powder formulation. The advantage of a directly compressible formulation is mainly the 
smaller number of production steps, which is connected to a smaller need for equipment, 
infrastructure, time and money. 
On the other hand, the compaction of directly compressible shows also some limitations, 
since not all the powders have the necessary plastic deformation nature and also the mixture 
itself does not show always a stably compounds proportion for bigger batch volumes. 
Another important factor in tablet production are the total production costs. Well –
compressible excipients are mostly expensive (Bolhuis, et al., 1996) while an introduction of 
a granulation step increases the production costs just slightly.   
For producing tablets with satisfying properties, a chosen amount of a powder mixture or a 
granulation is usually filled in a matrice die of a tablet press. Then, a certain external force is 
applied by two punches (usually in a vertical way by upper and lower punch) for a defined 
time. After the force application, the produced tablet is ejected from the die by the lower 
punch and finally collected in a specific collection place of the tablet press.  
The powder compaction process itself can be devided into four sequential steps (Rudnic, et 
al., 2005). 
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In a first phase, the applied force leads to an overcome of the friction between the powder 
particles. A first densification (packing) of the powder bed is reached by reduction of the 
apparent volume due to the interparticulate friction. In the second phase, the first physical 
force columns, chemical and physical particle bridges and reorganization of the particle 
molecules takes place. This leads to a first resistance of the powder bed to the applied force. 
The further application of an increased force leads to particle deformation, usually first in a 
reversible elastic manner followed by an irreversible plastic deformation or brittle fracture. 
This plastic and elastic powder behaviour is really dependant on the powder formulation and 
the nature (dwell time, punch shape, etc.) of the applied force.  
In the last phase of the compaction process, a stable tablet is usually built, whose nature and 
properties depend also much on the different process and formulation parameters.  
The described phases of the compaction process are shown as a schematic diagram of the 
powder bed / compact volume in dependence of the applied compaction force in the 
following Figure 10. 
 
Fig. 10: Schematic illustration of the compaction process 
 
For a better understanding of the compaction process, the general bonding mechanisms 
between the powder particles and the involved molecules have to be focused and taken into 
consideration.  
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The main involved bonding mechanisms are the following (Rumpf, 1958; Mueller, 2008): 
 Molecular and electrostatical particle attraction forces 
 Solid bridges (due to sintering, crystallization, melting, hardened binders and 
chemical reactions 
 Movable liquid bonding (capillary forces and surface tension forces) 
 Non freely movable binder bridges (adsorption layers, viscous binders) 
 Mechanical interlocking (shape-related particle bonding) 
In the research work of Fuehrer (Fuehrer, 1977; Mueller, 2008), the three main bonding 
mechanisms of a dry powder compaction were extracted. The following Table 1 lists further 
these mechanisms with corresponding dissociation energies and maximum attraction 
distances. 
Table 1: Bonding mechanism specifications for compacted dry powders (Mueller, 2008) 
 
 
The intermolecular forces cover the different physical forces acting between different 
molecular surfaces over a small distance. Namely the van der Waals forces, the electrostatic 
forces and the hydrogen bondings are considered in this term.  
Nyström et al. (Nyström, et al., 1993; Mueller, 2008) mainly focus on these intermolecular 
forces, describing them as being mainly responsible for the dominating bonding mechanism 
for pharmaceutical powder formulations. 
The solid bridges between particles are seen as the areas of real contact at an atomic level. 
In comparison to the mentioned intermolecular bondings, the maximum attraction distance is 
much smaller for these bridges. 
The mechanical interlocking between powder particles describes the twisting and hooking of 
the particles within the powder bed. This bonding mechanism can occur only when the 
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powder particle are in direct contact. 
The exact nature and strength of the different involved bonding mechanisms are really 
individual for every different powder formulation. For producing tablets with a specific 
behaviour, e.g. during disintegration in the GIT, the predetermination and knowledge of these 
involved mechanisms for the handled formulation can be really important.  
The microscopic influence of interaction between particles on the mechanical properties of 
particulate systems is described and evaluated in a detailed way in the research works of 
Forsyth et al. (Forsyth, et al., 2000) and Thornton et al.  (Thornton, et al., 1998). Forsyth et 
al. focus especially on the van der Waals forces, since they are considered as the dominant 
interaction for dry particles.  
The main understanding of these forces is crucial for many applications in industrial 
production of pharmaceutical dosage forms. For example, in challenges concerning powder 
mixing and flowability, the interaction nature between the powder particles become really 
crucial.  
Also particle deformability influences a lot the nature of the interparticle van der Waals 
forces. During compression, soft particles undergo plastic deformation, which results in an 
increase of the van der Waals forces between the particles or between the particle and the 
die wall. Additionally, the high number of irregularly shaped particles with a high variation of 
particle size makes the scientific understanding of particle behaviour very tricky.   
In general, the behaviour of interparticle forces is still far away from being well understood 
and an underestimation of these forces can have disastrous effects in powder technology.  
The surface areas of the particles in intimidate contact as results of interparticulate bonds are 
referred as true areas of contact. To characterize the mechanical behaviour of compacts, a 
relationship between true contact area and the mechanical properties is attempted. The true 
contact area is difficult to be measured in real tablets. Therefore the approach through the 
relative density is used as indirect method to measure the contact area (Holman, et al., 
1991). 
Because of all the mentioned challenges in investigation of the particle behaviour on a 
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microscopic level in addition with the low number of particles taken into consideration, the 
focus has to be set on investigation made on a macroscopic level. 
Powder behaviour under pressure and its predictabiliy  
The behaviour prediction of a powder formulation after application of a compaction force is a 
main aim and challenge for the industrial tablet production. In the last decades, multiple 
predictive techniques have been developed what may benefits in reducing development time 
and research material. The focus on prediction techniques for the properties of solid dosage 
forms can be divided into three categories: Mechanical properties of raw material, 
physicochemical properties of raw material and process monitoring. Hardy et al. provides a 
detailed overview about the actual predictive and correlative techniques (Hardy, et al., 2003).  
A model, or even a suitable fit of available data to a freshly designed multi-component 
powder formulation would be very valuable and appreciated to increase the efficiency of 
formulation design and so to reduce the number of time-consuming experiments.  
The mechanisms and phenomena of the powder compaction have been the subject of 
numerous research investigations during the last six decades. There has been a wide 
variation of the compaction parameters and the used equipment (Celik, et al., 1989).  
Today the number of mathematical equations proposed to characterize the compression is 
very high and many of them have been shown to have applicability only for a limited range of 
applied force and only for a limited number of materials. M. Celik gives a detailed and clear 
overview of the several data techniques (Celik, 1992). 
Kolarik (Kolarik, 1994) proposes a model to predict the yield strength of binary blends of 
thermoplastics on the basis of the phase continuity acquired from the Hill model for the 
elastic properties of systems with two components. This model takes into consideration the 
bicontinuous structure of a binary mixture. With this model, van Veen et al. (van Veen, et al., 
2004) developed a structure-dependent fit for a prediction of mechanical properties by taking 
into consideration the properties of the single materials and an interval of mixtures in which 
both components form a continuous structure in the compact. The developed equations 
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show a high validity for the investigated compounds (Sodium chloride and potato starch) but 
further enhancement with additional compounds and condition would be necessary to 
investigate the validity of this method for a global use. 
Mechanical strength 
The mechanical strength is a very important tablet property since it is responsible for many 
pharmacokinetical and pharmacodynamical behaviour of the resulting compact.  
Tensile strength can be seen as one of the most important parameters for characterising the 
mechanical behaviour of tablets, as the compact must possess a minimum mechanical 
strength to substain potential loading during processing and handling (Wu, et al., 2005). 
Belda et al. (Belda, et al., 2006) investigated the crushing strength of binary mixtures with 
adjusting the weight fraction of the components. They could observe a lowering of the tensile 
strength for non-extreme weight fractions. It was shown that a linear change of the crushing 
strength in dependence on the true volume fraction of the components could only be 
assumed if the single components deform to the same extent up to the point of fracture. This 
lead to the recommendation that as far as possible only components that deform equally 
during loading should be combined in tablets to avoid negative trends in the mechanical 
strength.   
Compaction of binary mixtures 
Researchers (e.g. Busignies, et al., 2006) have investigated the compaction of binary 
mixtures, whereas in most cases no simple relationship is found from the compaction 
properties of single materials and their proportions in the mixtures with the mechanical 
properties of the compressed tablets from binary mixtures. For the moment, there are a few 
papers available which propose a model for mechanical properties of compacted mixtures 
(Busignies, et al., 2006).  
The mechanical strength of a tablet depends on processing and formulation parameters. The 
strength of tablets compressed from binary mixtures can not be predicted from the 
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compaction properties of the starting material alone for constant processing parameters, 
because interactions between the materials can occur during the compaction process 
(Vromans, et al., 1988).  
Literature results for the compaction of binary mixtures show the complexity of the involved 
physical phenomena and the big challenge to define a single theory by e.g. designing an 
equation for explaining the tensile strength of binary tablets from the behaviour of individual 
components. 
A main focus has been set to the compressibility of powder formulations. Busignies et al. 
investigated the compressibility of MCC, lactose and anhydrous calcium phosphate by 
designing binary formulations and further compaction. Compression cycles were investigated 
for the specific compaction energy, which showed a linear change with mass composition 
and the specific expansion energy which didn’t show any linear behaviour. Additionally, a 
simple mixing rule with the porosity was designed to predict the mean yield pressure of a 
binary mixture by knowing the yield pressure of the single components. The experiment 
results with the used binary mixtures could validate this mixing rule.  
Also the particle size of the substances in a powder formulation can have an important 
impact on the compactibility. Barra et al. (Barra, et al., 1999) show that the compactibility of a 
powder mixture depends mostly on the compactibility of the percolation material, whereas in 
case of no interaction between the materials, an intermediate compactibility of the powder 
can be found. An important outcome of the mentioned work is the possibility of formulation 
modification by sieving some the components, e.g. an increase of the API without loosing the 
compactibility of the formulation may be possible. 
Michrafy et al. (Michrafy, et al., 2007) investigated the tensile strength of single component 
and binary tablets designed with lactose, MCC, and lactose with SMCC and SMCC-HD. The 
increase of the tensile strength with increasing relative density and with increasing MCC in 
the mixtures could be shown. A successful trial to predict the tensile strength of binary tablets 
from the characteristics of the single-component tablets with extensions of the Ryshkewitch-
Duckworth model was performed. According to the authors, none of the designed model can 
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be considered as best one for tensile strength prediction of binary powders, since every 
model depends on multiple factors. 
Kloefer et al. (Kloefer, et al., 2010) introduced a power law equation to predict tablet strength 
with compaction pressure. Different grades of MCC, lactose and mixtures thereof were used 
for investigation.  
Basically, it showed good fitting for low pressure ranges, whereas for tablets produced with 
higher densities the model showed a significant deviation from the measured data.  
Wu et al. (Wu, et al., 2006) showed the functional dependence of the tensile strength with the 
solid fraction or porosity of pharmaceutical excipients and of their binary, ternary and four-
component mixtures at various concentrations. The logarithm of tensile strength was 
proportional to the solid fraction, which led to a model development on the basis of 
Ryshkewitch-Duckworth equation (Ryshkewitch, 1953).  
The model validity could be shown from Wu et al. (Wu, et al., 2006) with experimental data. 
Rasenack et al. (Rasenack, et al., 2002) describe a method for the tabletability by taking into 
consideration the final compact. Compression parameters like the total energy of 
compression, the plastic deformation and the local displacement were collected and 
combined in an equation for a calculation of tabletability. A challenging element in this 
method is the difficult transferability of this method to other machines because of the high 
sensitivity in deviation of these data. 
Magnesium stearate in powder mixtures 
The addition of Magnesium stearate on a tablet formulation normally decreases the tablet 
strength. An explanation for this phenomenon is provided by De Boer et al. (De Boer, et al., 
1978) stating that the reduction of bonding force between particles occurs due to the 
presence of a magnesium stearate film on the particle surface.  
A different approach is the explanation of relative decrease in tensile strength of a 
formulation due to the addition of magnesium stearate as a measure of particle 
fragmentation during compaction (Johansson, et al., 1995).  
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Van Veen et al. (van Veen, et al., 2005) show no significant influence of Magnesium Stearate 
on the compaction properties of MCC (Emcocel 90M). Nevertheless, for the projects of this 
PhD – thesis magnesium stearate was excluded from the powder compound and its use was 
decided to be just in a manual way after every compression by applying a small amount on 
the die wall and the punches with following cleaning by usage of compressed air.  
Percolation theory 
A very important subject in compression studies is the occurrence of the percolation 
phenomenon. Percolation is mainly responsible for the irregular change of powder 
formulations properties with adjustment of the quantity of one formulations’ component. 
Binary mixtures can be seen as systems made of three phases: Two particle phases and the 
pore space. Numerous research papers describe in details the percolation phenomenon   
(eg.  Van Veen, et al., 2000 ; Leuenberger, et al., 1997 ; Blattner, et al., 1990).   
An important element of the percolation theory is the occurrence of the so called percolation 
thresholds. Let’s take as example a binary mixture of components A and B. If the fraction B is 
small, the particles are isolated inclusions by forming a dispersed phase. Component A, as 
component with the higher proportion, forms a continuous phase. The presence of a 
dispersed phase usually changes the behaviour of the continuous phase due to the 
localization of tensions. By increasing the fraction B, these particles form aggregates.  
By continuing the increase of compound B, a percolating B network occurs for a 
corresponding specific concentration of B. This concentration is called the percolation 
threshold,e.g pc1. By further increasing of compound B, both compounds form a network up 
to the upper percolation threshold pc2.  
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Fig. 11: Particle association below and above the percolation threshold (TDA) 
Understanding the percolation phenomenon helps a lot for investigating and analysing 
elements of a specific powder formulation.  
A further point to take into consideration is the occurrence of three kinds of interactions in a 
binary mixture of elements A and B:  
(1) A binds preferentially with A / B binds preferentially with B;  
(2) the affinity of A for A is the same as A for B, the same for B;  
(3) A binds preferentially with B. 
Compaction behaviour of binary mixtures 
The percolation thresholds in a binary mixture compact depend on the relative 
concentrations and the relative bond-forming properties (Holman, 1991; Leuenberger, 1982; 
Busignies, et al., 2006).  
Ramirez et al. (Ramirez, et al., 2004) show the usage of percolation theory and application to 
several tablet properties. They recommend avoidance of formulation design with mixing 
fraction close to the thresholds.  
Busignies et al. (Busignies, et al., 2006) measured binary mixtures of lactose, MCC and 
calcium phosphate concerning inter alia tensile strength. No linearity could be noticed with 
regular change of compound load. More, a negative deviation from a proportional 
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relationship could be observed.  Some compound concentration with very different tensile 
strength behaviour were related to the percolation threshold. Two statistical approaches are 
used here, which show some good fitting with the experimental data and the validity of these 
statistical approaches could be demonstrated for the used material. 
M. Kuentz et al. (Kuentz, et al., 2000) investigated the compaction properties of Paracetamol 
and Avicel 101 as a binary mixture made with a well compressible and a poor compressible 
compound. The percolation theory was taken into consideration for the relationship of tensile 
strength vs. compaction pressure and the tensile strength vs. relative density. The validity of 
the percolation equation models could be shown for all measured pressure and fraction 
ratios. Additionally, the dilution capacity was introduced. The presented tools in this 
publication may be promising for being applied to mixtures of more than two substances, if 
only one compound is well compactable. 
In the compression studies of van Veen et al. (Van Veen, et al., 2000) with no presence of 
mutual interactions on the individual densification behaviour of components, the mixtures’ 
yield pressure could be calculated by linear interpolation of the yield pressure of the two 
materials involved. 
For the change of the tensile strength with increasing quantity of Pregelatinised starch (with 
sodium chloride) the tensile strength of tablets with 100% pregelatinised starch is higher that 
of tablets containing 100% sodium chloride which indicates larger cohesive forces between 
pregelatinised starch particles as compared to sodium chloride particles (Van Veen, et al., 
2000).  
With increasing the % of pregelatinised starch the tensile strength initially decreases, which 
indicates the smaller adhesive forces of between sodium chloride particles and 
pregelatinised starch particles than the cohesive forces between the particles of the pure 
material. 
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Mathematical equations for prediction of powder compaction behaviour  
Mathematical equations are really favoured for the measurement and possible prediction of 
compaction mechanisms and properties of the powder formulation and/or the final compact.  
A compaction equation relates some compaction elements with the applied compaction 
pressure. The initial aim for fitting the data to an equation is to linearize the data and the 
corresponding plots. That way, comparisons can be applied easier between data sets. Also, 
the use of fitting parameters is really favoured for comparison reasons. 
Till today, numerous equations have been proposed for analysis of compaction steps. While 
some seem to have a theoretical basis e.g. the Kawakita (Kawakita, et al., 1970) equation,  
many of them are purely empirical fits of specific limited data and can not claim any general 
validity (Denny, 2002).  
For a reliable and satisfying application of compaction equation to investigate and compare 
compression of powder formulations, an equation should do more than only linearize the 
data (Denny, 2002). The parameters should somehow relate to basic physical and 
mechanical properties of the compacted material. Ideally the equation should apply to all 
materials, compacted the same way.  
There are specific elements which should be considered during compaction and application 
of a compaction equation (Denny, 2002): (1): The method of die filling should be stated, (2): 
The use of internal lubricants should be minimized since they strongly affect the outcome of 
the result, (3): The satisfactory and detailed characterization of the primary material, (4): 
Minimization of die wall effects by choosing low die wall to thickness ratios, (5): Porosity 
measurement. 
The porosity measurement and the corresponding measurement of true density and relative 
density is one of the most challenging step for the evaluation of compaction data. Small 
deviations on the true density measurement and/or the dimension measurement of the 
compact can lead to significant discrepancy of the outcome data (Celik, 1992). 
After compaction, usually an elastic relaxation of the tablet occurs, which can be noticed by 
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an increase of the tablets height. 
An increase of tablet height and volume after compression can be the result of two 
phenomena (Van Veen, et al., 2000): 1. decrease in material density and 2. increase in tablet 
porosity. 
Van veen et al. show an independent increase of porosity for all investigated blends of 
sodium chloride and pregelatinised starch in the range of the applied compaction pressures. 
The Heckel-Plot 
The Heckel-equation can be seen as one of the most widely used mathematical tool for the 
evaluation of the tablet compressibility. In the method-section of the research project 1, the 
Heckel-Plot is mathematically described. 
A detailed evaluation of this equation was performed and published by Denny (Denny, 2002) 
and also by Sonnergaard (Sonnergaard, 1999). There are some important points of criticism 
for this equation. There is the assumption of the isotropy of the compressed powder, which 
occurs also for a big number of compaction equations. This assumption is not ideal. Another 
point is the occurrence of a curved reason for low compaction pressures. In the past, this 
curved region was explained as phase of rearrangement. Research on this field shows in 
some cases brittle fracture in this region. A big point of criticism is the occurrence of strong 
deviations by comparing the published data for similar material by different authors. A 
possible reason for this deviation can be the already mentioned difficulty for a reliable 
measurement of true density, porosity and relative density. Since the Heckel-Plot follows a 
three steps transformation of the data, a small error can lead to tremendous effect.  
Additionally, it seems unrealistic to look for a universal simple formula for the entire 
compression process, since it consists of several stages.  
It can also be argued that materials which readily form strong interparticulate bonds will lead 
to tablets with higher tensile strength. Because of these strong interactions, there will be a 
greater compression resistance during the process.This is translated into greater energy 
requirement to make the tablets stronger. 
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Modified Heckel-Plot 
Kuentz and Leuenberger (Kuentz, et al., 1999) designed a modified Heckel equation which 
takes into consideration a pressure susceptibility, defined as decrease of porosity under 
pressure. The detailed derivation for the modified Heckel equation can be found in the 
method-section of the Research projects 1 and 2.  
The classical Heckel-equation assumes a constant pressure susceptibility while in this 
publication the susceptibility corresponds to the relative density and additionally, a term for 
the critical density has been introduced, which stands for the relative density where a rigidity 
between the punches starts to occur. 
The compressibility of powder formulations was since a longer time ago a main target for 
scientific research with support of mathematical equations. The general principle can be 
seen as the analysis of quantitative data to a relation in pressure to volume reduction or 
pressure to porosity (Kawakita, et al., 1970). The aim of this data collection and fitting to 
equation is, as analysed in details a few paragraphs ago, the finding of linear behaviour and 
the comparison between powder formulations.  
Leuenberger equation 
An important approach in practice is the focus on the production of tablets with adequate 
strength. This ability of a powder formulation to be compressed into tablets with specified 
strength can be expressed as the formulations’ compactibility. Leuenberger derivated an 
equation (Leuenberger, 1982), which includes one factor for compressibility and one factor 
for compactibility. The inclusion of a term for compactibility makes this equation, the so-
called Leuenberger equation, an attractive tool for investigating powder formulations. 
A detailed derivation and application proposals for this equation can be found in the method- 
section of the Research project 1.  
The literature evaluation shows the attractivity of investigation for multiple-component tablets, 
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preferable binary mixtures with a well compressible and a poorly compressible compound.  
What is usually the effect of a small compound quantity adjustment to the compressibility of a 
formulation? Is there a proportional behaviour of the compressibility to the quantity of a 
specific compounds’ quantity?  
An investigation of binary mixtures with adjustment of one compound or complete 
replacement of one compound by a comparable compound and following evaluation with 
different mathematical tools can show the behaviour of the formulation compressibility and 
the influence of adjusting the weight ratio of the used compounds. E.g. the use of the 
additivity rules for the Leuenberger equation can be investigated with this approach. Also a 
comparison of the fitted technical factors for the different equation can provide essential 
information for the usage and comparability of the methods. 
This PhD-thesis and especially the research project 1 mainly focus on these questions and 
issues.   
Instrumented tablet presses 
The instrumented tablet presses are used in research and development of tablet formulations 
and also in the industrial manufacturing of compacts. The application focus of instrumented 
tablet presses in research & development is mainly set on the analytical measurement power 
(physical characterization of the compression properties) while in production their use is 
mainly focused on the ensurance of a constant tablet quality (Belda, et al., 1998). 
The demands concerning precision and accuracy of the measurements can vary significantly 
in dependence on the aim and purpose for which the data are collected. While in many cases 
a specific instrument with constant settings for application in one and only repeatable 
process step may be sufficient, in other cases a high reproducibility is a main priority (for 
example for determining and monitoring the quality of the formulation and the final compact). 
The repeatability of the results plays an important role, namely the confidence, that same 
results can be achieved with different machines has to be reached.  
An instrumentation of a tablet press turns the manufacturing machine into an analytical tool 
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which can support crucially the scaling up process of a new formulation and the tablet design 
from the stage of Research & Development to industrial production (Belda, et al., 1999). 
Instrumentation can be applied to eccentric presses, rotary presses and compaction 
simulators (Barra, et al., 1998; Ilkka, 1998; Abdel-Hamid, 2011).  
The use of the tabletting press as an analytical instrument presumes a high precision and 
accuracy of the obtained results. This is a big challenge since the specifications of an 
instrumentation and data acquisition system after initial design and setup may change with 
installation of the device on the tablet press (Waring, et al., 1986; Steffens, 1978). 
A tablet press is mainly designed for an optimal tablet production with a highest possible 
performance. The installation of a high-precise measurement instrument in such a press, 
within a given geometrical environment, may be very challenging and may influence crucially 
the characteristics and quality of the measuring system (Goodhart, et al., 1968; Lammens, et 
al., 1979; Belda, et al., 1999). Also some mechanical setups can have a negative impact on 
the response of the analytical instrument. 
The sensor of the analytical instrument plays a key role in the data measurement for 
instrumented presses. The sensor in an instrumented press is a transducer device, which 
transforms a certain type of energy into another one (Bubb, 2008). A battery can be seen as 
a transducer, since it converse the chemical energy of the batterie parts into electrical 
energy. The sensors used in instrumented tablet presses convert a physical parameter into 
an electrical signal which is measurable and recordable. The following Fig. 12 shows the 
different ways of signal conversions which are executed by sensors in tablet presses. 
 
Fig. 12: Sensor signal conversions in tablet press                                                                        
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These challenges can be illustrated by the usual piezo-electric load washers, installed 
between the punch and punch holder for the measurement of the lower and upper punch 
force (Schmidt, et al., 1986; Lindberg, 1972; Belda, et al., 1998). Because of the direct 
connection of the load cells to the punch setup, an exchange of these punches is usually 
connected to a further reinstallation of the sensors. Since such a punch reinstallation 
changes the configuration and the location of the installed transducers, a recalibration of the 
instrumentation is unavoidable.  
The calibration process for installed press instrumentation is a tricky point in this subject. An 
optimal established calibration process must be repeatable and should not influence at all the 
measurement outcomes. The question arises, how such a robust system can be created, 
since there will be a small variation in the compaction process of the tablet press, the 
installation of the press instrument will influence the whole process and the signal sensors on 
the press will also show some variation in the outcome signal.  This chain of process 
parameters with individual small variations can lead to a final resulting process with a 
significant variation. Therefore, a reliable setup of the instrumented tablet press and the 
calibration process has to be planned.  
Even though, the mentioned challenges have to be overcome, instrumented tablet presses 
are a very important support for the development of tablet formulations. 
For the measurement of compression and ejection forces, there are piezoelectric and strain 
gauge-based sensors used. While piezoelectric sensors were favoured because of their 
small size and their high-frequency response, its usability only for dynamic events and signal 
changes because of small cable movements are a crucial issue. The strain – gauge based 
sensors show an advantage for static event measurement and do not show a signal 
decrease to zero within a few seconds even if a force is still applied (Bubb, 2008). 
Piezoelectric force transducers are made with quartz or piezoceramic elements. The 
orientation of the cut quartz crystal to the axes is really precise in dependence to the 
application of the sensor (Cocolas, et al., 1993). When a change in load is applied on the 
crystal, an electric signal output is generated. This way, the piezoelectric load cells are an 
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attractive solution for dynamic events (Celik, 1992). 
The strain gauge cell can be seen as a useful and common tool for the measurement of data 
in an instrumented tablet press. The strain gauge (or strain gage) is a tool device, which is 
used to measure the strain of an object. What is a strain? Strain is defined as the amount of 
a body deformation due to an applied force. From a mechanical point of view, the strain is 
seen as the fractional length change of the measured physical body, as illustrated in the 
following Figure and Equation. 
 
 
Fig. 13: Definiton of Strain (taken from: National Instruments) 
L
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Equation 9: Physical Strain (taken from: National Instruments) 
 
 
There is no clear picture about the exact discovery of the strain-induced resistance change in 
electrical wires. Lord Kelvin mentioned this effect already in the 19th century (Bubb, 2008). 
During the 1930s, Edward E. Simmons and Arthur C. Ruge developed the first real device 
with this technology. One of the most common strain gauge types is made of a flexible 
backing supporting a metallic foil pattern (Electronical source: http://www.omega.co.uk; 
01.11.2011). This devices are then attached by an adhesive material, like e.g. 
cyanocacrylate (Electronical source: efunda.com; 01.11.2011), to the object to be measured. 
When the object is deformed or relocated, the foil is deformed, generating a change in its 
electrical resistance.  
L 
D 
L 
Force Force 
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Fig. 14: Bonded metallic strain gauge (taken from: National Instruments) 
 
The strain gauge has to be designed that way, that a proper instrument mounting can be 
made which is important for a reliable measurement. The following table shows the most 
important desired features, a stran gauge instrumentation should show (Chalmers, 1992): 
- Small mass and size, with high resistance 
- Satisfying stability, repeatability and linearity over a wide strain range 
- Easy production in different sizes and configurations 
- Reasonable sensitivity to strain 
- A low production and handling cost 
- Ability to control effects of environmental influences, like e.g. temperature 
- Suitability for static and dynamic meausurements 
- Ability of remote recording 
The desired reasonable sensitivity to strain is a main challenge in the design of a strain 
gauge instrumentation, since in practice such a measurement has an outcome of a little bit 
more than a few millistrain. This way, the strain measurement recquires sensitivity to very 
small changes in resistance (National Instruments, 2011). The most accurate way for 
reaching this kind of sensitivity and meeting the requirements listed above the design and 
implementation of measurement systems like e.g. Wheatstone bridge or Quarter-Bridge 
Circuits are recommended and usually taken into consideration (Little, 1992; Kalsi, 2010; 
Bakshi, et al., 2007). 
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Compaction simulators 
Apart of instrumented tablet presses, the use of compaction simulators can be seen as a 
promising approach for the investigation of the compaction process. There are several 
different compaction simulators on the market, which show a wide range of mechanical and 
technical properties. Basically, all compaction simulators have at least a load frame, a 
hydraulic unit and a data acquisition system (Bourland, et al., 2008; Abdel-Hamid, 2011). The 
use of the compaction simulator is the most common approach for dynamic compaction 
testing. The sophisticated control and monitoring of the compaction process with the 
simulator is an important reason for choosing this kind of machine for tests, since it provides 
an essential flexibility in compression conditions. For example the possibility of investigating 
compaction under constant velocity conditions for the compression and decompression 
phases is a big advantage of some compaction simulators towards instrumented tablet 
presses (Amidon, et al., 2009). There are many variables in a tablet press which can be 
simulated in a reliable way. Compaction forces, punch velocity, tableting speed, dwell time, 
relaxation and the influence of upper & lower compression rolls are main investigation 
targets, which can be reached by a simulator. On the other hand, the heat generation in the 
tablet press die after a longer batch run and the exact contact points and positions of the 
punch and the rolls during the compaction step are not easy to be simulated. Also, since 
there are usually small powder amounts applied in a simulator for investigation, the feeding 
setup of an industrial press differs crucially from the powder supply of a compaction 
simulator. By simulating similar dwell times like in a rotary press, the simulator instrument 
can be used for raw material evaluation concerning e.g. basic compaction mechanisms, 
study of process variables like compression force and speed, investigation of scale-up issues 
and industrial production and many more factors.  
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Presster 
Also ―linear‖ tablet press emulators, like the Presster have shown essential utility by offering 
many of the advantages of a conventional compaction simulator as the easy use and the 
flexibility. The Presster was developed by Metropolitan Computing Corporation Inc. NJ, USA 
in the late 1990s and has the crucial ability to simulate the globally available rotary tablet 
presses (MCC online, URL: http://www.mcc-online.com/presster.htm, 01.11.2011).  A main 
special feature of the Presster is that compression rolls of the same dimensions as the 
simulated rotary press have to be installed. This way, the compression profiles are really 
similar to those of the simulated tablet press (Picker, 2003).   
The design basically resembles a single station rotary press with all its parts, which are not 
arranged in a circular path but on a straight line. For being able to record exact measurement 
data, the sensoring system of this machine is based one pair of punches and one single die. 
A turret-analogue carriage with the tooling set is the central part of the machine. This 
carriage is driven horizontally through the machine. It passes the dosing cam, the upper and 
lower rollers of the pre-compaction, the roller set of the main compaction station, ending at 
the ejection cam and the take off bar. The punch tools, the dies, the precompaction and the 
compaction rolls are in the most cases the same, which are used in the rotary press 
(Neuhaus, 2007). For measuring the punch displacement, so called linear variable differential 
transformers (LVDTs) are used (Fig 15) (Abdel-Hamid, 2011). 
 
Fig. 15: Linear variable differential transformer for measuring punch displacement 
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These devices work by measuring the position of a core rode insinde the cylinder relative to 
a predefined zero position. The resulting voltage shows a proportionality to the object 
displacement. As seen in Fig 15, on the Presster both LVDTs are installed into the same 
carrier as the die. This way, the applied compaction force during the powder compaction has 
only a limited influence on the punch displacement measurement. Since different punch 
formats can be used and also compaction rollers with a wide range of diameters can be 
installed, practically all market available rotary presses can be simulated                       
(Natoli, et al., 2009; Levin, et al., 2000). 
Fig 16 illustrates the basic set up of the Presster with all the main elements (Neuhaus, 2007).  
 
Fig. 16: Schematic view of the Presster instrument 
The Presster compaction simulator is connected to an electronic data acquistion system and 
a software program, which allows all the technical experiment parameters to be set on a 
personal computer. Also the monitoring and the data outcome analysis is made on the IT 
system. This way, parameters, like e.g. gap, resulting compaction force, dwell time, ejection 
angle, can be chosen and also adjusted fast and easy, allowing the operator to investigate 
the influence of all these elements on the resulting tablet and the powder formulation 
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behaviour under pressure.  
The following Fig 17 shows illustrative print screens of the Presster computer software 
program with its main screen, motor speed adjustment with calculation of dwell time and 
tooling selection. 
 
Fig. 17: Presster software: main screen, motor speed adjustment with calculation of dwell time and tooling selection 
After completion of an experiment run, the measurement results of all sensors are collected 
by the Presster software and shown numerically and graphically. Examples of this 
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measurement can be seen in Fig 18 for numerical illustration in Microsoft Excel, compression 
curves and Ejection / Take – off force diagrams (Abdel-Hamid, 2011). 
 
Fig. 18: Excel  - sheet of Presster measurement data 
 
 
Fig. 19: Ejection force and take off force diagram: (1) Ejection force; (2) Take off force; (3) Lower punch displacement 
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Fig. 20: Compression data diagram for pressures and displacements: (1) Compression force of upper punch;      
(2) Compression force of lower punch; (3) Upper punch displacement; (4) Lower punch displacement;                      
(5) Radial die-wall pressure (not monitored in the research projects of this PhD thesis) 
For very precise investigations of powder behaviour under punch pressure, precise 
measurement instruments from the field of mechanical engineering can be taken into 
consideration. 
Zwick 1478 TM 
The Zwick 1478 TM is a high-precision measurement instrument for engineering processes 
and material tests. The main design of this machine is a vertically movable platform, whose 
position and moving speed can be adjusted and monitored in a very precise way. Also the 
data outcome of the numerous installed sensors is really precise. This way, even the 
smallest deviation in a measurement process can be recognized immediately and corrective 
actions can be implemented. The Zwick 1478 is really recommended for exact, slow speed 
powder compaction, whereas industrial tablet production condition can not be simulated. A 
good example for the possible use of Zwick 1478 is the generation of force-time or force-
displacement diagrams to investigate factors like compaction force and compaction speed to 
the compressibility of a powder formulation. The sensoring on the Zwick 1478 is mainly 
based on strain gauges, which is a satisfying choice for this kind of instrument, since strain 
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gauges can register in an exact way forces and displacements of a dynamic process. 
Near-Infrared Spectroscopy 
The choice of Near – Infrared Spectroscopy is a well received and reliable analytical 
approach for a wide range of different fields and industries like agrochemistry, food industry, 
cognitive neuroscience, medical diagnostics and also pharmaceutical technology.  
The physical absorption band of Near-Infrared Spectroscopy is in the range of around       
750 nm to 2500 nm (12,800 – 4000 cm-1). The main source for the occurrence of the 
absorption bands is the overtones and combinations of fundamental mid-IR stretching and 
bending modes (Saeed, et al., 2009). X – H, X=C, N or O functional groups are the main 
chemical target groups in Near – Infrared Spectroscopy due to their absorption band intensity 
in the NIR – region.  A crucial analytical factor here is the weak absorptivity of these band 
signals which allow, in combination with high scattering, the measurement of condensed-
phased pharmaceutical powders, e.g. in form of thick tablets, without need of special sample 
preparation as for example the destruction of the powder compact  (Saeed, et al., 2011). 
Also the possibility of measuring diffuse transmission and reflexion can be performed, due to 
the sensitivity of NIR on scattering effects  (Siesler, et al., 2006). 
Brief history of Near-Infrared Spectroscopy 
Near-Infrared energy was discovered and first time investigated by Herschel in the 19th 
century. The time till the first industrial application was long. Actually, the first systematic 
application in the world industry began in the 1950s by introducing NIR measurement 
devices as add-on units to optical instrument which were focusing on the scientific 
measurement of visible, ultraviolet or mid-infrared light wavelengths (van de Hulst, 1969). In 
the 1980s the first single, stand-alone NIR instruments appeared on the industrial market. 
Their design and setup were basically concepted for an application in the field of chemical 
analysis. The development of light-fiber technique in the optic science and the introduction of 
monochromator-detectors lead to the design of NIR instruments with powerful application 
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ways in scientific research. 
Basic characteristics of Near-Infrared Spectroscopy 
A crucial characteristic of the near-infrared spectral region is its unique features, where for 
examples techniques and experience from IR spectroscopy can’t be used. This led to a need 
of wide research & development for the handling of the photon energy and spectral light 
behaviour in the NIR region. Since the interaction between solid materials and NIR light is 
different than light photons in the IR or UV-VIS region, the choice of NIR spectrometry can 
open new ways of research and investigation in science. 
Molecule atoms show always a certain movement, which is mainly dependent of the 
environmental temperature. The potential energy of the molecules is a crucial factor here. 
The binding potential of the present electrons and the repulsive force between atomic nuclei 
of two molecules play an important role for the final energy level between the molecules. The 
energy level between the molecules is mainly dependent of their room distance. Also the way 
of reaching the final distance between the molecules plays an important role. The 
displacement of molecules within the system leads to a change in the final potential energy 
level, with the absolute energy value change being non-proportionally different by displacing 
the molecules in a positive or negative direction (Saeed, 2011).  
In an ideal harmonic potential system, the way of displacement plays no role for the bonding 
energy level between the molecules. The real anharmonic potential system shows effects 
which are significant for the NIR science. By overcoming more than one energy level after 
certain displacement of the molecules, a weak energy absorption can occur. Also the gap 
between the certain energy levels is no more constant in the anharmonic system. Pasquini 
(Pasquini, 2003) discusses in a detailed way the summarized phenomena of harmonic and 
anharmonic potential energy models. The understanding of the potential energy within a 
system and the awareness of the individual vibrational energy for every specific molecular 
system is really important for the usage ability of NIR in chemical and pharmaceutical 
sciences.   
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When a radiation is applied to a molecular system, the system responds in a selective way, 
since the final respond is dependent on the match of the radiation energy with the energy 
difference between the vibrational levels of the targeted system itself. The possible matching 
of the radiation frequency to the potential energy gaps of the system is determining the 
absorbance, partially absorbance or non-absorbance of the incoming frequency.  
The incoming radiation energy can interact with a molecule system only if it can affect its 
energy level and changing its dipole moment. Polyatomic molecules can show transitions in 
two vibrational modes at once. In this case we talk about combination bands. They can have 
a significant impact in NIR. Very common is the influence of an NIR spectrum by absorptions 
of C-H, O-H and N-H functional groups in combination with bands from lower frequency as 
C-C and C=O. This effect can be useful in model development for quantitative analysis in the 
pharmaceutical field (Siesler, et al., 2006). 
The interaction between the near-infrared radiation and the targeted solid particles leads 
usually to a weak absorbance and a high scattering. For solid compacts, the near- infrared 
radiation passes usually in the tablet interior part and even transmits it completely. This way, 
powders and compacts can be investigated by NIR without any sample preparation.  
Two main measurement principles are applied in the NIR spectrophotometry for scientific 
investigation of pharmaceutical samples: Diffuse transmittance and diffuse reflectance.  
A high number of scientific contributions on the two methods can be found in the available 
literature (e.g. Siesler, et al., 2006; Ciurczak, et al., 2002;  Saeed, 2011). Since the diffuse 
transmittance approach was used in the research work of this PhD thesis, the focus in the 
follwoing paragraphs was set to this technique.   
Diffuse transmittance in near-infrared spectroscopy 
Diffuse transmittance can be measured in a reliable way only in the NIR region. 
Measurements in the UV and IR region have not shown comparable success up to now.   
The transmittance T is defined as the ratio of light intensity transmitted through an empty 
system (I0), for example a cuvette, and light intensity transmitted through the investigated 
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sample) (IS). The Beer-Lambert equation is the basic approach for measuring and 
understanding the absorbance and transmittance of NIR radiation (Eq. 10) 
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Equation 10 
 
where A: Beer-Lambert optical absorbance,  T: transmittance ration, a=absorption coefficient, 
b=pathlength (sample thickness), c: concentration of absorbing species. 
For the use of the Beer-Lambert relation with NIR spectroscopy in powder technology, we 
have to take a nonlinear deviation of the radiation transmittance into consideration (Owen-
Reece, et al., 1999).  
The Beer-Lambert equation assumes that the photons are either transmitted or absorbed. 
When NIR radiation hits a powder particle, also scattering and reflection of the photons in all 
possible directions can be noticed. This phenomenon is crucial for the application of diffuse 
transmission, since a photon, which is reflected on a particle in a powder bed will then hit a 
second powder particle, where again transmission, absorption, scattering and reflection can 
occur. It can be assumed, that during a measurement, the total pathlength of the photons 
within the powder bed can reach values within a wide range. If we assume the investigated 
powder bed or tablet to have a thickness T, the values of the total photon pathlengths will 
show a normal distribution on an average amount bigger than T (Saeed, 2011).   
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Fig. 21: Types of NIR radiation with solid powder systems, in practice, only diffuse transmission and reflection are seen   
(Saeed, 2011). 
The mentioned phenomena (absorptivity, reflectance, scattering, way of transmission) may 
vary significantly between different investigated samples and powder formulations. Multiple 
material qualities, as e.g. particle morphology, particle size, bulk and true density play an 
important role here.  
The expected total average wavelength and the nonlinear deviation of the sample relative to 
the Beer-Lambert relation are really difficult to be predicted in practise. 
Near Infrared Spectroscopy Instrumentation 
The near-infrared spectrometer consists of a light source, a detector and a dispersive 
element (like a prism or diffraction grating) for the control of the light wavelength. Additionally 
to this, interferometers are used for fourier transform NIR – spectrometers.  
Measurement of near-infrared diffuse transmission and spectral 
analysis 
The near-infrared diffuse transmission measurements can provide essential information on 
the investigated sample. With proper measurement settings of the near-infrared 
spectrophotometer and with a reliable mathematical model design for analyzing the spectra, 
significant physical or chemical characteristics of the sample can be measured.  
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The finding of the optimal measurement setup starts already at the choice of the most 
suitable spectrophotometer. There are numerous instrument types available on the market 
with a wide variation of properties and technical strengths (Siesler, et al., 2006). 
The FT (Fourier transform) – NIR spectrometer applies the mathematical operations of 
function decomposition to separate the signals into frequency spectrums. There is a powerful 
application field for FT-NIR spectrometers and big advantage of these instruments can be 
seen towards other spectrometers.  
FT-NIR spectrometers can be used when high-resolution capabilities are important or if many 
different kinds of sample interactions are needed. Also the constance of the spectral 
resolution across the whole spectral range and its adjustability make the FT-NIR an attractive 
instrument for reliable measurements (Saeed, 2011). All frequencies are detected 
simultaneously with this instrument and the accuracy of the wavelength is powerful.   
The initial spectral signal is usually very confusing and spectral preprocessing methods have 
to be applied to find correlations between the spectral signal and the properties of the 
respective sample.  The first step usually is the application of chemometric multivariate 
analysis. Since the nature environment is really multivariate, this is the only way to get 
enough correlation data by treating multiple measurements simultaneously. A high 
information collection in a relatively short time can be reached.    
But there is an additional challenge we have to face in the finding of a reliable NIR – 
measurements system: The NIR spectral signal shows an uninformative variance which can 
occur by slight differences between the sample properties or by a variation in the operational 
parameters of the spectrometer. 
The successful way to minimize these effects is the application of so called mathematical 
pretreatments to the spectra. There are many options for such pretreatments. Nevertheless, 
every of these pretreatments is applicable only for a certain range of products and 
conditions.  
Standard Normal Variate (SNV) and Normalization by Closure (ncl) are two examples of 
mathematical pretreatments. In SNV, the spectra are treated with substraction of each 
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spectrum mean and normalization of the length to 1. Ncl is also used as spectral 
pretreatment, by reducing the baseline variations and smooth the signal in a mathematical 
way.   
In a next step, vector geometry is usually introduced to detect the variable factor within the 
signals which correlate with a physical or chemical property of the powder system. For 
example, PLS (partial least square) algorithms can be used to construct a calibration model 
or also in a later step a reference model to measure and predict scientific powder properties 
in a future measurement of a comparable sample. In PLS, vector projections are designed 
with the spectral and also with referencing data. In the next step, these factor vectors are 
moved towards each other, till the linear fitting reaches a satisfying level. The final aim of 
PLS is to find the vector, which is the best compromise of the spectral factor and the 
reference factor.  
For the final design of the calibration model, the design of the prediction model and the 
validation of these models there are a big number of statistic elements to take into 
consideration (Latent variables, predicted residual errors, BIAS, validation models, RMSEP, 
etc.). The detailed explanation of all these elements would go definitely beyond the scope of 
this PhD thesis and would very probably lead to an unnecessary confusion for the reader. 
Therefore, a reference is made here to the method section of research project 2 and the wide 
scientific literature in this field (e.g. Howard, et al., 2003; Naes, et al., 2010). 
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Research Project 1:  
Compressibility of binary powder formulations: 
Investigation and evaluation with compaction 
equations 
 
 
Abstract  
The purpose of this work was to investigate and evaluate the powder compressibility of 
binary mixtures containing a well-compressible compound (microcrystalline cellulose) and a 
brittle active drug (paracetamol, mefenamic acid) and its progression after a drug load 
increase. Drug concentration range was 0 – 100% m/m with 10%-intervals. The powder 
formulations were compacted to several relative densities with the Zwick material tester.  
The compaction force and tensile strength were fitted to several mathematical models to 
fitting that gives representative factors for the powder compressibility.  
The factors K and C (Heckel and modified Heckel equation) showed mostly a non-linear 
correlation with increasing drug load. The biggest drop in both factors occurred at far regions 
and drug load ranges. This outcome is crucial, since in binary mixtures the drug load regions 
with higher changeover of plotted factors could be a hint for an existing percolation threshold.  
The susceptibility value (Leuenberger equation) showed varying values for each formulation 
without the expected trend of decrease for higher drug loads. 
The outcomes of this study showed the main challenges for good formulation design.  Thus, 
we conclude that such mathematical plots are mandatory for a scientific evaluation and 
prediction of the powder compaction process. 
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Introduction 
One of the most efficient processes for producing single dose medication is the compaction 
of pharmaceutical powder mixtures into tablets. Compacts are trusted by professionals and 
consumers worldwide. The easy administration for the patient and the simple handling of the 
active drug dose makes the tablet a very favoured dosage form (Natoli, et al., 2009).  
For obtaining desired properties of compacts, the usage of powder formulations commonly 
consisting of one or more additives is preferred in the pharmaceutical and food industry. 
Whereas there are data available for single materials, in case of multi-component powder 
mixtures, numerous time-consuming experiments have to be performed to find appropriate 
formulations. 
In the last years, there was an increasing pressure on pharmaceutical companies to reduce 
the time from drug discovery to marketed products, thus reducing costs and maximize the 
patent life of a drug. This need has initiated the development of predictive techniques that 
may have the benefit in reducing development time and research materials (Hardy, et al., 
2003). 
Even though some authors (Forsyth, et al., 2000; Thornton, et al., 1998) investigated and 
evaluated in a detailed manner the microscopic interaction forces between particles and their 
influence on the mechanical properties of particulate systems, the behaviour of interparticle 
forces is still far from being well understood and an underestimation of these forces can have 
tremendous effects in powder technology.  
It is not easy to investigate directly the microscopic particle behaviour during compaction. 
Therefore, the investigation focus on a macroscopic level is gaining more importance.  
The design of a powder formulation for industrial tablet production prerequisites a 
satisfactory compressibility of the powder and a tensile strength of the final compact in an 
acceptable range.  
In the scientific field of pharmaceutical technology there is a distinction made between the 
terms compressibility and compactibility. Whereas the compressibility is defined as the 
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general ability of a powder to decrease in volume under pressure, the compactibility is seen 
as the ability of the powdered material to be compressed into a tablet of specific strength 
(Leuenberger, et al., 1982).  
The mechanisms and phenomena of powder compaction have been the subject of numerous 
research investigations during the last six decades. There has been a wide variation of the 
compaction parameters and the used equipment (Celik, et al., 1989).  
Many powder properties and also external factors have an impact on the quality of the final 
tablet (Barra, et al., 1999; Ryshkewitch, 1953; Rasenack, et al., 2002; Kawakita, et al., 1970; 
Ritschel, 2002; Nyström, et al., 1996; Ragnarsson, 1996). Therefore to date, numerous 
mathematical equations and approaches proposed to characterize the powder compaction 
exist. Many of these equations can be applied only to a restricted range of compaction force 
and only for a limited number of materials (Celik, 1992; Kolarik, 1994; van Veen, et al., 2004; 
Wu, et al., 2005).  
Crucial tablet quality characteristics are the relative density and the mechanical strength. The 
surface areas of the particles in intimidate contact as a result of interparticulate bonds are 
referred as true areas of contact. Since the true contact area is difficult to measure in real 
tablets, the relative density is used as indirect method of measurement (Holman, et al., 
1991). A big challenge for the relative density calculation of a powder is the scientific 
measurement of the true density (Paronen, et al., 1996). Several factors, like the bulk 
material, the chosen investigation method and the used analytical machines can have an 
impact on the determined true density value.  
The pycnometric approach, especially helium pycnometry, is preferably used for true density 
measurements (Paronen, et al., 1996). One important issue to be taken into consideration 
here is the possible presence of impurities and even absorbed water, which could cause 
significant variations. Even during compression the particle density can change due to 
occurrence of polymorphic phase transitions.  
An experimental error of the true density measurement can have a significant impact on 
compaction factors outcomes. Gabaude et al. (Gabaude, et al.) showed the fundamental 
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consequences of a true density experimental error on the data fitting to the Heckel-Plot. 
Paronen and Ilkka (Paronen, et al., 1996) underlined the importance of repeated 
measurement for a precise true density determination. 
For such a reliable determination of the compact’s relative density, the tablet dimensions play 
an important role. The height and diameter of a tablet can be measured basically with an ―out 
of die‖-approach, in the most cases with a digital calliper, or ―in die‖ with the support of a 
precise compaction apparatus.  
The measurement with a digital calliper does not take into consideration the elastic 
relaxation, occurring after the compaction step. Since this relaxation leads to an increase of 
the tablet height, it influences the factor values of the fitted plots (Celik, 1992). Celik and 
Marshall (Celik, et al., 1989) found a significant influence of the tablet dimension 
measurement method (―out of die‖ or ―in die‖) for the final plotting of the Heckel equation. 
Also Denny (Denny, 2002) mentioned the challenge of different tablet dimension 
measurement. Both approaches can be chosen from a scientific point of view, but a clear 
statement of the chosen method should be made. Additionally, for a powerful comparison of 
two different data sets, the same choice of measurement parameters should be made for 
both sets.    
Mechanical strength is another crucial tablet property since it is responsible for many 
physical, pharmacokinetic and pharmacodynamic aspects of the resulting compact. The 
strength depends on several processing and formulation parameters. It can be seen as one 
of the most important parameters for characterising the mechanical behaviour of tablets, as 
the compact must possess a minimum mechanical strength to sustain potential loading 
during processing and handling (Wu, et al., 2005; Belda, et al., 2006; Michrafy, et al., 2007; 
Kloefer, et al., 2010; Wu, et al., 2006; De Boer, et al., 1978; Johansson, et al., 1995). 
The strength of tablets compressed from binary mixtures cannot be predicted from the 
compaction properties of the starting material alone because interactions between the 
materials can occur during the compaction process (Vromans, et al., 1988).  
A very crucial parameter in compaction studies of binary mixtures is the percolation 
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phenomenon. Percolation is mainly responsible for the irregular change of powder 
formulations properties with quantity adjustment of a component. Binary mixtures can be 
seen as systems made of three phases: Two particle phases and the pore space. Numerous 
research papers describe in details the percolation phenomenon and the role of the 
percolation thresholds (Leuenberger, et al., 1997; Leu, et al., 1993; Blattner, et al., 1990; 
Holman, et al., 1991; Leuenberger, 1982; Krausbauer, et al., 2008). The percolation 
thresholds in a binary mixture compact depend on the relative concentrations and the relative 
bond-forming properties (Holman, 1991; Leuenberger, 1982; Busignies, et al., 2006).  
Literature results (Barra, et al., 1999; Belda, et al., 2006; van Veen, et al., 2005; Van Veen, 
et al., 2000; Leueneberger, et al., 1985) for the compaction of binary mixtures show the 
complexity of the involved physical phenomena and the big challenge to define a universal 
equation, e.g. for predicting the tensile strength of binary tablets from the behaviour of 
individual components. 
A representing example of this prediction difficulty is the work of Nokhodchi and Rubinstein 
(Nokhodchi, et al., 1998; Nokhodchi, et al., 2001; Nokhodchi, et al., 1998), where binary 
mixtures of ibuprofen and hydroxypropylmethylcellulose were investigated with focus on the 
compressibility and the tensile strength behaviour with different drug loads. A non-linear 
relation between the tensile strength and the drug load could be noticed for all compaction 
speeds applied. Also the influence of the moisture content, the compaction speed and the 
applied compaction force was investigated by this group and the importance of these factors 
on the compression nature could be shown.  
A compaction equation relates some compaction elements with the applied compaction 
pressure. The initial aim for fitting the data to an equation is to have a linear relationship with 
the corresponding plots. With this approach, comparisons can be more easily applied 
between data sets. Additionally, the fitting parameters of the applied equations can be used 
for data comparison. 
To date, numerous equations have been proposed for the analysis of compaction steps. 
While some seem to have a theoretical basis e.g. the Kawakita (Kawakita, et al., 1970) 
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equation, many of them are purely empirical fits of specific limited data and cannot claim any 
general validity (Denny, 2002).  
A reliable compaction equation to investigate and compare powder formulations should 
achieve more than only linearizing the data (Denny, 2002).  The equation parameters should 
somehow relate to basic physical and mechanical properties of the compacted material. 
Ideally the equation should apply to all materials, compacted in the same way.  
The Heckel-equation can be seen as one of the most widely used mathematical tool for the 
evaluation of tablet compressibility. A detailed evaluation of this equation was performed and 
published by Denny (Denny, 2002) and also by Sonnergaard (Sonnergaard, 1999).  
Celik and Marshall (Celik, et al., 1989) investigated numerous excipients by developing the 
corresponding Heckel-Plots. Nonlinearity was observed in many of these profiles, which were 
obtained under dynamic conditions.  
Kuentz and Leuenberger (Kuentz, et al., 1999) designed a modified Heckel equation which 
takes into consideration a pressure susceptibility, defined as decrease of porosity under 
pressure. The classical Heckel-equation assumes a constant pressure susceptibility while in 
the modified Heckel equation the susceptibility corresponds to the relative density. 
Additionally, a term for the critical density has been introduced, which stands for the relative 
density where a rigidity between the punches starts to occur. 
For a long time, the compressibility of powder formulations with support of mathematical 
equations has been the main target for scientific research. The general principle can be seen 
as the analysis of quantitative data to a relation in pressure to volume reduction or pressure 
to porosity (Kawakita, et al., 1970). The data collection and the fitting to the mathematical 
equations leads to an accurate evaluation of the equation parameters and to a scientifically 
reliable comparison between powder formulations.  
An important approach in practice is the focus on the production of tablets with adequate 
strength. This ability of a powder formulation to be compressed into tablets with specified 
strength can be expressed as the formulations’ compactibility. Leuenberger derived an 
equation (Leuenberger, 1982), which includes one factor for the compressibility and one for 
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the compactibility. The inclusion of a compactibility term makes this equation, the so-called 
Leuenberger equation, an attractive tool for investigating powder formulations. 
The evaluation of the scientific literature (Ramirez, et al., 2004; Kuentz, et al., 2000; Fell, 
1996; Leuenberger, 1985; Amin, et al., 2004) demonstrates the attractivity and need of 
multiple-component tablet investigation, preferable binary mixtures consisting of a well 
compressible and a poorly compressible compound.  
Nevertheless, a simultaneous application of different plots (e.g. Heckel-Plot, Kawakita 
equation) to similar compacts with following scientific comparison of the factor values is still 
rarely found in the literature.  
Research aim 
In this study, the focus was set on the compressibility change of a binary mixture, consisting 
of a well compressible and a brittle, poorly compressible compound with stepwise increase of 
the brittle active drug.  
To investigate this behaviour with model formulations, the challenge of the analytic capability 
of the powder compressibility was taken into consideration.  
A way to describe the powder compressibility is the fitting of compaction data sets to specific 
mathematical equations. Such equations contain factors, which were described in the 
literature as representing the powder compressibility. The Heckel-Plot, the modified Heckel-
Plot and the Leuenberger equation belong to this kind of equations. 
By compacting one formulation and measuring the properties of the final compact 
(compaction force, thickness, porosity, tensile strength), the collected data set can be applied 
on the three mathematical equations for plotting the compressibility factors in a reliable way.   
The comparison of these data can provide interesting outcomes concerning the validity of the 
investigated equations, since all the compressibility factors should have a similar behaviour 
with systematic change of binary mixture components.  
As brittle, poorly compressible API, paracetamol and mefenamic acid were chosen in this 
study, since they have similar particle size. The basic difference between the two chosen 
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compounds is the significantly higher tendency of sticking for mefenamic acid (Bhadra, et al., 
2004) (Kimura, et al., 2007). As ductile, well compressible excipents, the microcrystalline 
celluloses MCC 101L and MCC 102G were chosen, since they are both known for their high 
compressibility, since they differ in particle size (Picciochi, et al., 2010; Adam, et al., 2000; 
Kothari, et al., 2002; De la Luz Reus Medina, et al.).    
Theoretical section 
In this study, three mathematical equations have been chosen for the plotting of the 
compaction outcomes and the tablets properties.  
1. The Heckel-Plot (Heckel, 1961; Heckel, 1961),  2. The modified Heckel-Plot (Kuentz, et 
al., 2000) and 3. The Leuenberger equation (Leuenberger, 1982) (Leuenberger, et al., 1984). 
Heckel- Plot 
The Heckel – Plot is still the most commonly used equation in the pharmaceutical 
compaction studies. It was developed by Heckel and published in 1961(Heckel, 1961; 
Heckel, 1961). The main approach in this equation is assuming similarity to a first-order 
chemical reaction. This approach was proposed earlier also by other research workers as 
e.g. Shapiro and Kolthoff (Shapiro, et al., 1947; Athy, 1930).  
APk
D

1
1
ln   
Equation 11 
 
where D is the relative density of a powder compact at pressure P. Constant k is a measure 
of the plasticity of a compressed material. 
The Constant A is related to the die filling and particle rearrangement before deformation and 
to the bonding of the discrete particles. 
In the early 1970s, the constant K was related to the mean yield pressure (Py) by Hersey and 
Rees (Hersey, et al., 1970). The following equation shows the inverse relation of Py to the 
ability of the material to deform plastically under pressure.  
K= (1/Py) 
Equation 12 
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Modified Heckel- Plot 
For a more holistic approach of the powder behaviour under pressure, the investigation focus 
of Kuentz and Leuenberger (Kuentz, et al., 2000)  was set to the pressure susceptibility (p). 
This parameter represents the decrease of porosity under pressure. Compacts obtained at 
very low pressures are of special interest in this approach, because of their transition state 
between a powder and a tablet. There is a range of limitation for the definition of the pressure 
susceptibility below some relative density and above the corresponding porosity, because no 
rigid structure exists in this pressure region.  
The pressure susceptibility can be as a function of porosity and compression: 




d
d
p 
1
      
Equation 13 
For a mathematical definition of the above described limitation range, a threshold value of 
the porosity c and the corresponding relative density c were introduced. These factors 
define the values, where a rigidity starts to evolve.  
These thresholds can be called critical, since they are crucial for the existence of the 
pressure susceptibility.   
In the classical Heckel equation, the susceptibility p equals to the constant K. With the new 
approach, the classical Heckel model needs to be replaced by an alternative equation, with a 
stronger focus on the susceptibility. The following equation was introduced: 
cc
p
CC





      
Equation 14 
The combination of equations (11) and (14) leads to a modified Heckel equation:  
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Equation 15 
ρ is the relative density, σ is the pressure, ρc is the critical density and C is a parameter, 
claimed to represent the powder compressibility . For the description of material properties, 
the constant K from the Heckel equation and the constant C from the modified Heckel 
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equation can be determined. Ductile, highly compressible and soft powders have higher 
values for C and K than poorly compressible, brittle and hard powders. 
The parameterc has been defined as the rigidity threshold. It represents the critical relative 
density, producing a negligible mechanical resistance between the punches. With a strict 
geometrical focus, this threshold represents the transition point between dispersed solid in 
air and voids in a solid matrix.  
Leuenberger equation 
The Leuenberger equation was introduced in the early 1980s by  Leuenberger (Leuenberger, 
1982; Leuenberger, et al., 1984).  
It is based on the assumption that the cross-sectional area A of a cylindrical tablet contains a 
number N+ of bonding contact points and a number N- of non-bonding contact points. The 
following equation describes the contact points over the cross-sectional area 
    NNNaNNaNA
with
00  
Equation 16 
where A is the cross-sectional area and a is the unit area per bonding point. 
With the postulation of the hardness proportionality to the number of bonding points N+ (: 
proportionality factor), Equation 17 was stated: 
)( 0   NNNP   
Equation 17  
 
By taking into consideration that the relative decrease in the number of non-bonding points 


N
dN
 has been assumed to change proportionally to the applied compression force and in 
connection with the relative density dc, the following equation can be proposed (: 
proportionality factor) 
rc d
N
dN
 


 
Equation 18  
 
After numerous mathematical steps and introduction of additional physicochemical powder 
technology rules the Leuenberger equation (Equation 19) is reached.  
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In a first phase, the Brinell hardness was used for this equation, but numerous authors, like 
Blattner (Blattner, et al., 1990) suggest the application with the tensile strength t, the relative 
density r and the compaction pressure . This fitting allowed the determination of the 
maximum possible tensile strength tmax at zero porosity and the pressure susceptibility t.  
      
Equation 19: Leuenberger equation 
where σtmax is the tensile strength (kg/cm
2) when P (compression pressure) → ∞ ,  ρr → 1, 
and γ is compression susceptibility. A main focus has been set to the factor , since it 
expresses the compressibility of the powder formulation.  The compactibility, defined as the 
ability of the powder to be compressed to a tablet of specific strength, is represented by the 
maximal tensile strength σtmax. 
Binary mixtures: compaction properties and percolation 
theory 
 Leuenberger (Leuenberger, 1985) proposed special additivity rules for the parameters Pmax 
and of the Leuenberger equation (with Brinell hardness) for binary mixtures. A dependence 
of the initial conditions was mentioned for the specific choice of one of the three following 
equations (Leuenberger, 1985; Leuenberger, et al., 1985): 
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Equation 20: Calculation of Pmax for binary mixtures 
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Equation 21: Calculation of Pmax for binary mixtures 
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Equation 22: Calculation of Pmax for binary mixtures 
with x as proportional load of one component in the binary mixture, P(A,B or max) as Brinell 
hardness for the respective formulation and Pww as interaction term, representing the ratio of 
adhesive to cohesive forces between unlike particles or molecules.  
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For the calculation of , the following equation was proposed by Leuenberger: 
BA xxmixture   )1()(  
Equation 23: Calculation of   for binary mixtures 
Amin and Fell (Amin, et al., 2004) investigated binary mixtures containing excipients of 
plastic/brittle and plastic/plastic deformation properties. They mentioned the possible 
definition of lower and upper percolation thresholds for the compressibility of binary powder 
mixtures containing a well compressible and a poorly compressible compound, by gradual 
increase of one compound. These percolation thresholds correlate to the critical 
concentration of the two components. Close to the percolation threshold, a significant 
disruption in the compact’s properties can be observed, either in a physical manner or 
through a noticeable change of the tablet strength. This effect is known as critical 
phenomenon.  
Amin and Fell (Amin, et al., 2004) prepared mixtures with PVC/Eudragit, PVC/MCC           
and PVC / lactose. The binary mixtures were designed with PVC-loads of 0%, 20%, 40%, 
60%, 80% and 100%.  
Irregular progression of the Pmax and could be noticed with increasing drug load and some 
significant changes were noticed at some drug loads. In general, specific critical drug loads 
were found, where the existence of a percolation threshold was strongly assumed. Even for 
binary combinations with of two plastic components, percolation thresholds could be found. 
Leuenberger, Rohera and Haas (Leuenberger, et al., 1987) investigated powder formulations 
of caffeine with PEG 4000, Sodium stearate or magnesium stearate. A smooth linear 
decrease of the -value with increasing caffeine load could be noticed in their study. This 
linearity changed significantly at some specific drug loads. These drug loads were registered 
as percolation thresholds.  
The focus of studies on binary mixtures found in the available literature sources is usually set 
to one specific mathematical equation.  
Application of the same data set to different compressibility equations with following analysis 
of the outcomes is still very rarely found in the literature.    
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Materials and Methods 
Materials 
Paracetamol (Mallinckrodt, Batch 0048992565) and mefenamic acid (Sigma-Aldrich Inc., 
Batch 093K1608) were used as active ingredients. 
Two kinds of microcrystalline cellulose (MCC 101 L, Pharmatrans Sanaq AG, Batch MC-
160802) and MCC 102G (Pharmatrans Sanaq AG, Batch 140358) were chosen as 
excipients. 
True density measurement of pure materials 
A helium pycnometer (AccuPyc 1330,Micromeritics, USA)  was used to measure the true 
density of the different powders. A repeated measurement design with three independent 
measurements was chosen to confine the experimental error. 
Density calculation of powder mixtures 
The true density of the produced powder mixtures was calculated using the obtained results 
of the true density measurements for all starting materials (see equation 24): 
100
][[%]][[%]
][
ExcipienttrueExcipientAPItrueAPI
mixturetrue
CC 


  
Equation 24 
where CAPI[%]  is the concentration of active ingredient, CExcipient [%]is the concentration of 
the excipient, true[API] and true[Excipient] are the corresponding true densities.  
In order to obtain tablets with a specific relative density, the corresponding tablet height was 
calculated using true density results of the powder mixtures. 
Particle size measurement 
Particle size in volume for all samples was measured by laser diffraction (Malvern 
Mastersizer X, Malvern, UK) using the dry method.  For each compound, the average of 
three sample measurements (mass: 5g each) was taken.   
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Design of powder formulations 
Each of the two active drugs (paracetamol or mefenamic acid) was mixed with one of the two 
excipients (MCC 101 or MCC 102). A drug concentration range of 0-100% (m/m) in 10%-
intervals was chosen for the design of the formulations, as shown in Table 2:  
Table 2: Investigated powder formulations 
API Excipient drug loads [%] 
Paracetamol MCC 101  
Paracetamol MCC 102 10 -100 
Mefenamic acid MCC 101 10% - steps 
Mefenamic acid MCC 102  
 
The formulations were prepared as follows: 
All powders were sieved (mesh size 355 m) before weighing and mixing (Turbula mixer, 
Type T2A, Willy A. Bachofen AG Maschinenfabrik, Basel, CH) for 5 min. After the second 
sieving (mesh size 355 m), the formulation was further mixed for 5 min. 
Compaction 
Tablets were prepared using a Zwick Universal Testing instrument (Type 1478TM, Zwick 
GmbH, Germany) with flat faced round punches of 11 mm diameter and a weight of 300 mg.   
The designed formulations were compressed to relative densities of 0.75; 0.82; 0.8975,     
and 0.997.  
The Zwick material tester provided the corresponding data concerning compaction force and 
ejection force for every single tablet. 
For the determination of the linear part of Heckel-Plots, some compaction tests were 
performed using a compaction simulator (Presster, Metropolitan Computing Corporation, 
USA). The chosen formulations were investigated by simulating the Korsch PH336 rotary 
tablet machine with 36 stations. A powder mass of 300 mg was added manually into the die 
without feeder and then compacted with a 10 mm flat punch to a range of final gaps between 
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upper and lower punch from 1.6mm to 4.6mm.  The corresponding compression force was 
between 0.1 and 20.0 kN. 
The dimensions of the tablet were measured with a digital calliper immediately after the 
compression. The short time frame between compaction and dimension measurement did 
not allow the elastic recovery to reach a significant value. The tablet dimension was essential 
for calculating the relative density of the tablet.  
Measurement of tablet tensile strength  
The Tablet Tester 8M, Pharmaton, Switzerland was used to measure the breaking force of 
the tablet. The corresponding tensile strength was calculated according to equation 25. 
TD
CS
TS




2
   
Equation 25
where TS is the tensile strength [N/mm2], CS is the crushing force [N], D is the diameter 
[mm], and T is the thickness [mm] of the tablet. The diameter and thickness of tablets were 
measured with a three-button digital calliper. 
Equations and concepts of Physics for the calculation       
of the outcomes 
The obtained data were analyzed according to the equations of the Heckel-Plot, the modified 
Heckel-Plot and the Leuenberger equation by using Mathematica 7.0 (Wolfram  Research 
Inc., USA), Excel (Microsoft, USA), GraphPad Prism (GraphPad Software  Inc, USA) and 
OriginPro (OriginLab Corporation, USA).  
In the theoretical section the scientific background of these equations is described in details.  
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Results and discussion 
True density and particle size measurement  
Table 3 shows the true density, the particle size average value and the median value of all 
powder compounds (incl. standard deviation between the three measurements). The true 
density of the excipients was found to be significantly higher than the true density of the 
investigated active drugs. With these data and Equation 24, the true density of the different 
powder mixtures was calculated. The average particle size was determined in the range of 
74-83 μm, except for MCC 102, where it was around 120 μm. 
Table 3: True density and particle size distribution of components 
  
                  Particle size distribution 
API True density [g/cm
3
] average [m] SD [m] median [m] SD [m] 
Paracetamol 1.2211 82.8 5.79 51.4 1.08 
Mefenamic acid 1.1641 74.1 6.05 38.4 1.83 
MCC 101 L 1.4795 83.4 2.31 73.8 0.88 
MCC 102 G 1.4345 119.7 0.15 114.1 0.53 
 
Compaction force behaviour with increasing drug load 
The behaviour of the compaction force with increasing drug load was investigated for the 
designed formulations.  
All combinations of API and excipient showed a decrease of compaction force with 
increasing drug load, except for the compaction to the relative density of 0.997. 
For the compaction to the relative density 0.75 a linear compaction force reduction with 
proportional increase of the drug load could be noticed for all investigated combinations of 
API and Excipient. For the combination of mefenamic acid and MCC 102 this linearity was 
shown for r  0.75, 0.82 and 0.8975.  
An example of this linear behaviour is given in Fig. 22, with the combination of mefenamic 
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acid and MCC 101, compressed to a relative density of 0.75.  
 
Fig. 22: Mefenamic acid drug load [%] vs. RCF [N] 
As mentioned before, an exception here was the compaction to a relative density of 0.997. 
For these tablets, the resulting compaction force did not show any logical trend with 
increasing drug load. Additionally, the standard deviation for the compaction of the same 
formulation was very high. During the compaction of a powder formulation to very low 
porosities the expected plastic deformation of the particles is more and more replaced by a 
fracture deformation. This combined occurrence of plastic and fracture deformation lead to 
this very unpredictable behaviour of the powder bed after application of such high punch 
forces.   
Outcomes of Tensile strength measurement  
For being able to further investigate the compression properties of the formulations with 
taking into consideration the noticed compaction force decrease with increasing drug load, 
the quality of the final compacts, especially the tensile strength had to be investigated.   
The tensile strength of the compacts decreased for all drug/excipient combinations with 
increasing drug load. The combinations of mefenamic acid / MCC 101 and mefenamic 
acid/MCC 102 showed a logarithmic decrease with increasing drug load. Fig. 23 shows the 
tensile strength results for the combination mefenamic acid / MCC 101. The behaviour of the 
tensile strength for the combination paracetamol/MCC 101 and paracetamol / MCC 102 
showed a decrease with increasing drug load but not in a clear logarithmic way, except for 
the tablets with relative density 0.997.  
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Fig. 23: Mefenamic acid / MCC 101: Tensile strength [MPa] vs. drug load [%]  
 
Ejection force measurement 
The ejection force showed linear increase with increasing drug load only for mefenamic acid/ 
MCC powder mixtures, compressed to high relative densities (r = 0.875;0.997). This 
confirmed the results of previous research work by Kimura et al. (Kimura, et al., 2007). For 
the other powder mixtures, there was no clear correlation between drug load and ejection 
force (data not shown). 
Calculation and Evaluation of the technical factors 
The collected compaction data allowed us to further investigate the formulations with support 
of mathematical tools in form of the Heckel-Plot, the modified Heckel-Plot and the 
Leuenberger equation. 
With the plotted equation factors, the compressibility, i.e. the ability of a powder to decrease 
in volume under pressure (with Heckel- /modified Heckel-equation and Leuenberger 
equation) and the compactibility, i.e. the ability of the powdered material to be compressed 
into a tablet of specific strength (with Leuenberger equation), were investigated for the 
different formulations.   
Since the investigated binary mixtures consisted of a poorly compressible active 
pharmaceutical ingredient and a well-compressible excipient, a compressibility decrease 
 93 
 
could be expected with increase of the active pharmaceutical ingredient. The almost linear 
decrease of the resulting compaction force and the logarithmic decrease tensile strength for 
higher loads of active pharmaceutical ingredient were clear hints for this compressibility 
reduction with rising drug load in this study.  
Compressibility parameters: factor K (Heckel-Plot),      
factor C (modified Heckel-Plot) and factor (Leuenberger 
equation) 
The factor K of the Heckel equation, the factor C of the modified Heckel equation and the 
factor of the Leuenberger equation are mentioned in the literature as quantitative 
parameters for the determination of the compound’s ductility and compressibility.  
Therefore, it was assumed and expected, that the values of these factors as well as their 
change with increasing drug load would show some logical proportionality and follow 
corresponding profiles. For a scientific substantiation of this assumption, a comparison 
between these three factors was performed. 
For a reliable calculation of the factor K, a determination of the Heckel - curve’s linear part for 
the investigated formulations had to be established.   
Therefore, some formulations, namely paracetamol 20% / MCC 101L 80%  (m/m); 
paracetamol 40% / MCC 101L 60% (m/m) and mefenamic acid 20% / MCC 101L 80% (m/m) 
were compressed into tablets within a wide area of relative densities. Since this approach 
provided us a lot of measurement points on the whole range of the Heckel-curve, the linear 
part of the plot could be distinguished very clear. Fig. 24 shows an example for this approach 
and the distinction of the linear part. The area of linearity was really comparable for all 
investigated formulations.    
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Fig. 24: Heckel-Plot for the determination of its linear part 
This finding allowed us a systematic evaluation and comparison of all calculated Heckel-
Plots.   
As a second step, the modified Heckel-equation and the Leuenberger equation were applied 
to the data set of the investigated powder formulations. This application allowed us to 
calculate the factors C and c from the modified Heckel-Plot and the factors and tmax from 
the Leuenberger equation.  
The result of these mathematical fitting steps is a numerical value of the different parameters 
for every formulation (see table 5, page 103). 
For a reliable evaluation of the outcomes, the values for factors K, C and were plotted 
against the drug load for every combination of API and Excipient. The curve progression was 
investigation in details. The main focus was set on the decrease of the factor value with 
increasing drug load.  
The Fig. 25a-d shows the values of factor K, C and for the investigated formulations and 
their progression with increasing drug load.  
 
(a) Binary mixture Paracetamol / MCC 101                       (b) Binary mixture Paracetamol / MCC 102 
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(c) Binary mixture Mefenamic acid / MCC 101                              (d) Binary mixture Mefenamic acid  / MCC 102 
 
Fig. 25: parameter values (k, C, ) vs. drug load [%] 
 
Factors K and C 
The calculated value results for  factor C  were all much smaller than the values for factor  K. 
The grade of difference was found to be about a factor between 2 and 4. This outcome is in 
good agreement to the literature values (Kuentz, et al., 2000).  
Further, the parameters K and C showed a decrease of the compressibility with increasing 
drug load (Fig. 25), which was in agreement with the theoretical expectation. The decrease 
was not linear but occurred stepwise. A main reason for this gradient is the percolation 
phenomenon, which plays a significant role here.  
For low drug loads, the settings of the powder formulations are controlled by the excipient. 
With increasing drug quantity the settings are little by little controlled by the active drug. This 
transition of the formulation parameters to be more and more similar to the active drug is not 
occurring linearly but there are specific drug loads, where an extreme changeover can be 
observed. These critical drug loads are dependent on many compound settings and factors 
and are really specific for every powder formulation. The knowledge of these critical drug 
load regions is really relevant for a formulation design and can lead to a first screening of e.g. 
the ideal drug concentration in a powder mixture. 
In the following section ―Parameter value progression with increasing drug load‖ the regions 
of higher changeover, containing the assumable percolation threshold, could be identified by 
evaluating the numerical difference of the factor values between the formulations plotting 
them against the drug load – change steps.  
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For some combinations, even an increase of the values K or C could be noticed with higher 
drug load, like paracetamol 30% - 40% with MCC 102G (m/m) and mefenamic acid 30% - 
70% with MCC 101L(m/m). For the same formulations a high standard error of the calculated 
values was noticed, e.g. for the combination of Paracetamol and MCC 102 G. Therefore it 
can be stated that this increase could have occurred due to external factors, which 
influenced the compaction process.  
The outcomes showed the difficulty of compressibility comparison for two formulations with 
similar factor values of K or C.    
Factor  
The values of parameter  (gamma) do not show any specific trend with increasing drug load. 
The data fitting faced a limitation for high drug loads. As mentioned in the paragraph 
―Outcomes of Tensile strength measurement”, the tensile strength of the final compacts 
decreased very rapidly with increasing drug load, and also the resulting compaction force 
showed lower values for higher API-concentrations. After a certain drug load, these low 
values for resulting compaction force and tensile strength made a successfull plotting of the 
Leuenberger curve to the data points  impossible. Therefore, no factor values could be 
determined for after a certain drug load.  
Nevertheless, this plotting limitation could be seen also as a indicator of a formulation 
compressibility. A formulation which need to be compressed into tablets with very low 
porosity for reaching a  sufficient hardness is the best example for a formulation with low 
compressibility. 
Very interesting is the progression of value with rising drug load. Even though, there was a 
decrease expected, no trend could be recognized. The values were really individual for every 
formulation and only the plotting limitation was a hint for a compressibility reduction.  As 
mentioned in the theoretical section an additivity rule (Equation 23) for the powder 
susceptibility  was proposed by Leuenberger (Leuenberger, 1985). Since the progression of 
 with increasing drug load did not show any linear behavior for the investigated formulations, 
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this additivity rule could not be verified in this study. 
The irregular progression of the powder susceptibility value  with increasing drug load 
matched well to the research outcomes of Amin and Fell (Amin, et al., 2004). In their study, 
irregular curve progressions with some drug load regions containing a noticeable changeover 
of value were found. Amin and Fell were suspicious that these regions contain a percolation 
threshold.   
For all investigated combinations of brittle drug and well-compressible excipient, there was 
an abrupt changeover to an impossible fitting after a certain drug load.  The highest drug 
loads of possible plotting measurement showed - values in a normal range and no 
systematic decrease could be noticed. As can be read in the following section ―Leuenberger 
equation: tmax (maximum tensile strength)‖, a tendency hint was provided only by the 
decrease of the tmax –value for higher drugloads.  
A very unique factor value progression could be noticed for the binary mixtures of 
paracetamol and MCC 102. The formulation with 50% drug load showed a much lower value 
(4.8 x 10-3 MPa) for the pressure susceptibility than the formulations with 40% and 60% 
drugload (24.68 x 10-3 MPa and 28.22 x 10-3 MPa respectively).  The reason for this low 
outcome value for the formulation with 50% drugload can be found in the corresponding 
tensile strength values of the tablets compressed with this formulation. These tensile strength 
values were significantly lower than the values for the tablets of the 40% and 60% drug 
loads..  
Even though, the susceptibility of every formulation was very specific without any big 
tendencies visible, this data point was very conspicuous. This special outcome could not be 
explained only with the percolation theory but maybe unknown external influences could 
have lead to this deviation. For the combination of paracetamol / MCC 101 an increase of the 
-value could be shown for drug loads between 40% and 70% . In the case of the mefenamic 
acid / MCC 102 – combination, a much smaller -value was shown for the 50%- and 60% - 
drug loads and a higher -value was evaluated for the 70% load. This characteristic increase 
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of the value occured due to the higher tensile strength values for this formulation.  
Effect of drug load on equation parameters   
After evaluation of the factor values with increasing drug load for the different combinations 
of API and Microcrystalline Cellulose, the focus was set to the determination of the drug load 
regions with higher decrease of these factors.  
This value decrease can be seen as powerful hint for the existence of a percolation threshold 
in this region.  
For a clear observation and evaluation of these regions, the parameter value differences 
between the drug load regions were calculated and plotted graphically. This calculation was 
performed with all the three parameters and the results were plotted together on same 
diagrams.  
The following figure illustrates these parameter differences graphically.  
 
(a) Binary mixture Paracetamol / MCC 101                         (b) Binary mixture Paracetamol / MCC 102 
 
(c) Binary mixture Mefenamic acid / MCC 101                             (d) Binary mixture Mefenamic acid  / MCC 102 
Fig. 26: Value differences between drug loads:  factor K, C [MPa 
-1
] and factor  [10-3  MPa -1] vs. drug load [%] 
Fig. 26 shows that in most cases the regions of higher value change did not match between 
the evaluated factors. Also the value decrease of the factors values did not occur in a parallel 
way. Nevertheless, there were some points recognized, where some parallel parameter 
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value change occurred. All drug load regions with higher factor value decrease are illustrated 
in the following table 4. 
Table 4: drug load regions [%] with higher factor value decrease, 
Matching between parameters: k-C italics; k-underlined; k-C-bold 
            drug load region [%] with higher factor value decrease
API Excipient k         [MPa
-1
] C        [MPa
-1
]         [10
-3
 MPa
-1
]
Paracetamol MCC 101 L 50-60 ; 90-100 10-20;50-60 20-30;30-40
Paracetamol MCC 102 G 40-50;60-70;90-100 10-20;30-40;50-60; 60-70 40-50;60-70
Mefenamic acid MCC 101 L 30-40;70-80;90-100 30-40;70-80;90-100 40-50;60-70
Mefenamic acid MCC 102 G 20-30 ;40-50;70-80;90-100 20-30 ;40-50;70-80;90-100 10-20;40-50;70-80  
For the formulations with mefenamic acid as active drug, a correlation of the regions with 
higher factor value decrease could be noticed for the factors K and C. The drug load regions 
of 40-50% and 70-80% (m/m) mefenamic acid with MCC 102 G as excipient showed a strong 
correlation even between all the three factors. 
For the binary mixtures of paracetamol with MCC 102G a correlation between the three 
factors could be found in the 60-70% (m/m) drug load region.  
Nevertheless, this correlation of all three factors could not be noticed for any other drug load 
region.    
The formulations with paracetamol as active ingredients show a correlation between K and C 
in regions 50-60% (m/m) of paracetamol with MCC 101 L. For the combination of 
paracetamol with MCC 102 G a stronger decrease of k and  was noticed at the drug load 
region of 40% (m/m) and 50% (m/m) .  
No consistency in the profile between the factors can be found for the other drug load 
regions with bigger drop in the factor values.  
As main outcome of this evaluation, we can underline the small number of correlating drug 
load regions with bigger drop in the values between the three factors. Even though, the 
experiments were performed with four different combinations of API and excipient, only three 
drug load region could be found, where this correlation occurred. 
For a systematic analysis of percolation threshold regions of binary mixtures, the outcomes 
may differ in dependence of the chosen fitting equation, at least for the investigated 
combinations of API and excipients.  
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A possible explanation of the individual way of progression of the  – value was the high 
sensitivity of the Leuenberger equation to small deviations in a data set.  
The software fitting could demonstrate the crucial change of the factor values when a small 
deviation occurs in the data set.  
Critical relative density c 
Another important factor in the modified Heckel-equation is the critical relative density c. It 
represents the relative density where a rigidity starts to evolve and a negligible mechanical 
resistance between the punches can be registered. A detailed calculation and evaluation of 
the critical relative density is performed for all designed formulations.  
The results are shown in Fig. 27. 
   
(a) Binary mixture Paracetamol / MCC 101                             (b) Binary mixture Paracetamol / MCC 102 
   
(c) Binary mixture Mefenamic acid / MCC 101                                   (d) Binary mixture Mefenamic acid  / MCC 102 
Fig. 27: Critical density critical  vs. drug load [%]:  
             progression of the investigated binary mixtures with increasing drug load 
According to Kuentz et  al. (Kuentz, et al., 1999) the c is based on the powder’s 
microstructure and for the most investigated powders, it is located between the bulk and the 
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tapped density. Since for our investigated formulations it showed a tendency of increase with 
increasing drug load, one can say that it somehow represents the brittleness of the 
investigated formulations.  
An important finding here was a parrallel increase of the critical density with decrease of 
factor C.  
One main reason for the parallelism in the outcomes is the fact, that the factors C and c 
originate form the same equation. Since the equation was fitted to both factors, a kind of 
dependence between the factors within this equation could be expected.   
Also for the critical density the higher changeover between some drug loads could be seen 
as a hint for an existing percolation threshold. No special analysis was performed here since 
these regions were identical with the regions of the value C, due to the mentioned 
parralelism. 
Leuenberger equation: tmax  (maximum tensile strength) 
With the support of the Mathematica software, the curve fitting allowed us to evaluate also 
the maximum tensile strength tmax . This factor can be seen as a numerical description of the 
formulation compactibility (Leuenberger, 1982; Leuenberger, et al., 1984), which is defined 
as the ability of the powder to be compressed to a tablet with a specific strength.  
Fig. 28 shows the values of the maximum tensile strength for the investigated formulations.  
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(a) Binary mixture Paracetamol / MCC 101                          (b) Binary mixture Paracetamol / MCC 102 
    
(c) Binary mixture Mefenamic acid / MCC 101                               (d) Binary mixture Mefenamic acid  / MCC 102 
Fig. 28: maximum tensile strength tmax  [MPa] vs. drug load [%]: 
progression of the investigated binary mixtures with increasing drug load 
 
A clear tendency of decrease with increasing drug load could be noticed for the investigated 
formulations apart from some single regions. The tendency could not be captured in a 
mathematical way since the slope of decrease was very individual for every combination of 
active drug and excipient. The combination of mefenamic acid and MCC 102 showed some 
changeover between 40% and 50% of drug load 
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Table 5: values of k [MPa
-1
], C [MPa
-1
], [10-3 MPa-1] 
API Excipient
Paracetamol MCC 101L
drug load [%] k SD (k) C SD 
10 0.01423 0.000710 0.008524 0.000837 0.006677
20 0.01433 0.000302 0.003332 0.000691 0.008395
30 0.01358 0.000768 0.002648 0.000419 0.006058
40 0.01387 0.000506 0.003287 0.000157 0.002950
50 0.01351 0.000373 0.003468 0.000127 0.004842
60 0.0085 0.000401 0.000981 0.000078 0.005877
70 0.00764 0.000283 0.001431 0.000128 0.006869
80 0.00767 0.000321 0.001074 0.000076 nfp
90 0.00809 0.000306 0.000583 0.000082 nfp
100 0.00311 0.000103 0.000539 0.000039 nfp
API Excipient
Paracetamol MCC 102G
drug load [%] k SD C SD 
10 0.01925 0.000629 0.01289 0.001046 0.007740
20 0.01879 0.000328 0.009379 0.001113 0.007048
30 0.0219 0.000465 0.01212 0.001105 0.015473
40 0.02162 0.000461 0.007383 0.000950 0.024679
50 0.01684 0.000301 0.00742 0.000319 0.004802
60 0.01607 0.000405 0.004361 0.000638 0.028216
70 0.00965 0.000280 0.002349 0.000153 nfp
80 0.00918 0.000259 0.002234 0.000117 nfp
90 0.00792 0.000373 0.000457 0.000053 nfp
100 0.00311 0.000103 0.000539 0.000039 nfp
API Excipient
Mefenamic acid MCC 101L
drug load [%] k SD C SD 
10 0.01604 0.000193 0.009392 0.000500 0.00657
20 0.01584 0.000289 0.009741 0.000565 0.006776
30 0.01575 0.000420 0.01056 0.000821 0.005979
40 0.01419 0.000376 0.007049 0.000553 0.007885
50 0.01483 0.000452 0.006744 0.000530 0.005553
60 0.01513 0.000457 0.007725 0.000584 0.004416
70 0.0158 0.000356 0.006585 0.000366 nfp
80 0.01474 0.000250 0.004813 0.000158 nfp
90 0.01472 0.000188 0.005014 0.000205 nfp
100 0.00839 0.000245 0.001573 0.000184 nfp
API Excipient
Mefenamic acid MCC 102G
drug load [%] k SD C SD 
10 0.02075 0.000383 0.01513 0.000724 0.00586
20 0.02077 0.000453 0.01494 0.000861 0.00368
30 0.01946 0.000389 0.01178 0.000864 0.004813
40 0.01953 0.000296 0.01229 0.000662 0.004862
50 0.01787 0.000392 0.008444 0.000663 0.001711
60 0.01787 0.000235 0.007301 0.000287 0.00191
70 0.0175 0.000205 0.007554 0.000473 0.003693
80 0.01558 0.000217 0.005754 0.000272 nfp
90 0.01444 0.000230 0.004382 0.000203 nfp
100 0.0084 0.000313 0.001573 0.000184 nfp  
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Evaluation of the mathematical equation factors 
In this study, each of two brittle active pharmaceutical ingredients were blended with one of 
two ductile, well compressible excipients to binary mixtures within a wide range of drug loads 
(0% - 100%).  In total, 38 different formulations were designed and  compacted to tablets of a 
relative density between 0.75 and ~ 1. The resulting compaction pressure and the hardness 
of all the produced compacts were measured and registered.  
The collected data were then evaluated with the Heckel-Plot, the modified Heckel-Plot and 
the Leuenberger equation. Each of these three equations contains a factor which is assumed 
to represent the compressibility of the investigated powder formulation. For a reliable 
compressibility determination and for the evaluation of these three equations, it was 
important to compare all the calculated factor values of the three equations individually for 
each formulation.   
By analyzing the resulting compaction force and the tensile strength of the produced tablets, 
a reduced compressibility could be noticed with increasing drug load, which was supported 
by the occurrence of very weak and crumbly compacts for formulations with higher drug 
loads. Also the augmented powder sticking at the upper punch and the die wall at higher 
drug loads was a clear hint for a low compressibility. These findings lead to the conclusion 
that compressibility reduction with increasing drug load would result in lower equation factor 
values. The value outcomes for factor C and K could confirm this expectation in most cases. 
But in some single cases the factor values stayed constant or even showed slightly higher 
values after increasing of the drug load. This could be explained only by external factors 
influencing the compaction process. Some expected deviations (Paronen, et al., 1996) in the 
true density measurement could be a feasible reason for single unexplainable factor value 
progressions with increasing drug load.  
On the other hand, the stepwise reduction of the factors K and C with increasing drug load 
instead of a linear reduction was already expected due to the percolation phenomenon. For 
every investigated combination of active pharmaceutical ingredient with excipient a higher 
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value change was expected in two drug load regions over the range of 0% to 100%. These 
regions are usually found close to the lower and upper percolation threshold. The evaluation 
of the results showed that the drug load regions with a higher changeover of the factor 
values did not always match between the two plots. Therefore a clear distinction of a lower 
and a higher threshold was not possible. 
A crucial point in the analysis of these outcomes is the investigation of the possible external 
parameters, which could influence the measurement results. The correct tablet dimension 
measurement and the determination of the linear curve region in the Heckel-Plot were the 
two main sources of error in this study. Since the tablet dimensions were measured with an 
―out of die‖- method, namely with a digital calliper, the elastic relaxation, occurring directly 
after the compaction step, was expecting to influence the factor values of the fitted plots 
(Celik, 1992; Celik, et al., 1989). In our study, this influence could be a seen as insignificant 
because the same measurement method was used for all the formulations (Denny, 2002). 
The tablet dimension measurement took place directly after the compaction, not allowing the 
tablet to relax elastically over time.   
The second important parameter is the correct and reliable detection of the linear Heckel-plot 
region, as mentioned by Denny (Denny, 2002) and Sonnergaard (Sonnergaard, 1999).  The 
determination of the linear curve region was successfully performed with support of the 
Presster-simulator. This step was in fact very crucial for our study. Without exclusion of 
tablets with very low and very high relative densities, very essential calculation deviations 
would occur for factor K.   
The limitation of fitting the compaction data to the Leuenberger equation for higher drug 
loads was a clear indication of a compressibility decrease and its occurrence on the specific 
drug load region could be seen as a hint for the upper percolation threshold. In general, the 
progression of the powder susceptibility valuewith increasing drug load was not convincing 
for representing the powder compressibility, since a value decrease with higher drug loads 
could not be shown. Also the additivity rule (Equation 23) could not be verified. This irregular 
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progression of the powder susceptibility value  with increasing drug load was also found in 
the research work of Amin and Fell (Amin, et al., 2004) with binary mixtures of plastic and 
brittle compounds.  
On the other hand, the maximal tensile strength tmax was shown to be a good and reliable 
outcome for the compactibility of the investigated powder formulation and it can be seen as a 
good hint for screening formulations which would lead to tablets with a desired hardness.  
Conclusion 
A scientific approach for the investigation and determination of a powder formulation’s 
compressibility needs an evaluation with mathematical tools by taking into consideration the 
physical nature of the powder and its compaction. A numerical measurement of the powder 
compressibility would support the design of powder formulations and their qualitative 
improvement   
In this study, binary mixtures, consisting of a well-compressible and a brittle substance, were 
evaluated with three different equations (Heckel-Plot, modified Heckel-Plot and the 
Leuenberger equation). All three plots contain a factor assumed to represent the powder 
compressibility. One main focus was set on the progress of the compressibility factor values 
with increase of the brittle drug in the binary mixture.     
The assumed compressibility factors of the Heckel- and the modified Heckel-Plot could show 
the compressibility reduction after increasing the load of the brittle compound, but since the 
compressibility reduction profiles were not comparable between the factors, none of them 
could be determined as ideal representative of the powder compressibility. Especially the 
drug load ranges within the percolation thresholds were not in agreement between the 
plotting results of the two equations for all the investigated formulations.  
The powder compressibility  of the Leuenberger equation could not determine the 
compressibility reduction of the investigated formulations with increasing drug load but the 
limited plottability, especially for brittle formulations showed the usability of this equation for a 
general compressibility distinction of a formulation.   
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The outcome of this study could show clearly that with the current scientific knowledge the 
development of a classical numerical categorization for the powder compressibility is still a 
challenge. Especially for formulations with similar compaction nature, a mathematical 
comparison of compressibility faces a lot of difficulties. 
By taking into consideration the numerous different compaction techniques and settings, the 
high probability of variation and deviation for the measurement of powder and tablet 
properties (true density, porosity, tablet volume, etc.) and the possible deviations in the raw 
material from batch to batch, the solution for an optimal investigation and prediction of a 
powder compressibility would be the choice of several mathematical equations for every 
designed formulation by considering all important process parameters.  
The behaviour of powder formulations during compression is a very challenging issue in 
tablet manufacturing and an exact lab scale investigation of the blend before the industrial 
application is very essential to understand the formulation properties and compressibility 
limits for a robust tablet production. 
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Research Project 2: Assessing compressibility 
and compactibility of powder formulations  
with Near-Infrared Spectroscopy 
Abstract 
Context 
The compressibility and compactibility of a powder formulation is usually determined by 
compaction and following destructive tensile strength and relative density measurement of 
the final compact.   
Objective 
In this study, a non-destructive method with Near-Infrared Spectroscopy was designed and 
evaluated for the measurement of powder compressibility and compactibility.  
Materials and Methods 
12 different formulations with a wide range of difference in properties were investigated by 
compaction and analysis of the resulting tablets.  Two similar tablet batches were produced 
with every formulation. Relative density and tensile strength were measured with the 
traditional, destructive method on one tablet batch while a newly developed non-destructive 
chemometric Near-Infrared Spectroscopy method was applied for the second batch.  
The outcomes of the two approaches were compared to validate the developed method. 
All data sets were applied to three established mathematical equations to calculate equation 
factors, which are claimed to represent the formulation compressibility and compactibility.  
The study focus was set on the equation factor value comparison between the traditional and 
the newly designed method.  
Results & Discussion 
The results showed a high similarity between the outcomes of the two methods. An essential 
difference was noticed for the outcomes of the equation factors after application to the 
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Leuenberger equation.   
Conclusion 
The approach with the Near-Infrared Spectroscopy is suggested as a promising tool for a 
reliable inline quality monitoring in the tablet manufacturing process.  
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Introduction 
The most common dosage form on the pharmaceutical market is the tablet. The production 
of tablets should be as economical as possible and the production should only comprise a 
few working steps (Rasenack, et al., 2002). 
Studies of tablet formation by direct compression are focused on single powders, powders 
with small percentage of binder and granulated powders.  
Since it is a big challenge to predict the compaction properties of powder mixtures from the 
properties of the individual components, a main focus has been set to the development of 
prediction techniques for a successful design of reliable powder formulations (Michrafy, et al., 
2007).  
The main prerequisite for a reliable formulation is a satisfactory compressibility of the powder 
and tensile strength of the final compact in an acceptable range.  
All the mechanisms and phenomena of powder compaction have been the subject of 
numerous research investigations and already a wide variation of compaction parameters 
and used equipment have been investigated (Celik, et al., 1989). Nevertheless, the 
compaction process is still far from being completely understood.  
Multitudinous powder properties and external factors have an impact on the quality of the 
final tablet (Rasenack, et al., 2002; Barra, et al., 1999; Nyström, et al., 1996; Ragnarsson, 
1996).  
This led in the last decades to the choice of many different approaches for characterization of 
powder compaction along with the development of numerous mathematical equations.  
The choice of the most preferable equation out of this wide collection is challenging because 
every equation can be applied only to a constricted range of compaction force and to a 
limited number of materials (Celik, 1992; van Veen, et al., 2004). 
The relative density of a compact and its tensile strength can be seen as a basic and crucial 
tablet quality characteristic.  
The relative density is assumed as the true area of contacts between particles as a result of 
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interparticulate bonds. It is usually calculated with the true density value of the powder 
(Holman, et al., 1991) and represents in an inverse way the porosity of the compact. 
The mechanical strength is a very important tablet property since it has crucial impacts on 
itspharmacokinetical and pharmacodynamical behaviour.  The strength depends on several 
processing and formulation parameters.  
An essential focus is set on this parameter for characterising the mechanical behaviour of a 
compact, as the tablet must possess a minimum mechanical strength to sustain potential 
loading during processing and handling (Michrafy, et al., 2007; Wu, et al., 2005). 
A compaction equation relates compaction elements with the applied compaction pressure. 
The initial step for fitting the data to an equation is to linearize the data and the 
corresponding plots. With this approach, comparisons between data sets are simplified and 
also the fitting parameters of the applied equations can be used for data comparison. 
Till today, numerous equations have been proposed for the analysis of the compaction 
process. While some seem to have a theoretical basis e.g. the Kawakita (Kawakita, et al., 
1970) equation, many of them are purely empirical fits of specific limited data and cannot 
claim any general validity (Denny, 2002).  
For a reliable and satisfying application of compaction equation to investigate and compare 
compression of powder formulations, an equation should not only linearize the data (Denny, 
2002).   
The parameters should relate to basic physical and mechanical properties of the compacted 
material. Ideally the equation should be allowed to be applied to all materials which are 
compacted in the same way.  
The compressibility measurement of powder formulations with support of mathematical 
equations has been since a longer time ago a main target for scientific research. The main 
principle is the analysis of quantitative data like a relation of pressure to volume reduction or 
the relation of the applied pressure to the corresponding porosity (Kawakita, et al., 1970). 
The aim of this calculation step is the determination of a linear relation and in a second step 
the comparison between powder formulations.  
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One of the most known mathematical approaches for the evaluation of tablet compressibility 
is the Heckel-equation. The detailed evaluation of the Heckel-equation was performed and 
published by J.M. Sonnergaard (Sonnergaard, 1999) and P.J. Denny (Denny, 2002). 
Celik and Marshall (Celik, et al., 1989) investigated numerous excipients by developing the 
corresponding Heckel-Plots. Nonlinearity was observed in many of these profiles, which were 
obtained under dynamic conditions.  
A modified Heckel equation was designed by Kuentz and Leuenberger (Kuentz, et al., 1999) 
which takes into consideration the pressure susceptibility, defined as decrease of porosity 
under pressure. The classical Heckel-equation assumes a constant pressure susceptibility 
while in the designed modified Heckel-equation the susceptibility corresponds to the relative 
density. Additionally, a term for the critical density has been introduced, which represents the 
specific relative density where a rigidity between the punches starts to occur. 
The ability of a powder formulation to be compressed into tablets with specified strength can 
be expressed as the formulations’ compactibility. Leuenberger developed an equation 
(Leuenberger, 1982), which includes one factor for the compressibility and one for the 
compactibility. This inclusion of the compactibility term makes this equation, the so-called 
Leuenberger equation, an attractive tool for investigating powder formulations. 
Near-infrared spectroscopy (NIRS) is an analytical technique with various applications in the 
pharmaceutical field. Major advantages of NIR spectroscopy are its non-destructive nature, 
no need for sample preparation and immediate delivery of results. NIRS has proven its ability 
to analyze intact pharmaceutical dosage forms such as tablets. 
Quantification and qualification of active pharmaceutical ingredients and other tablet 
constituents is well established (Cruz, et al., 2011; Dou, et al., 2005; Ito, et al., 2010;  
(Blanco, et al., 2000; Alvarenga, et al., 2008; Karande, et al., 2010). Tablet physical 
properties, e.g. relative density and tensile strength, contribute to high extent to NIR signal 
(Blanco, et al., 2010) and are usually considered as interferences. Various spectral 
preprocessing methods are applied to NIR spectra in order to minimize these effects (Heise, 
et al., 2002). Variations in compression force during tableting process have been reflected in 
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variable relative densities and tensile strengths of the tablets. This effect is observed in NIR 
spectra as baseline shift (Kirsch, et al., 1999;  Blanco, et al., 2006). The spectral effect 
caused by varying relative density/tensile strength could be used to quantify these tablet 
parameters (Blanco, et al., 2010;  Short, et al., 2009).  
Theoretical section 
For this study, the compaction outcomes have been plotted with the Heckel-Plot (Heckel, 
1961; Heckel, 1961), the modified Heckel-Plot (Kuentz, et al., 2000) and the Leuenberger 
equation (Leuenberger, et al., 1984; Leuenberger, 1982). 
Heckel- Plot 
The Heckel – Plot is still one of the most commonly used equation in the pharmaceutical 
compaction studies. It was published by R.W. Heckel in 1961 (Heckel, 1961; Heckel, 1961). 
In this equation, the first-order kinetics type of reaction behaviour of the voidage reduction 
with applied pressure has been approached. 
APk
D

1
1
ln
  
Equation 25  
where D is the relative density of a powder compact at pressure P. Constant k is a measure 
of the plasticity of a compressed material. 
The Constant A is related to the die filling and particle rearrangement before deformation and 
to the bonding of the discrete particles. 
Modified Heckel- Plot 
The pressure susceptibility (p) is defined as the decrease of porosity under pressure. This 
term is assumed to be constant in the Heckel-Plot.  
Kuentz and Leuenberger (Kuentz, et al., 2000) incorporated the pressure susceptibility (p) in 
their calculation and developed a modified Heckel-Plot:  
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Equation 26  
ρ is the relative density, σ is the pressure, ρc is the critical density and C is a constant, which 
is claimed to represent the compressibility of a powder.  
For the compressibility calculation of powder formulations, the constant K from the Heckel 
equation and the constant C from the modified Heckel equation can be determined.  
Well compressible, ductile and soft powders have higher values for C and K than poor 
compressible, brittle and hard powders. 
The parameterc is defined as rigidity threshold. It represents the critical relative density, 
producing a negligible mechanical resistance between the punches. With a geometrical 
focus, this threshold represents the transition point between dispersed solid in air and voids 
in a solid matrix.  
Leuenberger equation 
This equation was developed and published in the early 1980s by H. Leuenberger 
(Leuenberger, et al., 1984; Leuenberger, 1982).  
 
Equation 27 
σtmax is the tensile strength (kg/cm
2) when P (compression pressure) → ∞ ,  ρr → 1, and γ is 
compression susceptibility, expressing the compressibility of the powder formulation.  
This equation allows the compressibility to be further determined and in a second step the 
compactibilty, defined as the ability of the powder to be compressed to a tablet of specific 
strength, can be evaluated by focusing on the maximum tensile strength tmax . 
Each of these three described equations contain a specific factor which is claimed to 
represent the compressibility of the formulation.  
By fitting the measured and recorded compaction data to these three mathematical 
equations, those technical factors (k, C, ) can be calculated and evaluated.  
Since these factors represent the similar tablet quality parameter, the outcome values were 
)1(max
rett
 
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expected to show a certain proportionality between each other for the whole collection of 
formulations.  
PLS regression for evaluation of the Near-Infrared Spectroscopy signals 
Partial least squares regression (PLS regression) is a statistical method to create a linear 
regression model by projecting the predicted variables (y) and the observable variables (x) to 
a new space (Bastien, et al.). PLS finds the fundamental relations between the matrix of 
predictors (X matrix) and the matrix of responses (Y matrix), i.e. it can be seen as a latent 
variable approach to model the covariance structures in these two matrices. The goal of PLS 
regression is to predict Y from X and to describe their common structure. A PLS model to 
determine the multidimensional direction in the X space explains the maximum 
multidimensional variance direction in the Y space. PLS regression is particularly useful 
when the matrix of predictors has more variables than observations, and when there is 
multicollinearity among x values. It can analyze data with strongly collinear, correlated, noisy, 
and numerous x variables, and also simultaneously model several response variables. 
Aim of the Study 
In this paper the authors propose a NIRS method as an alternative to the conventional 
determination of tablet relative density and tensile strength. Multivariate prediction models for 
the respective tablet parameters were created. Every chosen formulation was compressed 
into tablets with different relative densities.  
As next step, the tablet parameters of tensile strength and relative density were measured 
with NIR and also in the traditional way. The data set with the values received from the NIR 
spectras and also the data of the traditional method were fitted into mathematical equations 
used for the evaluation of powder compressibility and compactibility properties. The 
outcomes of the two data set evaluations were compared and tested for potential similarity.  
With this approach, an alternative method for the assessment of compaction properties of 
powder formulations was established and evaluated. 
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Materials and Methods 
Materials 
For a reliable study of the compressibility measurement with the support of Near-Infrared 
Spectroscopy, favored excipients differing in mechanical properties (compressibility, ductile 
or brittle behaviour under pressure, disposition of sticking, etc.) were chosen to be 
investigated.  
Also binary mixtures of a poorly compressible API and a well-compressible filler were 
investigated and evaluated in this study. 
An overview list of all investigated formulations is given in the following table 6. 
Table 6: List of investigated powder formulations 
Formulation Drug load [%] 
Single powder  
MCC 101 L  
MCC 102 G  
Emcompress anhydrous  
Starch 1500  
Binary mixture  
Paracetamol / MCC 101 L 20 
Paracetamol / MCC 101 L 40 
Paracetamol / MCC 102 G 30 
Mefenamic acid / MCC 101 L 20 
Mefenamic acid / MCC 102 G 20 
Mefenamic acid / MCC 102 G 40 
Paracetamol / Parteck M 200 20 
Paracetamol / Parteck M 300 20 
 
Mefenamic acid (Sigma-Aldrich Inc., Batch 093K1608) and Paracetamol (Mallinckrodt, Batch 
0048992565) were chosen as brittle, poorly compressible API. They have both a similar 
particle size distribution. Mefenamic acid (Picciochi, et al., 2010; Adam, et al., 2000) differs 
basically from Paracetamol because of its very high tendency to stick on the die wall and the 
punches.  
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The microcrystalline celluloses MCC 101 L (Pharmatrans Sanaq AG, Basel, Switzerland) and 
MCC 102G (Pharmatrans Sanaq AG, Basel, Switzerland) were chosen as ductile, well 
compressible excipients. Both are known for their high compressibility, even they differ in 
particle size (Kothari, et al., 2002; De la Luz Reus Medina, et al.; Abdel-Hamid, et al., 2011).   
The directly compressible Mannitol products Parteck M200 and Parteck M300 (Merck KGaA, 
Darmstadt, Germany) show a plastic deformation behaviour during compaction (Abdel-
Hamid, et al., 2011).  
Anhydrous calcium hydrogen phosphate (Emcompress anhydrous, JRS Pharma, Rosenberg, 
Germany) can be used as excipient or as a calcium source in nutritional supplements. The 
predominant deformation mechanism for this powder is brittle fracture. This simplifies the 
scale-up to market production since the sensitivity to the strain-rate is reduced. However, at 
higher pressures, capping and lamination can occur. In this study, Emcompress anhydrous 
was chosen for investigating the influence of brittle deformation on the compressibility 
prediction with NIR. For the compaction of Emcompress, an external lubrification of the 
punch and die wall with Magnesium Stearate (Mg-stearate, Sandoz AG, Basel, Switzerland) 
was performed to keep the sticking tendency of the powder and the tablet ejection force on 
acceptable levels.   
Pregelatinized starch (Sta-Rx 1500, Colorcon, Idstein, Germany) is a modified starch which 
is chosen in tablet production as binder, disintegrant and diluent. Its compressibility is not 
very satisfying, but a plastic behaviour under pressure is mentioned in the literature (Ilkka, et 
al., 1993). 
A detailed overview of the individual deformation behaviour of the investigated compounds 
can be seen in the following table (information taken from Abdel-Hamid, et al., 2011).  
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Table 7: Deformation mechanisms of investigated powders 
Material  Deformation mechanism 
Paracetamol  Elastic, Brittle 
Mefenamic acid Brittle, sticky  
Microcrystalline Cellulose powder MCC 101,102 Viscoelastic  
Emcompress anhydrous powder Brittle  
Parteck M200, M300 Plastic 
Sta-Rx 1500 Plastic  
 
True density measurement  
The true density of the investigated powders was measured with an AccuPyc 1330 helium 
pycnometer (Micrometrics, Norcross, GA, USA). Values were determined as the mean of 
three or five parallel measurements. 
Design of binary powder mixtures 
All powders were sieved (mesh size 355 m) before weighting and mixing (Turbula mixer, 
Type T2A, Willy A. Bachofen AG Maschinenfabrik, Basel, CH) for 5 min. After the second 
sieving (mesh size 355 m), the formulation was mixed for further 5 min. 
Methods: Calculation of the true density for binary mixtures 
The true density of the binary mixtures was calculated using the obtained results of the true 
density measurements for all starting materials (see equation 28): 
100
][[%]][[%]
][
ExcipienttrueExcipientAPItrueAPI
mixturetrue
CC 


  
Equation 28 
where CAPI[%]  is the concentration of active ingredient, CExcipient [%]is the concentration of 
the excipient, true[API] and true[Excipient] are the corresponding true densities.  
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Partical size distribution 
A Malvern Mastersizer X (Malvern Instruments, Worcestershire, UK) was applied to 
determine the average particle size by laser diffraction. 3 measurements were performed for 
each sample. The values of mean and median particle size, the span and the specific 
surface area were detected. 
Powder compaction  
The powder compaction was operated using a mechanical compaction simulator (Presster, 
Metropolitan Computing Corporation, New Jersey, USA). The tablet press Korsch PH336 
with 36 stations was simulated. A flat-faced B-Tooling with 10mm of diameter was chosen for 
compacting tablets of 300 mg weight. The powder feeding was performed manually and an 
external lubrification was applied to prevent sticking of punches and tools during compaction.  
In a first step, some preliminary experiments were performed to determine the maximal gap, 
where a robust tablet could be produced. Then, the gap was decreased continuously in small 
steps to receive resulting compaction forces from 0.5 kN to 20.0 kN.   
For every formulation, two different compaction speeds were applied. One was 
corresponding to 100’000 tablets / hour (dwell time: 9.6 ms) and the second was 
corresponding to 216’000 tablets/hour (dwell time: 4.4 ms). A batch of around 40-80 tablets 
was produced with lower speed and one batch of around 40-80 tablets was produced with 
application of the higher speed. Every batch contained tablets with a uniformly distributed 
range of applied compaction force, from 0.5 kN to 20.0 kN. This compaction design led to a 
wide distribution of the final compacts’ relative density. 
Measurement of tablet tensile strength  
The breaking force of the produced tablets was measured with the Tablet Tester 8M (Dr. 
Schleuniger, Pharmaton, Switzerland). The tensile strength was calculated according to 
equation 29. 
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


2
   
Equation 29 
where TS is the tensile strength [N/cm2], CS is the crushing force [N], D is the diameter [cm], 
and T is the thickness [cm] of the tablet. The diameter and thickness of tablets were 
measured with a three-button digital calliper.  
NIR measurements 
Spectra were recorded in diffuse transmission measurement mode on a Fourier transform 
near infrared spectrometer NIRFlex N-500 (Büchi Labortechnik AG). A Diffuse Transmittance 
measurement module, mounted on a polarization interferometer, was equipped with tablet 
sample plate with ten iris apertures. Source of radiation was a Tungsten halogen lamp. 
Temperature controlled Indium-Galium-Arsenide (InGaAs) detector was positioned 
externally, above the sample holder. Each spectrum was an average of 64 scans at a 
resolution of 16cm-1. Spectra were scanned over the spectral range of 11520 – 6000 cm-1 
(870 – 1660nm). In total, 1381 data points were collected (Data point interval: 4, Apodisation 
for phase correction: Blackman, Photometric dynamic range: 2 AU, Wavelength accuracy: +-
0.2 cm-1, Signal to noise ratio: 10000, Number of scans per second: 2-4, Analog-Digital- 
Changer: 24 Bit). 1203 tablet spectra from 22 batches were collected by NIRWare software 
(Büchi Labortechnik AG) and further analyzed by NIRCal 5.2 chemometrics software (Büchi 
Labortechnik AG). The NIR spectras were measured 48 hours after compression and 
storage of the compacts in a glass dessicator over white silica gel beads (1-3 milimeters 
layer). 
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Model development 
Collected spectra from each batch were split into a calibration set, an internal and an 
external validation set in a proportion 25/25/50 %. Samples in all the sets were spanning the 
relative density range from 0.5 to 1.0 and tensile strength range from 0.1 to 9.4 MPa. 
Spectral preprocessing methods were applied to the raw spectra in order to reduce the 
excessive baseline variations and ordinate offsets caused by different physical properties of 
the samples and to group the spectra with similar values of analyzed tablet parameters. The 
light scattering information is correlated to the relative density and tensile strength of the 
compacts and enables the quantification of these parameters. Standard Normal Variate 
(SNV) and Normalization by Closure (ncl) were applied to reduce the scaling of the spectra 
due to very wide range of the compact porosity. Normalisation by Closure (ncl) spectral 
pretreatment is used to reduce the baseline variations due to different particle size or packing 
density differences (Martens, et al., 1989). It is a wavelength dependent pre-processing 
method. Savitsky - Golay first derivative (9 points) was used to correct for the baseline 
offsets and to minimize the noise by imposing the signal smoothing effect. 
Calibration models for the prediction of relative density and tensile strength of the tablets 
were constructed using PLS algorithm. The number of significant latent variables (LVs) was 
chosen based on the value of sum of squares of the spectral residuals (X-PRESS) assuring 
adequate reconstruction of the spectra by the models and secondly, based on the calibration 
and validation predicted residual error sum of squares (C-set and V-set PRESS), as well as 
on the values of the root mean square error of prediction of an external validation set 
(RMSEP), validation set BIAS and coefficient of determination (r2). The quality of the models 
was evaluated by calculating the root mean square error of calibration (RMSEC) and also the 
root mean square error of internal validation (RMSEV). The most important figures of merit 
were RMSEP of the external validation set and the r2. Apart from the r2, linearity was 
assessed by evaluating the slope and the intercept of the calibration line. The prediction 
residuals were tested for the normality. Durbin-Watson test was applied to the prediction 
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residuals to check if there are some evidences of serial correlations. Every model was tested 
for the outliers in both calibration and validation set by visual inspection of the scatter plots of 
the scores, Mahalanobis distances, spectral residuals and original vs. predicted property 
scatter plots. Obtained calibration models were fine-tuned by outlier exclusion and 
wavelength selection. Calibration wavelength regions were selected by observing the 
pretreated spectra, loadings and PLS regression coefficients.  
Equations and concepts of Physics for the calculation       
of the outcomes 
The obtained data sets of relative density, compaction pressure and tensile strength were 
analyzed and evaluated with the equations of the Heckel-Plot, the modified Heckel-Plot and 
the Leuenberger equation by using Mathematica 7.0 (Wolfram Research Inc., USA), Excel 
(Microsoft, USA), GraphPad Prism (GraphPad Software Inc, USA) and OriginPro (OriginLab 
Corporation, USA). For every formulation, there were two data sets evaluated, one of the 
traditional method application and a second data set obtained with the predicted method. 
Mathematical comparison of the technical factors 
An essential part in this study was the scientific evaluation of the technical factor outcomes 
obtained with the two data sets (traditional measurement vs. NIR) for every formulation.   
In a first step the obtained values of an equation factor were plotted on a two-dimensional 
diagram, where the x-axis represents the values calculated with the traditional method and 
the y-axis represents the predicted values for the different formulations.  
The similarity between the outcomes of the two methods can be declared, if the data points 
on the diagram can be fitted with a high coefficient of determination (r2) on a trendline on the 
form of the following equation 30, with values for  preferably close to 1 and a value for  
close to 0.    
  xy   
Equation 30 
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Results  
True density of components 
The following table shows the true density values of all pharmaceutical powders used in the 
investigated formulations. Since a main criterion of the component choice was the similar 
range of true density, no big deviation can be noticed between the true density values of the 
chosen components. The only exception here is Emcompress anhydrous, whose true density 
was almost double.   
Table 8: True density of components 
Powder True density [g/cm3] SD [g/cm3] 
Paracetamol 1.22 0.00 
Mefenamic acid 1.16 0.00 
MCC 101 L 1.48 0.01 
MCC 102 G 1.43 0.00 
Emcompress anhydrous 2.49 0.00 
Parteck M 200 1.52 0.00 
Parteck M 300 1.39 0.00 
Pregelatinzed starch 1500 1.50 0.00 
 
Particle size measurement 
Since the influence of the particle size was a main investigation target in this study, a focus 
was set on the particle size distribution of the investigated material.  
In the following table, the mean value and the median value (incl. standard deviation) of the 
handled compounds is shown.  
The mean particle size between the investigated compounds showed a wide range from 
74.13 μm for Mefenamic acid up to 248.70 μm for Parteck M 300.  
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Table 9: Particle size distribution of investigated compounds 
Powder Mean [m] SD [m]  Median 
[m] 
SD 
[m] 
Paracetamol 82.78 5.79  51.35 1.08 
Mefenamic acid 74.13 6.05  38.35 1.83 
MCC 101 L 83.35 2.31  73.76 0.88 
MCC 102 G 119.74 0.15  114.06 0.53 
Emcompress anhydrous 188.02 2.90  181.71 3.02 
Parteck M 200 149.22 2.55  131.15 1.99 
Parteck M 300 248.70 5.49  179.04 5.38 
Pregelatinzed starch 1500 94.90 0.03  86.51 0.16 
Powder compaction: Technical factor outcomes 
The relative density, compaction pressure and tensile strength were recorded for every 
single tablet. This data set was applied to the Heckel-Plot, the modified Heckel-Plot and the 
Leuenberger equation for fitting. With this approach, the technical factors of the plots were 
calculated.   
Table 10 shows the values for the factors k (Heckel-Plot) and C (modified Heckel) of all 
investigated powder formulations. 
The formulations Paracetamol / Parteck M200 (20% drug load) and Paracetamol Parteck 
M300 (20% drug load) could not be compacted successfully with the higher compaction 
speed since the distinctive sticking tendency of the formulations did not allow an application 
of a high compaction speed. Therefore, these formulations are skipped in the part (b) of the 
table.  
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Table 10: technical factors of the investigated formulations: (a) low speed; (b) high speed 
                          (a)        
     value k [Mpa-1]      value C [Mpa-1]
tra SD tra SD
MCC 101 (100%) 0.01289 0.0001598 0.00886 0.0009103
Paracetamol  / MCC 101 L (20%) 0.009729 0.0002309 0.002869 0.0001015
Paracetamol  / MCC 101 L (40%) 0.0101 0.0001972 0.004342 0.0000955
Mefenamic acid / MCC 101 L (20%) 0.01352 0.0003581 0.006664 0.0002033
MCC 102 G (100%) 0.01623 0.0002451 0.01273 0.0004921
Mefenamic acid / MCC 102 G (20%) 0.01439 0.0003148 0.006273 0.000537
Mefenamic acid / MCC 102 G (40%) 0.01048 0.0003815 0.00507 0.0002348
Paracetamol / MCC 102 G (30%) 0.0128 0.0001163 0.007499 0.0002061
Paracetamol / Parteck M200 (20%) 0.005413 0.000332 0.002054 0.0001315
Paracetamol  / Parteck M 300 (20%) 0.006301 0.0001224 0.002524 0.0000963
Emcompress (100%) 0.00162 0.0006309 0.000247 0.0000097
Starch 1500 (100%) 0.005043 0.0001389 0.001017 0.0000446  
    (b) 
     value k [Mpa
-1
]      value C [Mpa
-1
]
tra SD tra SD
MCC 101 (100%) 0.0126 0.0002089 0.0064 0.0001462
Paracetamol  / MCC 101 L (20%) 0.009018 0.0002466 0.00526 0.0001813
Paracetamol  / MCC 101 L (40%) 0.0107 0.0002046 0.00488 0.0001953
Mefenamic acid / MCC 101 L (20%) 0.01296 0.0004983 0.00466 0.000369
MCC 102 G (100%) 0.016 0.000709 0.01021 0.0009444
Mefenamic acid / MCC 102 G (20%) 0.01025 0.0004969 0.003378 0.0003149
Mefenamic acid / MCC 102 G (40%) 0.007095 0.0005402 0.002355 0.0003452
Paracetamol / MCC 102 G (30%) 0.01556 0.000161 0.009738 0.0004921
Emcompress (100%) 0.001657 0.0000608 0.000245 0.0000106
Starch 1500 (100%) 0.003842 0.0001623 0.001073 0.000216  
For a more convenient analysis and comparison, the outcome values were plotted on a bar 
chart (see Fig 29).  
At first sight, it could be noticed that the absolute values of k were higher than those of C for 
all investigated formulations. This was an expected outcome which fits to the literature 
(Kuentz, et al., 1999) because the mathematical structure of a plot mainly determines the 
absolute value of its factors. 
Technical factors gain only explanatory power when they are systematically collected and the 
data sets of different formulations and batches are compared.   
The value ratios between investigated formulations showed a parallel proportionality for the 
values C and values k.  
Some deviations were noticed for the formulations with MCC 101 L, compacted with the 
higher speed. In these cases, the value C was decreasing with higher drug load. In the 
meantime, the value k showed higher values with increasing drug load.  
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For the formulations with MCC 102 G and all the other single compound formulations, the 
ratios showed the expected parallel value trends for the two compaction speeds.  
In a further step, the evaluation focus was set to the factor value comparison between the 
formulations.  
For this study, some single powders, like Emcompress, Starch 1500, and a number of binary 
mixtures with a poorly compressible active drug (Mefenamic acid and Paracetamol) and 
Microcrystalline Cellulose (MCC 101 L and MCC 102 G) as filler were investigated. The main 
scientific focus was the evaluation and comparison of the technical factor values for different 
drug loads and for different single powders.  
For the binary mixtures, a decrease of the compressibility with increasing drug load was 
expected and also noticed during handling. Since the investigated factors values k (Heckel-
Plot) and C (modified Heckel-Plot) have been claimed (Heckel, 1961; Kuentz, et al., 2000;  
Leuenberger, et al., 1984; De Boer, et al., 1978) to represent the formulation compressibility, 
lower factor values were expected with increasing drug loads.    
The pure MCC 102 G showed the highest factor values of all investigated formulations, 
followed by binary mixtures (20% drug load) of MCC 102 G with Paracetamol or Mefenamic 
acid.   
Paracetamol (30%) / MCC 102 G showed higher factor values than Mefenamic acid (20%) / 
MCC 102 G. This outcome allowed us to assume a stronger negative influence of Mefenamic 
acid to the compressibility of a binary mixture than Paracetamol. 
The binary mixtures with MCC 101 L showed a confusing outcome: For the formulation with 
40% of Paracetamol some higher factor values were noticed than for the formulation with 
20% of Paracetamol. 
By assuming the factor values to represent compressibility, this outcome would show a better 
compressibility of a binary mixture after increasing the poorly compressible compound. Such 
a behaviour would not be realistic and could not be supported with literature findings. Also 
physical aspects, like the occurrence of percolation can not provide an explanation for such a 
behaviour.  
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    (a)      (b) 
Fig. 29: values k and C of investigated formulations: (a) low speed; (b) high speed 
Powder susceptibility  
The data sets of all investigated formulations was fitted to the Leuenberger equation. 
Leuenberger et al. (Leuenberger, et al., 1984) claimed the parameter powder 
susceptibility) of this equation to represent the compressibility of a formulation.  
Therefore, the outcome values for  were expected to be somehow proportional to the 
calculated values for factors k and C.  
The powder susceptibility values for the investigated formulationsare depicted in the 
following bar chart.  
  
   (a)      (b) 
Fig. 30: powder susceptibility  : (a) low speed; (b) high speed 
The factor calculation showed a high susceptibility for low speed compaction of single 
powder MCC 101 L and the high speed compaction of Mefenamic acid / MCC 101 L (20% 
drug load). For the other formulations their values were in a range between 0.0020 and 
0.0060, whereas a quiet significant standard deviation was noticed for the most formulations.  
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Even though, the single compounds of Microcrystalline Cellulose are known for their high 
compressibility the fitting outcome values were in the same order of magnitude as the 
biggest part of the formulations. 
A crucial finding was the fitting limitation for some formulations. The tensile strength values of 
the tablets compacted with these formulations showed significantly lower values than the 
tablets of the other formulations.  
The occurence of this plotting limitation is a clear hint for an essentialy low compressibility. A 
formulation which need to be compressed into tablets with very low porosity for reaching a  
sufficient hardness is the best example for a formulation with low compressibility.  
By comparing Fig. 29 with the bar charts of Fig. 30, no parallel value distribution for the 
parameter in relation to the factors k and C could be noticed.  
A possible explanation for this outcome is the different structure of the Leuenberger equation 
in comparison to the Heckel and the modified Heckel equation.  
Whereas the Heckel and modified Heckel equation have a two dimensional structure, the 
Leuenberger equation is based on a 3 –axis format.  
The additional axis arised from the tensile strength values, which are a main part of the 
Leuenberger equation, while the Heckel Plot and the modified Heckel equation are only 
considering the compression pressure and the relative density of the produced compact. 
The fitting of the data set to the Leuenberger equation uncovered a main element of this plot. 
As mentioned earlier, two compaction speeds were used in this project. For every 
formulation, one tablet batch was produced at lower speed and one batch at higher speed. 
Each batch contained around 40 to 80 tablets.  
With a data set in this size, the value of every single tablet had an essential influence on the 
curve fitting. A small change in a data set for a single tablet can lead to a big change of the 
susceptibility value after fitting.  
This could be a possible explanation for the deviation of the susceptibility values to the 
calculated numbers for the factors k and C.  
The necessity of three variables per compacted tablet instead of two in combination with the 
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high sensitivity of the curve fitting on single variable value deviations made the application of 
the Leuenberger equation to the compressibility measurement being a challenging approach 
for this project.  
Near – Infrared Spectroscopy measurement  
and model development 
 
The construction of the calibration models in this paper is given on an example of the tablets 
composed of microcrystalline cellulose 102G, manufactured using low tableting speed. After 
the spectra were recorded, as shown in Figure 31, different spectral preprocessing methods 
were applied in order to enhance the spectral data relevant to the analysis and to exclude the 
excessive scattering effect.  
 
Fig. 31: Transmittance spectra of MCC 102G tablets with increasing tensile strength and relative density 
Modeling the tablet relative density and tensile strength is based on a different degree of 
scattering between the samples but too high ordinate offsets and baseline shifts would impair 
the models. The criteria for the selection of the preprocessing method were the degree to 
which the preprocessed spectra are grouped according to the similar reference values and 
finally, the model performance (RMSEP). NIR transmittance values decreased regularly with 
an increase in the compression force applied to the powder bed as for an increase in the 
tensile strength and decrease in relative density of the tablets. Transmittance spectra were 
transformed to absorbance by Log 1/T function and it was noticed that the baselines are 
linearly shifted and no evidences of multiplicative effect were seen. The effect of the 
increasing compression force was seen as an overall spectral effect not related to the 
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specific wavelength since the tablet hardness does not have an analytical wavelength. 
Certain wavelength domains had higher correlation with the analyzed physical properties 
(r>0.90) and were selected for the construction of the calibration model. 
Tablet relative density models (Figure 32) gave the best performance when the 
Normalization by Closure (ncl) was applied, as seen in Figure 33.  
 
Fig. 32: Calibration and internal validation reference vs. predicted property  
scatter plot of MCC 102G tablet RD prediction model; In the upper left corner are the figures of model merit   
 
 
Fig. 33: Spectra of MCC 102G tablets pretreated with normalization by closure;  
The enlarged regions were used for calibration and show the grouping of the spectra according to RD. 
 
The pretreated spectra were clearly grouped according to different relative density values. 
The calibration wave-number range was selected based on the observation of the first 
loading plot (see Figure 34) and PLS regression coefficients. 
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Fig. 34: The first loading vector of MCC 102G tablet RD prediction model;  
The encircled regions carry the most spectral information and correspond to wave number regions used for calibration 
The wave-number range from 10600 cm-1 to 11520 cm-1 was excluded due to high ordinate 
offset which ncl could not account for. The best tensile strength model was obtained when 
the Standard Normal Variate (SNV) pretreatment was applied to correct for the linear 
baseline shifts and subsequently Savitsky-Golay first derivative to correct for the ordinate 
offset which enabled the wave numbers from 10600 cm-1 to 11520 cm-1 to be included in the 
calibration (see Fig. 35). The first loading vector was observed to check the wave number 
regions, i.e. variables that were modeled (see Fig. 36). 
 
Fig. 35: Spectra of MCC 102G tablets pretreated with Standard Normal Variate and Savitsky-Golay first derivative;  
The enlarged regions were used for calibration and show the grouping of the spectra according to TS. 
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Fig. 36: The first loading vector of MCC 102G tablet TS prediction model;  
The encircled regions carry the most spectral information and correspond to wave number regions used for calibration. 
After the preprocessing of the data, the spectra and the measured relative density and 
tensile strength reference values were subjected to PLS regression. The overview of the 
figures of merit of the created calibration models for all the formulations is given in table 11. 
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Table 11: Summary of the figures of merit obtained for the relative density and tensile strength calibration models 
    relative density models tensile strength models 
formulation  data pretreatment LV R2  RMSEP  data pretreatment LV R2  RMSEP 
F1 
LS ncl 2 0.997 0.0072 SNV 3 0.997 0.0908 
HS ncl 2 0.997 0.0090 ncl 2 0.998 0.1275 
F2 
LS ncl 3 0.999 0.0057 SNV, 1 D 2 0.999 0.1242 
HS ncl 3 0.993 0.0106 1 D 3 0.992 0.3099 
F3 
LS SNV 5 0.982 0.0058 SNV 2 0.923 0.0415 
HS SNV 5 0.992 0.0141 SNV 3 0.963 0.1211 
F4 
LS ncl 2 0.984 0.0101 ncl 3 0.983 0.0229 
HS ncl 5 0.973 0.0170 ncl 3 0.945 0.0336 
F5 
LS ncl 2 0.998 0.0066 SNV 2 0.999 0.0970 
HS ncl 4 0.995 0.0103 SNV 5 0.999 0.1062 
F6 
LS ncl 3 0.996 0.0105 ncl 2 0.999 0.0695 
HS ncl 4 0.997 0.0108 1 D 4 0.998 0.0917 
F7 
LS SNV 3 0.989 0.0092 ncl 2 0.992 0.0650 
HS SNV 3 0.981 0.0110 1 D 3 0.974 0.1461 
F8 
LS ncl  2 0.997 0.0062 SNV, 1 D 2 0.983 0.1530 
HS ncl 2 0.992 0.0104 SNV 4 0.988 0.2522 
F9 
LS SNV 2 0.999 0.0030 ncl  2 0.997 0.0350 
HS ncl 5 0.997 0.0090 ncl 5 0.988 0.0600 
F10 
LS ncl  2 0.998 0.0068 SNV 2 0.996 0.0582 
HS ncl 3 0.994 0.0080 SNV 4 0.985 0.0840 
F11 
LS ncl 3 0.992 0.0111 SNV 5 0.983 0.1313 
HS - - - - - - - - 
F12 
LS ncl 4 0.996 0.0077 SNV 4 0.996 0.1034 
HS - - - - - - - - 
 
  
Created calibration models were compared in terms of performance (RMSEP) and it was 
noticed that all the models for the prediction of relative density and tensile strength of the 
tablets made by high tableting speed show worse performance (higher RMSEP) comparing 
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to low tableting speed models (Figure 37). It was noticed that later models needed fewer 
latent variables to obtain the optimal model performance. This fact can be attributed to the 
poorer compaction reproducibility when the high tableting speed is applied to the powder bed 
since shorter dwell time gives less chances for particle bonding and the variations in compact 
density distribution are more pronounced (Tye, et al., 2005).  
The numerous powder formulations showed really individual compaction properties in terms 
of compressibility which enhanced the differences in the models obtained for the low and 
high tableting speed tablets. The difference in prediction accuracy was observed between 
the MCC 101L and MCC 102G. The smaller mean particle size of MCC 101L comparing to 
MCC 102G contributed to the smaller difference between the relative density (RD) and 
tensile strength (TS) prediction accuracy of the tablets compacted under low and high 
tableting speed. Small particles have higher specific surface area and higher probability of 
particle bonding and thus, are less sensitive to dwell time i.e. tableting speed. A difference in 
predictions for high and low tableting speed was observed for dicalcium phosphate tablets, 
which is attributed to the tablet density inhomogenity, i.e. picking and cracking.  
   
   (a)      (b) 
 
Fig. 37: Comparison of the RMSEP values of the external validation set relative density (a) and tensile strength (b) predictions 
for all the studied formulations; L: low tableting speed, H: high tableting speed. 
Comparison of numerical factors values,  
measured with traditional and predicted approach 
Every single tablet of the produced batches was investigated with Near-Infrared-
Spectroscopy. The measured data signal was then applied to the prediction model and the 
predicted values for relative density and tensile strength were determined and recorded.  
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In a second step, the diameter, height and hardness of the tablet were measured manually, 
which allowed us to calculate in the traditional way the relative density and the hardness of 
the tablets. 
The two data sets (traditional method and prediction model) were applied on the Heckel-Plot, 
the modified Heckel- Plot and the Leuenberger equation. With this fitting step, a calculation 
of the technical factor values of the three applied equations could be performed. 
A reliable evaluation of the designed prediction method for hardness and relative density with 
following determination of mathematical equation factor values (Heckel-Plot, modified 
Heckel-Plot and Leuenberger equation) prerequisited a scientific comparison of the final 
outcome values for the technical factors k, A, C, c, and tmax.   
Tables 12 and 13 gives an overview on the technical factor values for all investigated 
formulations. The outcomes are divided into one column for the traditional approach and one 
column for the NIR-approach.  
A significant finding was the really small difference between the fitted values of the traditional 
method and the values, determined with the designed predictive method for the factors k of 
the Heckel-Plot and C of the modified Heckel-Plot.  
The range of difference between the outcome values of the two methods was found to be 
within the standard deviation of both methods.  
This outcome similarity between the two methods is illustrated graphically in Fig. 38  
and Fig.39.   
A similar outcome could be found for the factor critical density c of the modified Heckel-Plot. 
As shown in Fig. 40 the value difference between the c of the traditional method and the 
predictive method was also very small and was found to be in the standard deviation range 
of the data sets. 
This outcome underlined the usability of the designed NIR - method for the reliable fitting of 
the used formulations to the Heckel-Plot and the modified Heckel-Plot. The particle size of 
the investigated powder did not show to influence the measurement in a negative way.  
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The comparison outcomes of the factors and tmax in Fig. 41 and Fig. 42 show some bigger 
value differences between the fitting results of the traditional and the predicted approach. 
Even though, for some formulations the value differences between the methods are very low, 
other formulations showed an essential difference between the methods.  
The reason for this difference can be explained with the three dimensional structure of the 
Leuenberger plot and also with the strong sensitivity of the fitting process to single data 
points.   
 
   (a)      (b) 
Fig. 38: low speed batches: values k (a) and C (b) of investigated formulations 
 
   (a)      (b) 
Fig. 39: high speed batches: values k (a) and C (b) of investigated formulations 
 
   (a)      (b) 
Fig. 40: critical data comparison: (a) low speed batches; (b) high speed batches 
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   (a)      (b) 
Fig. 41: gamma data comparison: (a) low speed batches; (b) high speed batches 
 
 
   (a)      (b) 
Fig. 42: tmax  data comparison: (a) low speed batches; (b) high speed batches 
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Table 12: outcomes of factor values by using the traditional (tra) approach or the developed method (pre) for low speed batches 
Low speed
Heckel equation
k 
tra SD pre SD tra SD pre SD
MCC 101 (100%) 0.0129 0.00016 0.0131 0.00018 0.6196 0.005686 0.6141 0.005827
Paracetamol  / MCC 101 L (20%) 0.0097 0.00023 0.0095 0.00027 0.9515 0.02797 0.9674 0.03324
Paracetamol  / MCC 101 L (40%) 0.0101 0.00020 0.0098 0.00033 0.9142 0.01833 0.935 0.03108
Mefenamic acid / MCC 101 L (20%) 0.0135 0.00036 0.0141 0.00090 0.7686 0.01219 0.739 0.02551
MCC 102 G (100%) 0.0162 0.00025 0.0172 0.00027 0.7778 0.01942 0.724 0.02128
Mefenamic acid / MCC 102 G (20%) 0.0144 0.00031 0.0146 0.00031 0.8257 0.02401 0.8103 0.02381
Mefenamic acid / MCC 102 G (40%) 0.0105 0.00038 0.0114 0.00032 1.205 0.04146 1.147 0.00349
Paracetamol / MCC 102 G (30%) 0.0128 0.00012 0.0126 0.00015 0.8302 0.01063 0.8371 0.014
Paracetamol / Parteck M200 (20%) 0.0054 0.00033 0.0058 0.00026 1.031 0.04882 0.9891 0.03756
Paracetamol  / Parteck M 300 (20%) 0.0063 0.00012 0.0062 0.00019 0.9484 0.01348 0.9553 0.00219
Emcompress (100%) 0.0016 0.00063 0.0016 0.00088 0.5763 0.006201 0.5814 0.008541
Starch 1500 (100%) 0.0050 0.00014 0.0055 0.00025 0.8105 0.006846 0.7839 0.01287  
Low speed
modified Heckel equation
C rcritical
tra SD pre SD tra SD pre SD
MCC 101 (100%) 0.008858 0.0009103 0.009703 0.0005259 0.1406 0.0344 0.1446 0.01911
Paracetamol  / MCC 101 L (20%) 0.002869 0.0001015 0.004728 0.0002159 0.3494 0.01054 0.3668 0.01615
Paracetamol  / MCC 101 L (40%) 0.004342 0.00009555 0.004292 0.0003808 0.401 0.007041 0.405 0.02799
Mefenamic acid / MCC 101 L (20%) 0.006664 0.0002033 0.006576 0.0005465 0.2869 0.009612 0.2864 0.02591
MCC 102 G (100%) 0.01273 0.0004921 0.01288 0.0004217 0.1145 0.02022 0.109 0.017
Mefenamic acid / MCC 102 G (20%) 0.006273 0.000537 0.006565 0.0005159 0.34 0.03353 0.3277 0.03165
Mefenamic acid / MCC 102 G (40%) 0.00507 0.0002348 0.005188 0.000234 0.4277 0.01526 0.4254 0.01502
Paracetamol / MCC 102 G (30%) 0.007499 0.0002061 0.007255 0.0002624 0.281 0.01209 0.291 0.01578
Paracetamol / Parteck M200 (20%) 0.002054 0.0001315 0.002131 0.0001315 0.442 0.01531 0.4349 0.01531
Paracetamol  / Parteck M 300 (20%) 0.002524 0.00009627 0.002413 0.00009075 0.4095 0.009965 0.4178 0.009578
Emcompress (100%) 0.0002473 9.689E-06 0.0002714 0.00007271 0.3667 0.00358 0.358 0.02421
Starch 1500 (100%) 0.001017 0.00004457 0.0008285 0.00006119 0.4608 0.007228 0.4863 0.01083
Low speed
Leuenberger equation
gamma stmax
tra SD pre SD tra SD pre SD
MCC 101 (100%) 0.0125674 0.00068575 0.0149438 0.00100839 7.31092 0.26855 6.77104 0.305785
Paracetamol  / MCC 101 L (20%) 0.00277092 0.00028592 0.002664 0.00022464 19.3791 1.46086 19.9551 1.33466
Paracetamol  / MCC 101 L (40%) 0.00180871 0.00026463 0.00172073 0.00030494 15.1827 1.91932 15.8972 1.5243
Mefenamic acid / MCC 101 L (20%) 0.0033108 0.00044002 0.00457211 0.0007182 12.9792 1.35817 10.0376 1.14665
MCC 102 G (100%) 0.00550401 0.00036034 0.00576584 0.00036034 17.0828 0.842176 16.438 0.842176
Mefenamic acid / MCC 102 G (20%) 0.00556456 0.00062708 0.00523316 0.00053796 5.79902 0.425104 6.03112 0.411804
Mefenamic acid / MCC 102 G (40%) 0.00552612 0.00085903 0.00670111 0.00602235 3.10846 0.308401 6.64314 5.29407
Paracetamol / MCC 102 G (30%) 0.0036032 0.00037179 0.00415382 0.0003549 8.20486 0.623178 7.6377 0.449094
Paracetamol / Parteck M200 (20%) 0.00331118 0.00044002 0.00260538 0.00044002 7.58712 1.35817 9.18249 1.35817
Paracetamol  / Parteck M 300 (20%) 0.00288876 0.00134468 0.00277918 0.00079557 8.84878 3.21327 9.4519 2.10216
Emcompress (100%) no fitting no fitting no fitting no fitting
Starch 1500 (100%) no fitting no fitting no fitting no fitting  
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Table 13: outcomes of factor values by using the traditional (tra) approach or the developed method (pre) for high speed batches 
Highspeed
Heckel equation
k 
tra SD pre SD tra SD pre SD
MCC 101 (100%) 0.0126 0.00021 0.0133 0.00002 0.6038 0.006316 0.5788 0.00736
Paracetamol  / MCC 101 L (20%) 0.0090 0.00025 0.0090 0.00031 0.8435 0.0323 0.8417 0.04055
Paracetamol  / MCC 101 L (40%) 0.0107 0.00020 0.0106 0.00022 0.8573 0.01609 0.8569 0.01709
Mefenamic acid / MCC 101 L (20%) 0.0130 0.00050 0.0134 0.00050 0.687 0.02717 0.6694 0.02527
MCC 102 G (100%) 0.0160 0.00071 0.0161 0.00094 0.5824 0.07407 0.5832 0.06701
Mefenamic acid / MCC 102 G (20%) 0.0103 0.00050 0.0108 0.00005 0.9561 0.04252 0.9305 0.04685
Mefenamic acid / MCC 102 G (40%) 0.0071 0.00054 0.0083 0.00042 1.221 0.05801 1.126 0.04216
Paracetamol / MCC 102 G (30%) 0.0156 0.00016 0.0154 0.00030 0.7544 0.01147 0.7752 0.01631
Emcompress (100%) 0.0017 0.00006 0.0016 0.00006 0.5658 0.00589 0.5688 0.05731
Starch 1500 (100%) 0.0038 0.00016 0.0035 0.00017 0.8692 0.01423 0.894 0.01696  
Highspeed
modified Heckel equation
C rcritical
tra SD pre SD tra SD pre SD
MCC 101 (100%) 0.006403 0.0001462 0.00618 0.0001238 0.1992 0.009304 0.2099 0.007997
Paracetamol  / MCC 101 L (20%) 0.00526 0.0001813 0.004955 0.0002648 0.2899 0.01385 0.3079 0.02068
Paracetamol  / MCC 101 L (40%) 0.00488 0.0001953 0.004752 0.0001761 0.3739 0.0137 0.3621 0.01176
Mefenamic acid / MCC 101 L (20%) 0.00466 0.000369 0.004514 0.0003011 0.3279 0.02752 0.3384 0.02274
MCC 102 G (100%) 0.01021 0.0009444 0.01007 0.0009158 0.122 0.04701 0.1267 0.03961
Mefenamic acid / MCC 102 G (20%) 0.003378 0.0003149 0.003211 0.0003774 0.4407 0.03456 0.451 0.03211
Mefenamic acid / MCC 102 G (40%) 0.002355 0.0003452 0.002278 0.0003239 0.5126 0.03159 0.5185 0.02997
Paracetamol / MCC 102 G (30%) 0.009738 0.0004921 0.009589 0.0004011 0.201 0.02412 0.209 0.01699
Emcompress (100%) 0.0002451 0.00001064 0.0002717 0.00001665 0.3667 0.003998 0.3588 0.005941
Starch 1500 (100%) 0.001073 0.000216 0.0009172 0.000208 0.4314 0.03572 0.4555 0.03657  
Highspeed
Leuenberger equation
gamma stmax
tra SD pre SD tra SD pre SD
MCC 101 (100%) 0.00147601 0.00014339 0.00092792 0.00023049 48.0388 4.26322 74.6734 17.5723
Paracetamol  / MCC 101 L (20%) 0.00276639 0.00028592 0.00279528 0.00022464 18.019 1.46086 17.8554 1.33466
Paracetamol  / MCC 101 L (40%) 0.0006 0.00027668 0.00172073 0.00027668 36.9461 2.22764 15.8972 2.22764
Mefenamic acid / MCC 101 L (20%) 0.00831021 0.00176721 0.0106034 0.00306169 6.33417 0.664641 4.72677 0.694805
MCC 102 G (100%) 0.00350423 0.00071901 0.00221382 0.00060147 20.3556 3.36363 30.7218 7.33262
Mefenamic acid / MCC 102 G (20%) 0.00608481 0.00089901 0.00596524 0.00087723 4.46376 0.422988 4.54984 0.433131
Mefenamic acid / MCC 102 G (40%) 0.00410826 0.00085495 0.00350502 0.00125187 2.40258 1.04732 2.66629 0.754081
Paracetamol / MCC 102 G (30%) 0.00422058 0.00037612 0.00217636 0.00058681 8.03293 0.516722 14.1599 3.39755
Emcompress (100%) no fitting no fitting no fitting no fitting
Starch 1500 (100%) no fitting no fitting no fitting no fitting  
For a further scientific substantiation of the found similarity of the equation factor outcomes 
between the traditional approach and the designed method with support of NIR, all the factor 
values were applied to a two – dimensional diagram. The data points were then fitted to the 
trendline according to Equation 30.  An example for this fitting step is shown in Figure 43. 
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Fig. 43: similarity evaluation of factor k for the investigated formulations 
In the following table 14 the values of  and can be seen for all investigated technical 
factors. A similarity between two data sets can be shown when  is close to 1,  is close to 0 
and especially the r2 is higher than 0.95. 
These conditions are fulfilled for the technical factors of the Heckel and the modified Heckel 
equation. The different particle size of the several chosen formulations did not show any 
influence on the reliability of the technical factor analysis with NIR.  
The factors  and tmax of the Leuenberger equation showed a significant deviation from the 
conditions for similarity. Especially the r2 – values have shown much lower values for these 
technical factors. This outcome underlines the non-similarity of the factor values for the 
Leuenberger equation between the traditional method and the approach with Near Infrared 
Spectroscopy. 
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Table 14: values of  and for the technical factors 
          (a) low speed compaction                (b) high speed compaction 
  r
2
k 1.0301 -0.00007 0.9923
A 0.95 0.0281 0.9757
C 1.0054 0.0002 0.9745
c 1.0213 -0.044 0.991
 1.2244 -0.0006 0.9727
tmax 0.8516 1.9632 0.9009   
  r
2
k 1.0076 0.0002 0.9908
A 0.8964 0.0707 0.9788
C 0.9892 -0.00009 0.9994
c 0.9997 0.0074 0.9925
 1.1682 -0.0008 0.8328
tmax 1.1952 -0.9466 0.7014
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Conclusion 
For the investigated formulations, the designed NIR method for determining the factors of the 
Heckel-Plot and the modified Heckel-Plot showed reliable results and outcomes. 
Essentially different outcome values were reached with the Near-Infrared Spectroscopy 
method for the factors of the Leuenberger equation (tmax).  
In this range of tablet numbers, the mathematical fitting to the Leuenberger equation showed 
a high sensitivity to deviations of the relative density and tensile strength of some single 
tablets.  
This sensitivity could be determined as essential reason of high outcome deviation between 
the traditional approach and the predicted method. The relatively high standard deviations of 
the calculated values for andtmax are an additional hint for this sensitivity. 
The choice of the formulations to be investigated in this study was made with the focus set 
on the different materials showing a widest possible range of particle size and a wide range 
of compression mechanisms. These factors showed not to influence the data outcomes of 
the designed method with Near-Infrared Spectroscopy.  
The newly designed method is suggested as a promising approach for a non-destructive 
compressibility measurement of powder formulations. A potential usage of Near-Infrared 
Spectroscopy inline during tablet production could be underlined with this study in a 
remarkable way.   
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Overall discussion of thesis outcomes 
The investigation of the pharmaceutical powder property ―compressibility‖ in tablet 
formulation design and manufacturing has been the main aim of this thesis. Even though, in 
the scientific world the term is clearly defined as the ability of a powder to decrease in 
volume under pressure (Leuenberger, 1982), it has been and still continues to be a crucial 
challenge to express the compressibility of a powder as a mathematical value.  
The numerical illustration of a material property, like e.g. the powder compressibility, is a 
crucial step in science, since it shows the complete understanding of this property and its 
interaction with other physical and mechanical factors. Additionally, the numerical expression 
of a material property allows scientists to further use it for research investigation of materials, 
tools, powder mixtures, mechanical devices and complex systems.  
Multitudinous trials have been made by a big number of scientists and research groups in the 
past to find the ultimate approach for a mathematical definition of the pharmaceutical powder 
compressibility. A big disadvantage of the available research studies is the fact, that the 
developed mathematical formulations were applied only to a limited number of different 
formulations and only for a certain condition of the compaction setup.  
Also the research outcomes on comparison between different mathematical approaches for 
powder compressibility determination are limited. Not to mention the gap in available 
literature for comparison of compressibility value change after slight adjustment of the 
investigated formulation between different approaches (e.g. Heckel Plot vs. Modified Heckel-
Plot).  
The research project of this thesis ―Compressibility of binary powder formulations: 
Investigation and evaluation with compaction equations‖ was targeting exactly these open 
questions by investigating binary mixtures of poor compressible API and well-compressible 
excipient and showing the differences between the results of the compressibility factor value 
by applying three different approaches (Heckel-Plot, modified Heckel-Plot, Leuenberger 
equation). Additionally, the progression of these factor values with slight adjustment of the 
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investigated formulation was investigated. Two very important outcomes could be shown with 
this investigation step: First, by increasing the amount of the poorly compressible API, the 
factor value claiming to represent the powder compressibility showed an individual 
progression without the expected regular value decrease for the three different approaches. 
Second, the progression of the factor values did not show the expected parallelism between 
the three approaches.   
In other words, it can be stated that the investigation of powder compressibility has to be 
planned, developed and performed in a careful way with clear definition of compaction 
method, compaction speed, choice of compressibility calculation approach, number of tested 
tablets and total batch size.  Especially for the comparison of different formulations, the 
consistency of these investigation factors is really important.  
In general, the research project could show that the application of the Heckel-Plot, the 
modified Heckel-Plot and the Leuenberger equation for an investigation of the compressibility 
value progression after slight adjustment of the formulation compounds is difficult to be 
recommended. The results of the factor values for the investigated formulations gave strong 
hints that the value differences between the formulations were not occurring only because of 
the physical and mechanical differences between the formulations but also because of some 
external factors which can never be kept 100% constant and also small differences of the 
physical particle nature within the same batch of the used compounds.  
The relevance of a constant compaction method for comparing the powder behaviour under 
pressure between two individual formulations could be shown in the research project  
―Assessing compressibility and compactibility of powder formulations with Near-Infrared 
Spectroscopy‖ where the powder formulations were compressed with two different tableting 
speeds, generating two different tablet batches for every powder formulation. The followed 
analysis of the two batches and application of the data to the Heckel-Plot, modified Heckel-
Plot and the Leuenberger equation showed the compressibility values to be crucially 
influenced by the tableting speed.  
Even though, this outcome is significant and important for the scientific field of solid dosage 
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forms, the main outcome of the research project was the applicability of Near-Infrared 
Spectroscopy for the measurement and monitoring of the powder compressibility (with 
Heckel-Plot and modified Heckel-Plot).  
The developed method allows the scientist to measure in a first step the relative density and 
the tensile strength of tablet without destroying the tablet. The designed method was applied 
to numerous powder formulations with a wide range of different compaction mechanisms. 
The results of the study showed the reliable applicability of the developed NIR-method for the 
investigated formulations.  
In a second step, and as a main part of this project, the detected data for relative density and 
tensile strength was applied to the Heckel-Plot, the modified Heckel-Plot and the 
Leuenberger equation. The results were really promising, since the compressibility factors for 
the NIR data application data showed similar values for the Heckel- and the modified Heckel-
Plot as the data collected with the traditional method.  
This outcome showed clearly that the developed NIR-application has an essential future 
potential for being used in commercial tablet manufacturing, quality assurance and quality 
control as a fast and reliable method for online-monitoring of the bulk compressibility, relative 
density and tensile strength of the produced tablets. The developed NIR-method is a 
sensitive tool for detecting quality deviations occurring during tablet production which can 
occur e.g. due to demixing of the formulation, higher powder formulation quality within a 
batch and incidents which change the established gap between upper and lower compaction 
punch of the tableting machine.  
A higher deviation of the relative density and the tensile strength of the tablets within a 
production batch can have a significant impact on the pharmacokinetical behaviour of the 
tablet within the patient’s GIT. Such an incident could lead in the last step to a 
pharmacodynamical effect of the active drug in the body being probably out of medical 
specification. This way, there is no guarantee that the level of the active drug in the body of 
the patient is within the therapeutical window and not too low or in the worst case too high, 
meaning toxic. 
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Such quality deviations can be prevented by guaranteeing a high quality of the raw material 
and by keeping the quality of every tablet manufacturing step on a highest possible level. 
Handling of the raw material, mixing and/or granulation, compaction, final packaging, logistic 
transportation and distribution: All these steps can have a crucial impact on the product 
quality.  
After having compacted the powder to the final tablet, its quality should be measured and 
monitored. That way, deviations in the compressibility value (hint to stronger deviation in the 
quality of the used powder), tensile strength and relative density can be reliably detected. 
The developed detection method with support of Near-Infrared Spectroscopy can be a good 
and reliable way of guaranteeing the patient a drug product of high quality and satisfying 
effect on treating the combated disease.     
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Final conclusion of thesis outcomes and outlook 
The powder compressibility is challenging to be precisely expressed since numerous 
different equations are available in the scientific literature, which claim to contain a factor 
representing the powder compressibility. The validity of these equations could be illustrated 
in the literature only for specific powder mixtures, compaction conditions and chosen tablet 
machine or compaction simulator.  
With the research results of this PhD thesis, this challenge was clearly underlined. The 
different absolute and relative compressibility values by applying different equations and 
approaches could show clearly the difficulty in the choice of the appropriate mathematical 
equation for a compressibility determination. It can be strongly assumed, that by slightly 
adjusting the compaction settings in the project 1 of this thesis, like e.g. the compaction 
speed, the outcome values for the compressibility factors would be again deviating crucially 
from the value reached with the actual conditions. Nevertheless, the role and influence of the 
numerous compaction factors is still poorly understood.  
There are still a lot of open questions, which need to be investigated and answered for a 
complete understanding and finding of a reliable mathematical approach for estimation of the 
powder compressibility.  
The physical nature of the particles within a powder formulation, the compaction setup and 
the influence of external factors can be seen as important target points for future research in 
this field.  
Even though, there has a crucial amount of research work been done in the field of powder 
compaction, the scientific knowledge is still in the fledgling state. 
The developed measurement method with support of Near-Infrared Spectroscopy showed 
really promising results. It would be interesting to see, if it can be applied to additional 
compressibility plots available in the literature.  
With the right research steps taken, one day there will be a huge number of different tablet 
properties and factors, which could be measured with support of Near-Infrared Spectroscopy. 
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This will support a lot the quality monitoring in tablet production, the optimization of the 
commercial tablet production and finally the complete understanding of the pharmaceutical 
powder compaction process. 
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